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Abstract 
An account is given of an investigation into the 
occurrence and n.ture of the bovine MHC, which is 
expressed as the bovine lymphocyte antigen (BoLA) system, 
in African and European cattle. 
A series of computer programmes was written to 
analyse, store and retrieve the data. A new means of 
clustering the reactivity of the antisera was used, which 
did not lead to "displacement" of the cluster after each 
amalgamation with a serum. 
The BoLA-typing was performed using a panel of 
antisera raised in Europe (which detected all of the 
internationally recognised BoLA specificities), and a 
panel of sera raised in Kenya during the course of the 
study. All internationally recognised specificities are 
believed to have been found in the African cattle, 
although some had significantly different frequencies in 
the two groups. Many of the European antisera which are 
operationally monospecific in Bos taurus cattle, showed 
extra activity in the African animals. There was evidence 
that two clusters (w9 and w20) could not be reliably 
detected in the African cattle with the reagents 
available. 
Monoclonal antibodies were informative when used as 
typing reagents, particularly in the elucidation of sub-
groups. The future role of such reagents in BoLA-typing 
seems great. 
Evidence was obtained for sub-groups of w8 and wlO. 
Five new BoLA-A locus alleles were detected by means of 
antisera prepared in Kenya. Two of these occurred at an 
extremely high frequency in African cattle, one being 
unique to these cattle. There was tentative evidence for 
MHC antigens whose expression was not controlled by the 
BoLA-A locus. 
Two broad groups of African cattle were tested, 
Borans and Zebus. Borans may not have any Ba1 taurt 
blood but have been intensively selected for beef 
production. The frequency of some BoLA specificities, 
which differed between the European and Zebu cattle, was 
intermediate in the Borans. In other cases, the frequency 
of specificities in the Borans more closely resembled that 
of the European animals than that of the Zebus. The 
possibility is discussed that relatively intensive 
selection of the Borans has shifted their BoLA profile. 
The results of this study were entirely consistent 
with the hypothesis that the bovine MHC is exposed to 
natural selection. It may therefore be of value in a 
programme of breeding aimed at increasing productivity 
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Chapter 1 
INTRODUCTION AND LITERATURE REVIEW 
Work on several species, particularly the human and 
the mouse, has provided a mass of evidence that the major 
hist.ocompatibility complex (MHC) plays a fundamental role 
in the regulation of the immune response (reviewed by Klein 
et al, 1983). Study of the human MHC has reached the 
point where decisions about diagnosis and treatment 
strategy of a number of diseases are influenced by the MHC 
genotype of the patient (Terasaki, 1980). In Europe, 
cattle are of great economic significance and a comparable 
knowledge would have considerable impact on the efficiency 
of the beef and dairy industries. This has prompted a 
number of groups to study the bovine MHC. All have so far 
concentrated their efforts on European cattle. 
In Africa, where annual food production is declining 
and the population increasing (Trail et a!, 1985), the 
value of such information would be even greater. Cattle 
are a vital means of generating protein, particularly in 
the semi-arid regions (Pratt and Gwynne, 1977). However, 
cattle are excluded from vast tracts of land by 
trypanosomiasis, while in other areas East Coast Fever 
causes high calf mortality, reduced productivity and 
4 
precludes the useLsusceptiDle breeds (Ristic arid McIntyre. 
1981; Irvin at al 	191 	If he etfecLs of these cc other 
diseases could be reduced by a breeding strategy based 
upon exploitation of certain MHC genes with given 
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characteristics, the increase in available food could be 
great. 
Before an attempt to look for associations between 
MI-iC phenotype and disease susceptibility may be made, it is 
necessary to be able to identify the MHC products. In 
European cattle, the gene frequency of unidentified 
class I alleles (the "null allele frequency) in several 
breeds has a mean of about 30% (Oliver et al, 1981; Anon, 
1982). In East Africa, preliminary studies showed that 
the frequency of the null allele was considerably higher 
than this and also that many sera which were operationally 
monospecific in Europe, contained extra antibody 
populations which caused reactions not due to the single 
specificity that the sera detected in European animals. 
This study was begun with the object of improving the 
definition of the MHC of East African cattle using 
conventional serology, the only approach so-far available 
that will allow rapid and inexpensive screening of large 
numbers of animals and of applying the new reagents in a 
population study of the indigenous breeds. 
1. Introduction 
The structure of the maj2f_Liistocomp !E~~ .ILD .11 .11: y_SgLnpl!2?~ 
In man the MHC is expressed as the HLA system. In 
the mouse it is known as the H-2 system. These are the 
two most fully understood MHC's and they are extremely 
similar to each other. Their products may be divided into 
two major groups, class I and class II, although there are 
genes within the MHC which are responsible for control of 
some complement components and these are sometimes 
considered to form a third class of MHC genes (Klein et. 
al, 1983). 
The - c lass _ I i. Y £ 
The serological identification of H-2 class I alleles 
was greatly facilitated by the microlymphocytotoxicity 
test of Gorer and O'Gorman (1956). This test makes use of 
the complement-dependent cytotoxicity of alloantisera 
which are specific for the products of particular MHC 
alleles. 	It is the basis of the serological tests which 
have been used ever since. 
The class I products of every species studied are 
glycoproteins of much the same form. The structure of the 
H-2 and HLA class I products is reviewed by Floegh et al. 
(1981). 	They comprise a membrane-embedded, glycosylated 
heavy chain in tight, but non-covalent association with a 
Beta-2-microglobulin molecule. The bulk of the molecule 
is extracellular but part of the heavy chain extends 
through the membrane and protrudes into the cytoplasm. 
3 
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The molecular weight of the heavy chain is 44,000 to 
48,000 daltons. The molecular weight of the Beta-2-
microglobulin is approximately 11,500 daltons, Beta-2-
microglobulin is not encoded within the HLA region 
(Goodfellow et al. 1975). There is significant sequence 
homology between the products of the HLA class I loci and 
those of the mouse, guinea pig and chicken (Silver, 1976; 
Longenecker and Mosmann, 1981; Ploegh et. al, 1981). These 
antigens are expressed on virtually every cell of an 
animal (Klein et a]. 1983). 
An outstanding characteristic of the MHC products of 
many species is their polymorphism. For example, the 
number of presently recognised alleles for the human 




(Bodmer and Bodmer, 1984a). 
In respect of this polymorphism, the MI-IC differs from 
almost every other known polymorphic system in which there 
are one or two very common alleles and a few much rarer 
ones (Dausset, 1981a). 
Some HLA alleles are more common than others and 
some are characteristic of certain populations (eg. 
Terasaki, 1980). The proportion of individuals who are 
heterozygous at the HLA A. B and D loci is greater than 
80% (Bodmer and Bodmer, 1978). There is considerable 
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debate over the origin of this polymorphism but it is 
becoming accepted that it is a reflection of the function 
of the MI-IC (Zinkernagel and Doherty, 1979). 
The products of the class I loci are highly antigenic 
and they are responsible for rapid allograft rejection 
(Klein et al, 1983). They have been shown to be involved 
in cellular interactions, particularly those involving 
cytolytic T-cells (CTL) (Doherty et al, 1976). 
The class II products were first detected by the use 
of the mixed lymphocyte culture (MLC) test (Bach and 
Hirschhorn, 1964; Bach and Voynow, 1966). They are thus 
sometimes known as lymphocyte defined (LD) loci. In man, 
the region which controls the response in an MLC was named 
HLA-D (Thorsby and Piazza, 1975). Subsequently, a series 
of antigens closely associated with HLA-D was detected 
serologically. These were known as HLA-DR (for D related) 
antigens (van Rood et al, 1977). 
The HLA-D region has since been shown to comprise at 
least three regions DP, DO and DR, each of which contains 
several loci (Bodmer and Bodmer, 1984a). The products of 
the DR and DO regions are defined both serologically and 
by MLC response. Those of the DP region are only detected 
by MLC (Bach, 1985). Monoclonal antibodies have proved to 
be of particular value in the serological definition of 
the HLA class II alleles (Bodmer and Bodmer, 1984a). 
5 
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The tissue distribution of the HLA class II products 
is different from that of the class I products in that 
they are expressed on the surface of a limited range of 
cell types, particularly macrophages, B-cells, and to a 
lesser extent, T-cells (Hammerlinq et a!, 1974; McDevitt, 
1978). Under certain conditions however many cell types 
can be induced to express class II products, for example 
human T-lymphocytes will express such antigens at a 
density comparable to that of B-cells following 
stimulation by antigens or mitogens (Evans et, 	, 1978, 
Zier and Zmijewski, 1984). 
Like class I products, the class II products show 
considerable polymorphism. By analysis of MLC, a total of 
25 class II alleles have been described and 16 antigens 
have been serologically defined (Bodmer and Bodmer, 1984a). 
The class II products seem to have a particularly 
important role in antigen presentation (Klein et a!, 
1981), which is in contrast to class I products which 
exert their greatest influence on CTL. 
1. Introduction 
There is a great deal of evidence that the MHC has an 
important function. Resistance or susceptibility to many 
diseases is related to the MHC phenotype of the 
individual, particularly in chickens (Collins et. al, 1977; 
Longenecker and Mosmann, 1981; Collins and Zsigray, 1984) 
and man, where findings of great significance to genetic 
counselling and clinical strategy have been made (reviews 
in Terasaki, 1980; Bodmer and Bodmer, 1984a). It was 
proposed by Dausset (1981a) that each MHC haplotype 
possesses a range of characteristics of resistance and 
susceptibility. For example the HLA-A3, 87, DR2 haplotype 
is associated with susceptibility to multiple sclerosis 
and protects against insulin-dependent juvenile diabetes. 
Further evidence that the study of BoLA is crucial to 
an understanding of the bovine immune system is provided 
by the role played by the MHC of other species in a rariqe 
of cellular interactions. For instance, H-2 class I 
products were shown to influence the ability of cytolytic 
T-cells to destroy virus-infected cells (Doherty et. a]., 
1976) and TNP-modified cells (Shearer et al, 1975; Forman, 
1975). Similar phenomena were subsequently shown with 
several species and several viral pathogens (Zinkernagel 
and Doherty, 1979). 
Class II products have been shown to control the 
collaboration between murine T and B cells, which is 
frequently required before B-cells can begin to produce an 
7 
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antibody response (Kindred and Shreffler, 1972; Katz et 
al, 1973a; 1973b). Similar interactions have since been 
suggested in the chicken (Vainio et al, 1984). Class II 
products also restrict antigen presentation by macrophages 
(reviewed by Munro and Waldman, 1978). 
i 
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The evidence that the MHC is  exp2E2q_ .~ q natural selection 
If the MHC is of as great significance as its 
associations with disease resistance and its involvement 
in a range of in vitro phenomena suggest, then it would be 
expected to show evidence that it is exposed to natural 
selection. There is a great deal of such evidence. 
jtq_p2jyM2Lptism of the MHC 
Possibly the most striking feature of the MHC is its 
polymorphism. Does this reflect selective pressures which 
favour a wide variety of alleles, or is it the result of 
the random drift of genes with products whose precise form 
is irrelevant to the fitness of the individual carrying 
them? There are a limited number of ways in which 
polymorphism may be maintained in a population. 
Neutral genes 
One of these is the effect of neutral genes 
(Lewontin, 1974; Nei, 1975). 	If the survival value of 
one allele is exactly the same as that of another allele, 
then their frequency in a population will be determined by 
chance alone. This situation may arise either because 
different alleles produce equally effective products, or 
because the locus has no function. 
Ohta (1976) discussed the effect of multiple, very 
slightly deleterious mutations in the maintenance of 
polymorphism, and concluded that mutations which have an 
1. Introduction 
effect on the fitness of an individual of less than 1% may 
play a part in the maintenance of polymorphism. This 
model however applies to large numbers of rare alleles and 
could not account for the large numbers of alleles with 
relatively high frequencies that are seen in the MHC. 
Disruptive selection 
Another way in which polymorphism may be maintained 
is by disruptive or apostatic selection. This is 
selection against the majority phenotype so that the 
fitness of an allele will not depend solely upon its own 
characteristics, but also upon its frequency in the 
population. This type of selection has been shown to 
occur in a number of predator/prey interactions where a 
predator acquires an increased ability to detect the 
common phenotype (Clark, 1969; Allen, 1976). A 
population which is polymorphic for a characteristic which 
forms part of the predator's "searching image' is less 
heavily predated than one which is monomorphic (Moment, 
1962; Croze, 1970). The nature of the resultant 
polymorphism will depend on the nature of the selecting 
factors and the nature of the alleles which are being 
selected. The crucial aspect of this type of selection, 
and the way in which it differs from those discussed 
below, is that it will tend to produce a specific, 
divergent population structure. The survival value of 
each allele is influenced by the presence of every other 




Heterozygote advantage is another phenomenon which 
may result in a balanced polymorphism. This is seen where 
the heterozygote has a selective advantage over the 
homozygote. 
Although population studies (Degos et a!, 1974) have 
not produced clear answers, there is evidence that 
heterozygote advantage occurs in HLA. The frequency of 
homozyqotes at the HLA-A. B, C and DR loci at the ninth 
HLA workshop was significantly below the level that would 
be expected if there was no heterozygote advantage (Klitz 
et al,1984). 
Differential chances of successful_repfgdgction 
Polymorphism may also be maintained by non-random 
mating or by interactions between the mother and foetus 
which favour differences between the haplotypes of the 
two. There is evidence that mice of different MHC types 
preferentially mate with each other (Yamazaki et a!, 
1976; 1978) and it is clear that mice can detect H-2 
differences between corigenic individuals by odour alone 
and that they can learn to distinguish recombinations 
within the H-2 region (Boyse, 1983). Rosenberg et a! 
(1983) reported the results of investigations into the HLA 
type of mating couples and found that there was a greater 
frequency of couples with identical HLA-A and B types than 
would be expected by chance. However, this may well be 
due to the influence of race and ethnic origin. 
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There is however, evidence (reviewed by Johnson, 
1982) that spontaneous abortions of unknown cause occur 
more often when the parents are of very similar HLA type 
that is, they share more than 3 alleles at HLA-A, B, C and 
DR. This would provide a mechanism for heterozygote 
advantage. An investigation by MacQueen and Sanfilippo 
(1984), based on the result of HLA-typings at one American 
laboratory, failed to support this suggestion but their 
study was based on relating the number of children per 
family to the HLA type of their parents and this would be 
expected to be an insensitive approach, particularly in 
America where family size is a very poor measure of 
fertility. 
Further evidence that the MHC has been exposed to 
selection is provided by the high linkage disequilibria 
which are characteristic of many HLA haplotypes (Grange et 
al, 1984) For instance, in some populations, the HLA 
A1/B8 haplotype frequency is more than four times greater 
than the product of the Al and B8 gene frequencies (Bodmer 
and Bodmer, 1978). 
Many alleles show this sort of linkage 
disequilibrium. Many linkage disequilibria are 
characteristic of certain populations (Pickbourne et a!, 
1978) and some alleles are more often in linkage 
disequilibrium than others (Bodmer and Bodmer, 1978). It 
is also clear that alleles of the HLA-B and HLA-C loci are 
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more often in linkaqe disequilibrium than alleles of other 
loci (Bodmer and Bodrner, 1978). Bodmer and Bodmer (1978) 
calculate that 66.5% of B/C haplotypes are due to linkage 
disequilibrium, while 21.7% of A/B and 34.3% of B/DR 
combinations result from this phenomenon. 
It is known (Jennings, 1917; Robbins, 1918) that in 
a random mating population at equilibrium and under no 
selective pressure, the linkage disequilibrium between 
any two loci will be zero. If it were not zero, then it 
would approach zero under such conditions at a rate of l-r 
per generation, where r is the recombination fraction of 
the loci. 
This being so, any linkage disequilibrium in a 
population must be the result of selection, non-random 
mating, or an effect of linkage which will eventually 
vanish. Since the value of r for HLA loci is small 
(Bodmer, 1984), any of the above factors will rapidly lead 
to significant linkage disequilibrium. Many A/B and B/D 
combinations are found in separate Caucasoid populations 
which diverged more than 5,000 years ago (Bodmer and 
Bodmer, 1978). This is strong evidence that these 
disequilibria result from selection, since 5,000 years 
would be more than enough time for these effects to vanish 




The function of the MHC 
The polymorphism, linkage disequilibria and species 
homology of the MHC appear to provide clear evidence that 
the MHC has been under strong selective pressure and 
therefore probably fulfills an important role. The 
attempts to explain this role as a means of preventing 
antigenic mimicry by pathogenic organisms were never well 
argued (reviewed by Longenecker and Mosmann, 1981) and 
such effects, if they exist, are not today considered 
significant. There is today only one group of theories 
which begins to suggest a function for the MHC which can 
account for its form, and these centre around the role of 
the MHC in interactions between cells of the immune 
system. 
T-cell interactions 
The demonstration (Doherty and Zirikernagel 1974; 
Zinkernaqel and Doherty, 1974a) that the ability of immune 
T-cells to kill virus infected target cells is MHC 
restricted, led to speculation that the polymorphism of 
the MHC is a result of the differential ability of the 
immune system to respond to certain viral antigens when 
they were associated with certain MHC antigens (Doherty 
and Zinkernaqel, 1975; Zinkernagel and Doherty 1974b). 
Early interpretations of this phenomenon invoked class I-
linked immune response (Ir) genes (reviewed by Adams and 
Brandon, 1981). However there is no need to look beyond 
the presently recognised class I products themselves to 
14 
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account for differences between individuals in their 
CTL/target cell interactions. 
The nature of the T-cell receptor, which makes the 
recognition of pathogen antigen in conjunction with an MHC 
product, has been the subject of much debate (reviewed by 
Matzinger, 1981). It is becoming widely accepted that one 
receptor is responsible for the detection of a single, 
pathogen-modified, self MHC antigen (or a non-self MHC 
product alone in the case of alloreactivity) (reviewed by 
Teale et. al, 1985a). Essentially then, the MHC is being 
seen as a means of marking changes in the antigenic nature 
of a cell. 
Since the basic structure of all MHC class I products 
is the same (Ploegh et al, 1981), it is not surprising 
that a non-self MHC antigen causes cytotoxicity in the 
same way as an altered self antigen. Which of these was 
the primordial role of the MHC is an interesting question. 
There is evidence of an MHC-like system in sponges, which 
may be analogous to the ancestral MHC, the function of 
this system appears to be the prevention of natural 
allografts (Curtis et al, 1982; Scofield et al, 1982). 
However, in modern vertebrates alloreactivity probably has 
no natural function. 
This model requires that different pathogen antigens 
are more readily seen against some MHC "backgrounds' than 
others. There is convincing evidence for this in the 
mouse where, for example, the ability of a strain to 
15 
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respond to vaccinia virus and lymphocytic choriomeningitis 
virus is influenced by genes of the class-I region 
(reviewed by Zinkernagel and Doherty, 1979). This 
hypothesis does not itself account for the conservation in 
evolution of the MI-IC products and it remains possible that 
the products of the MHC perform a greater role than simply 
acting as markers of infected or aberrant cells. The 
model does however explain the polymorphism of the MHC. 
The respqp ~2_2f the MHC to selection 
If it is accepted that each set of MHC alleles 
confers a particular set of disease resistance 
characteristics onto the individual bearing them, then a 
number of predictions may be made about the expected 
appearance of the MHC in a given population. 
Populations will tend to become polymorphic for MI-IC 
alleles because an individual will have a greater chance 
of surviving a given disease if it is heterozygous. Under 
a stable disease challenge, heterozygote advantage alone 
would tend to produce a population of individuals which 
are heterozygous for the alleles which confer greatest 
advantage in the face of diseases which are exerting the 
greatest selective pressures. Those few alleles would 
become fixed and less favourable ones would be lost. 
However, most diseases exert a selection which is 
frequency dependent. Under such a challenge, an 
individual in a population which is largely composed of 
susceptible members will suffer to a disproportionately 
16 
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greater extent than an individual in a population with few 
such members. This is because many diseases require rapid 
transmission between individuals to persist. This is 
particularly true of diseases with a high mortality since 
the pathogens must find a new host rapidly. Such diseases 
obviously also represent powerful selective pressures. 
Given a set of diseases which select in a frequency 
dependent manner and given alleles which have different 
characteristics of resistance to each, the resulting 
population structure would be a mosaic of different 
alleles. The exact form of the mosaic would depend on the 
nature of the disease challenge, the number of challenging 
diseases and the selective pressure that each exerts. 
It is not surprising that most of the associations 
seen between MHC and disease involve rare diseases and 
diseases of old age (reviewed in Albert et al, 1984). 
This is further evidence that the MHC does play a part in 
determining resistance characteristics. If each allele 
confers a characteristic set of resistances and 
susceptibilities, then when one allele became fixed in a 
population due to its beneficial effects it will carry 
with it a set of deleterious effects. These effects would 
become masked by a set of genes, which would accumulate 
around it in high linkage disequilibria to produce the 
optimal set of characteristics. The only deleterious 
effects of an allele which would not in time acquire such 
a set of linked genes are those which are not exposed to 
17 
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selection. Such effects are those which appear after 
reproductive age or which very rarely appear. 
Thus the explanation of MHC function based on the 
model of T-cell killing explains very well two of the most 
striking features of this region, its polymorphism and its 
linkage disequilibria. It also suggests that associations 
between MI-iC and a powerfully selecting disease will easily 
be seen only in those populations which have not been 
exposed to the disease for many generations. This is 
because MHC genes are inherited in large closely-linked 
groups and if each product has a given set of 
characteristics then it will be very difficult to 
determine the significance of each for any one disease by 
means of a population study. The only study that might 
have been expected to overcome this problem (de Vries, 
1979) did show evidence of such associations despite very 
unfavourable experimental conditions. The ideal 
experiment would involve the large-scale exposure of 
populations of known MI-IC type to a novel disease 
challenge. Obviously there would be some ethical 
difficulties in doing this with a human population. 
However, in East Africa, European cattle are frequently 
exposed to an environment that their ancestors have never 
experienced. This would seem to present a unique 
opportunity for this type of experiment. It was one of 
the main reasons for embarking upon this study. 
There is good reason to believe that an investigation 
of the bovine MI-IC may ultimately be of value to cattle 
18 
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breeding programmes by identifying BoLA alleles with given 
disease resistance characteristics. An understanding of, 
and an ability to identify, BoLA alleles is also essential 
to many investigations of the bovine immune system. An 
example is in the study of immunity to Theileria parasites 
where there is growing evidence that CTL are important in 
the immune response (Morrison et. al. 1985). 
19 
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m uc - 	- ci 
As well as mice, men and cattle, an MHC has been 
described in the chimpanzee (Balner e t 	1971a; 1971b; 
1974), the rhesus monkey (Balner et. al, 1971c), the guinea 
pig (Eliman et al, 1970; Schwartz et a!, 1976), the goat 
(van Dam, 1981), the rabbit (Tissot and Cohen, 1972; Chai, 
1974), the rat (Palm, 1964; Stark et a!, 1967), the pig 
(Vaiman et. al, 1970; 1972), the dog (Vriesendorp et al, 
1971; 1972), the chicken (Longenecker and Mosmann, 1981; 
Simonsen et a!, 1982), the hamster (Palm et a!, 1967), the 
sheep (Ford, 1974; Millot, 1978; Stear and Spooner, 1981) 
and the horse (Lazary et a!, 1980a and 1980b; 
Mottironi et. a!, 1981). 
These early studies emphasised homology of the MHC 
between species. However, recently evidence has appeared 
that the MHC's of some species are significantly different 
from the human and murine systems. It has been shown that 
although the Syrian hamster has at least two loci which 
express antigens homologous to the class I products of 
other species (Darden and Streilein, 1984), these products are 
monomorphic, or at least non-antigenic to conspecifics 
(Duncan et al. 1977 and 1980). This monomorphism may 
explain the inability of Zinkernaqel and Doherty (1979) to 
show MHC restricted T-cell killing in the hamster. Ohno 
and Wallace (1983) suggest that the monomorphism of the 
hamster implies that the MI-IC is redundant and that its 
conservation in other species is a result of chance. 
However, the hamster is unusual in that it leads a 
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solitary life and is exposed to little or no selection by 
viruses (Streilein et al, 1984) and it may be that these 
unusual conditions allowed a monomorphic population to 
survive following a severe population bottleneck. A 
species which has a similar ecology, the mole-rat, has 
been shown to have a highly polymorphic MI-IC (Nizetic et 
al, 1984), but there may be significant differences in the 
disease challenge faced by the two species and in their 
ancestry. 
The domestic cat shows evidence of a monomorphic 
class I MHC (Pollack et al, 1982) and the cheetah has been 
shown to be tolerant of allografts and also to have 
dramatically less polymorphism at many loci other than the 
MHC (O'Brien et al, 1985). It may be that this is due to 
recent bottlenecks in both populations, but it is 
interesting that two species of cat should both show an 
unusual MHC and also that both are particularly 
susceptible to viral pathogens ( Pollack et a!, 1982; 
O'Brien et a!, 1985). It would seem extremely worthwhile 
to examine the MHC, and other loci, in more members of the 
Fel idae. 
Other species which show evidence of unusual MHC 
expression are the dog, which may have only one class I 
locus, limited polymorphism and a broad tissue 
distribution of class II products (van der Feltz and 
Ploegh, 1984) and the rabbit, where there is good evidence 
of a single class I locus (Marche et. a!, 1985). 
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However, despite these differences there does appear 
to be an MHC in all mammals with products which are highly 
homologous to the human and murine products and even 
amphibians (Xerious) show such molecules (Flanjnik et al, 
1984). The differences between species should not however 
be ignored for they may provide valuable clues to the 
function and evolution of the MHC. 
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The bovine MHC 
The first evidence for an MHC in cattle was the 
demonstration of anti-lymphocyte activity in the sera of 
cattle which had received whole bovine blood innoculations 
(Borovska and Demant, 1967). Subsequently, McGary and 
Stone (1970), Ostrand-Rosenberg and Stormont (1974) and 
Folger and Hines (1976) reported allogeneic anti-bovine-
lymphocyte sera. 
The-bovine .class_I_pL2duSts 
In a brief report Schmid and Cwik (1972) claimed to 
have demonstrated the presence of 28 lymphocyte and 37 
granulocyte antigens on cattle leukocytes. They used 
typing sera produced by immunising cattle with cattle 
lymphocytes. Iha et al (1973) reported the cross-
reactivity of cattle-anti-cattle lymphocyte sera with HLA 
and other human antigens. This suggested that the sera 
were directed against the bovine MI-IC since many anti-MHC 
sera have been found to cross-react with MI-IC antigens in 
several species (Ivanyi, 1981). 
A small population study was made by Caldwell et aj 
(1977) who reported the results of testing lymphocytes of 
103 Holstein cattle against 11 alloant.isera. Four of 
these sera were made by lymphocyte innoculation and seven 
were parous sera. They suggested that cattle lymphocyte 
antigens were highly polymorphic and heritable. 
Caldwell and Cumberland (1978) presented evidence 
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that one of their clusters of typing sera appeared to 
detect a specificity which was more common in a herd of 
cattle with a high incidence of ocular squamous cell 
carcinoma than in a herd with a low incidence. However 
this difference does not persist when numbers of cattle 
showing lesions are compared with unaffected animals. 
There have been no further reports of such an association 
and it seems that the differences in antigen frequency 
between the herds were unrelated to this carcinoma. 
Comparison of almost any two herds will yield significant 
differences in BoLA antigen frequency (Oliver et al, 
1981). 
A strong argument that the antigens on lymphocytes 
which were detected by sera made by alloimmunisation were 
indeed the bovine MHC was made by Spooner et al (1978). 
They pointed out that the associations between MHC and 
disease susceptibility in other species provide a strong 
incentive to conduct this work in such an economically 
important group as cattle. They set out to produce highly 
specific alloantisera in order to simplify the 
interpretation of the results. They described, for the 
first time, the production of antisera by reciprocal skin 
grafts between dam/calf pairs. In this way they were able 
to reduce the number of foreign antigens to which the 
recipient was exposed, since half of the grafts genome 
was identical to that of the recipient. They produced 
high titre antisera (most were between 1/32 and 1/256, 
whereas most parous sera have titres below 1/32). These 
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workers also made extensive use of lymphocyte absorption 
to produce a panel of "operationally monospecific" 
antisera. Using a panel of 70 sera in one study and 35 in 
another they examined the segregation of 18 antigenic 
factors in 249 half sibling families. These families 
showed segregation of the 18 factors as co-dominant 
alleles at a single locus. A number of factors appeared 
to be inherited together and it was suggested that this 
may be due to linked loci but it is possible that it was 
due to cross-reactive antisera. 
Amorena and Stone (1978) describe the use of 67 anti-
lymphocyte antisera. They assigned each serum to one of 
11 groups on the basis of their reactions with cells from 
over 900 cattle of 60 sire families. They concluded that 
each of the 11 groups was detecting a single antigen and 
that the antigens were controlled by the alleles of a 
single locus. They proposed to call this locus the BoLA-A 
locus. They investigated the distribution of these 
alleles in 931 cattle of 5 dairy breeds and reported 
differences in the frequency of alleles between breeds. 
They performed skin grafting experiments on three cows 
which were matched with respect to these 11 alleles. 
Although the details of rejection times are not reported, 
rejection was delayed in BoLA-matched cattle by comparison 
with BoLA mismatched cattle. 
Further evidence that the BoLA system is highly 
polymorphic was provided by Caldwell et a! (1979). Their 
report, the only published work on the MHC of Bos indicus 
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type cattle, showed a higher frequency of undetectable 
products in Brahman/Hereford crosses than in any of the 
five Bos taurus breeds tested. These authors also 
referred to the first international meeting of 
laboratories working on the bovine MHC, which was held in 
France in 1977. This meeting was the first in a series 
which has contributed enormously to the understanding of 
the bovine MHC by allowing laboratories to compare the 
performance of their sera and to ensure a standardised 
nomenclature. 
Following the meeting in France, the first 
international BoLA workshop was held in Edinburgh in 1978 
(Spooner et. al, 1979a). Nine laboratories contributed a 
total of 249 sera which were tested in Edinburgh against a 
panel of 130 cattle of 21 breeds. The reactions of the 
sera were clustered by various methods and 11 of these 
clusters were assigned workshop specificities, prefixed by 
"w" to show their provisional nature. The agreed 
specificities were: 
wi 	................. 12 animals detected by 5 antisera 
w2 ................. 36 animals detected by 8 antisera 
w5 .................. 9 animals detected by 7 antisera 
w6 ................. 40 animals detected by 9 antisera 
w7 ................. 12 animals detected by 4 antisera 
w8 ................. 15 animals detected by 11 antisera 
w9 .................. 5 animals detected by 3 antisera 
wlO ................ 18 animals detected by 7 antisera 
wil 	................. 7 animals detected by 6 antisera 
w16 ................. 2 animals detected by 6 antisera 
w20 ................ 13 animals detected by 3 antisera 
By this system none of the animals tested had more 
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than two specificities. 11% of them had no specificity. 
48% had one and 41% had two. Since they were not a random 
selection, no attempt was made to compare frequencies of 
the specificities between breeds. 
The workshop also showed that the way in which the 
lymphocytotoxicity test is performed affects the result. 
Many sera were made by laboratories using slightly 
different test techniques to those used in the workshop, 
particularly in the amount of rabbit serum used as a 
source of complement. It is also clear that different 
batches of complement have different characteristics, a 
fact which has also been reported in relation to HLA-DR 
typing (Middleton, 1981). These variables may explain the 
poor repeatability of the reactions of many sera, and the 
fact that only 75% of sera gave any reaction at all. This 
was one of the reasons why the second workshop exchanged 
cells rather than sera. The meeting decided that the 
putative genetic region controlling the expression of 
these antigens be called the BoLA (bovine lymphocyte 
antigen) region. 
A study of the response of cattle to skin grafts was 
made by Spooner et. a! (1979b). It showed that grafting is 
a reliable means of producing high titre antisera and that 
the main activity of an antiserum produced by grafting is 
directed against a BoLA specificity of the donor. This 
report also illustrates the value of lymphocyte absorption 
of antisera to demonstrate operational monospecificity. 
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Absorption analysis of 18 sera which detected seven 
of the agreed BoLA specificities was carried out by 
Spooner et al (1980). All clusters except w9 showed 
evidence of sub-groups. That is, they contained sera 
whose reactivity was broader than most other sera of a 
cluster but which were still operationally monospecific. 
It was not clear whether these "tails" were due to true 
sub-groups detected by the less reactive sera, or to 
polyspecificity in the more reactive sera. Another 
possible explanation of a sub-group is the presence of an 
allele at a second locus in high linkage disequilibrium 
with the allele defined by the narrower sera. The 
extensive cross absorption studies of these workers did 
however, strongly support the conclusions of the BoLA 
workshop in the assigning of specificities to these 
clusters. 
Spooner and Brown (1980) reported the results of the 
BoLA typing of cell-lines infected by the protbzoan 
parasites Theileria parva and Theileria annulata. They 
showed that the BoLA types of the line donors were 
identical to those of the derived cell-lines and that the 
BoLA type of the lines remained constant with time and 
with the multiplication of the cells. There was one 
exception, which was subsequently shown to be due to the 
presence of a minor lymphocyte population in a chimaera 
(Teale et al, 1983). 
A family study of seven breeds (Oliver et al, 1981) 
provided further evidence that the 11 BoLA specificities 
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were in fact alleles at a single locus. 142 matings from 
15 bulls provided evidence that there was a significant 
difference between the frequency of these alleles both 
between breeds and between sexes. Differences between 
breeds are not surprising since European cattle breeds are 
genetically rather isolated from each other. The 
differences between sexes is harder to explain, but it may 
well be that the males were less closely related to each 
other than the females. 
In 1980 the second international BoLA comparison test 
was held in Wageninqen, Holland (Anon, 1982). Sixty 
lymphocyte preparations from USA, 60 from Edinburgh and 24 
from France were distributed to five laboratories for 
testing. 130 sera from five USA laboratories were tested 
in Texas and four European laboratories tested their own 
232 sera, a total of 362 sera. The results were analysed 
independently by two laboratories. This meeting confirmed 
the presence of all of the specificities agreed at the 
first workshop except wi, which was however allowed to 
stand. In addition, four new specificities were defined: 
w3 ..................... 5 animals defined by 3 sera 
w4 ..................... 7 animals defined by 2 sera 
w12 ................... 10 animals defined by 3 sera 
w13 .................... 4 animals defined by 4 sera 
Two sub-groups of w6 were also defined: 
w6.1 ...................8 animals defined by 	5 sera 
w6.2 ..................11 animals defined by 3 sera 
In this test 12% of the cells had no specificities, 
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45% had one and 43% had two. The agreement between the 
results of the two workshops was extremely good where 
cells had been tested in both. The second workshop did 
not provide any evidence of a second class I locus. This 
is perhaps surprising and it may reflect a real difference 
between the BoLA system and the MFIC of mouse and man. 
Many laboratories tested sera of narrow specificity which 
did not appear to cluster with sera from any other 
laboratories and so could not be considered to define a 
specificity. It may be that some of these were detecting 
antigens controlled by a second locus. The fact that no 
other laboratories produced sera which clustered with them 
may be because the antigens are more highly polymorphic, 
of restricted geographical distribution, are poorly 
antigenic, or any combination of these. 
There is strong evidence that the BoLA antigens 
described by the above reports are the bovine equivalent 
of the MLA and H-2 class I antigens. In addition to their 
polymorphism, the cross-reactivity of anti-BoLA antisera 
with HLA antigens (Iha et al, 1973) and the effect of BoLA 
matching on graft rejection times (Amorena and Stone, 
1978), there is evidence that the biochemical structure of 
the BoLA-A antigens is similar to that of the MHC antigens 
of other species (Fioang-Xuan et al, 1982a). This report 
showed that the structure precipitated by an anti-w16-
antiserum was a 44,000 molecular weight glycoprotein in 
non-covalent association with a smaller polypeptide of 
molecular weight 12,000. 
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There is also evidence that the BoLA products are of 
importance to the immune response of cattle. It has been 
shown (Teale, 1983; Dolan et al, 1984) that the anti-
Theileria immunogenicity of Theileria infected cell lines 
correlates with the degree of sharing of BoLA-A locus 
products between cell line and recipient. The mechanism of 
infectivity of this parasite is poorly understood 
(reviewed by Irvin et al, 1981) and the interpretation of 
this observation is not easy. Lowered immunogenicity may 
result from a simple rapid graft rejection phenomenon. 
Further proof that the BoLA antigens are important in the 
immune system has come with very clear evidence (Morrison 
et al, 1985) that CTL from cattle undergoing challenge by 
Theileria parya have a cytotoxicity which in vitro is 
restricted by products of the BoLA-A locus. 
There is some preliminary evidence of an association 
between haemolytic complement levels and BoLA type 
(Spooner and Lie, 1982). There is also evidence of close 
linkage between BoLA w16 and the M' red-cell antigen, this 
appears to persist in different European breeds and 
recombinants may have been observed (Leveziel , 1982) 
An important addition to the understanding of BoLA 
has come with the demonstration that at least some of the 
antigens detected by workshop agreed clusters can act as 
targets for MLC-generated CTL (Teale et a!, 1985a; 1985b). 
This is the case with the class I alleles of other species 
(eg. Nabholz et al. 1974) and thus the belief that the 
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BoLA class I alleles are the equivalents of those of HLA 
and H-2 is supported and the definition of the workshop 
specificities is confirmed. While BoLA-specific CTL 
cannot be considered as routine typing reagents they will 
certainly provide an extremely powerful means of analysing 
the validity of serologically defined clusters and 
suggesting means of improving typing reagents. These 
cells have since been cloned and maintained in culture for 
long periods (Teale, personal communication) and can 
provide a unique source of monoclonal bovine-anti-bovine 
reagents. 
THE BOVINE CLASS II GENES 
The evidence for the presence and nature of a bovine 
class II locus is much more limited than that for the 
class I locus. Usinger et a! (1977) demonstrated a bovine 
mixed lymphocyte response. Spooner et a! (1978) reported 
groups of class I-matched full siblings which were 
mutually non-reactive in the MLC while they were highly 
stimulated by their dams. Later, Usinger et a! (1981) 
confirmed that the locus controlling the MLR (which they 
called the BoLA-D locus) was closely linked to the BoLA-A 
locus. This was done by the use of large, full sibling 
families obtained by embryo transplantation. They showed 
that full siblings which shared class I alleles also 
shared class II alleles (that is they were mutual non-
stimulators in the MLR). This suggests linkage between 
the loci, but until more data are collected and 
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recombinants identified, it is not possible to be more 
precise about their relative location. 
There is evidence (Newman et a!, 1982) for the 
existence of antigens which appear to occur predominantly 
on bovine peripheral blood B-cells. This was obtained by 
the simultaneous use of a vital stain to identify dead 
cells and a fluorescent label to identify cells bearing 
immunoglobulin on their surface. 
An attempt to examine the structure of bovine class 
II gene products was made by Hoang-Xuan et a! (1982b). 
These authors used anti-HLA class II product-monoclonal 
antibodies and anti H-2-class II product-antisera to 
identify antigens in bovine lymphocytes. They showed that 
such molecules are structurally similar to murine and 
human class II antigens. It remains to be shown that 
these are functional equivalents of the human and murine 
class II molecules and that they they are involved in the 
bovine MLC response. It would be valuable to attempt 
blocking of the MLC with the antisera which precipitate 
these molecules. 
A monoclonal antibody has been described (Letesson et. 
a!, 1983) which detected a determinant on bovine B-cells 
but not T-cells; which is polymorphic, but probably 
supertypic in that it reacted with cells from 138 of 177 
cattle. The molecule precipitated by this antibody was 
shown to be structurally similar to the murine and human 
class II antigens. This is confirmation of the report of 
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Hoang-Xuan et a! (1982b) and the fact that the reagent 
used detected a polymorphic determinant strengthens the 
argument that there is a polymorphic bovine equivalent to 
the HLA-D region. 
Thus it seems clear that there are genes in cattle 
which are linked to the BoLA-A locus and whose products 
control MLC response. There is also good evidence that 
there are antigens with a structure, tissue distribution 
and polymorphism similar to that of the class II products 
of other species. This is powerful evidence for a bovine 
class-II region but there has not yet been a serious 
attempt to define its products. It would be particularly 
important to attempt a correlation between the 
serologically detected B-cell antigens and MLC reactivity. 
There have been reports of monoclonal antibodies 
(MoAbs) which appear to have BoLA specificity (Chardon et. 
a!, 1982; Spooner and Finder, 1983). In no case have 
these reagents consistently shown the same specificity as 
a workshop cluster or even an alloant.iserum. There are, 
however, no reports of systematic attempts to generate 
MoAbs for use as BoLA typing reagents, although Stone 
(1981) comments upon the desirability of such an approach. 
The recent HLA comparison test showed a major contribution 
by MoAbs to both class I and class II serology (Albert et 
a!, 1984) and it would seem that the serological 
definition of BoLA has reached a stage where such tools 
could be of great value, particularly in the definition of 
class II products. Their major advantage over 
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alloantisera is that they are available in unlimited 
quantity. 
Much work remains to be done on BoLA, but so far the 
only major difference between the bovine MHC and that of 
mouse and man, is the evidence that the bovine class I 
products may be under the control of a single locus. It 
seems highly likely that further class I loci will be 
revealed, but it is possible that they will be rather 
different from those of other species. Perhaps they are 
very closely linked to the BoLA-A locus or perhaps their 
products are much less antigenic than those of BoLA-A. 
It is probably true to say that every laboratory 
working in the BoLA field believes that they have sera 
which detect the products of a second (or third) BoLA 
class I locus and some have published reports which appear 
to support this belief (Stear et a!, 1982b). However, 
serology alone cannot provide sufficient information for 
the definition of a secohd locus. The identification of 
recombinants and the sequential precipitation of antigen 
molecules are two approaches which may be expected to 
yield such evidence. 
It may be significant that the method of approach of 
the invesigators of BoLA has been rather different from 
that of their H-2 and HLA counterparts. This is partly 
due to the differences in the species; studies on mice 
lend themselves to intensive genetic manipulation by 
carefully controlled breeding programmes. This is 
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impossible in the human field although here records of 
ancestry and medical records are often very good, and 
human breeding is much more random than cattle breeding. 
The study of BoLA has been characterised by the 
preparation of antisera with extremely good specificity, 
made possible by the ability to collect large volumes of 
blood for serum and absorption and by the use of planned 
immunisations. BoLA workers have also made use of 
international comparison tests in the same way as the HLA 
groups. It is likely that, without either one of 
these, the literature would abound with reports of 
multiple BoLA loci. 
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The origin and characteristics of the cattle 
The orig 	o__.b_ cattle L Africa  
The classification and origin of the cattle of Africa 
has been the subject of a number of reviews, notably those 
by Epstein (1971) and Mason and Maule (1960). Both of 
these studies relied heavily on physiological and 
anatomical characteristics in an attempt to trace the 
development of the cattle populations. The biochemical 
evidence which could prove useful in such a study is very 
limited. Baker and Manwell (1980) reviewed the literature 
on the biochemical polymorphisms of cattle. The very 
scanty information largely supports the basic ideas of 
both Mason and Maule (1960) and of Epstein (1971). 
European breeds are believed to be a result of 
successive migrations and specialised selection, based 
upon the longhorn type which derives from the wild ox Bos 
rirnigenius, with subsequent additions from the 
shorthorned Brachyceros type (Mason, 1976). 
Further human selection, combined with natural 
selection for fitness in hot and dry country, produced an 
animal in Baluchistan and Mesopotamia which was derived 
from the prirnigenius type but which had a large cervico-
thoracic hump and a long, hanging dewlap (Epstein, 1971). 
This is the Zebu. Zebus entered Africa in two waves, the 
first arrived between 1,000 years BC and 50 years AD. 
They interbred with the earlier longhorns to form the 
Sanga, which have small humps and long horns. The Sanga 
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moved into central and Southern Africa. 
The second wave of Zebus have thoracic humps and 
began to enter Africa in the 4th century AD. The major 
importations, however, did not begin until the Arab 
invasions which began in 669 AD. This second wave of 
Zebus displaced the Sanga in large areas, although in 
places Sanga/Zebu crosses seem to have been formed which 
still survive. The Zebus moved into West Africa, where a 
number of intermediate types were formed by crosses with 
the local humpless cattle. The Fulani breeds seem to be 
of this Zebu/longhorn mixture. 
The spread of the Zebu over Africa is attributed by 
Mason (1976) to a superior milk yield and to its 
adaptation to tropical and sub-tropical climates. He 
asserts that they are more resistant than European breeds 
to drought, parasite challenge and a low nutritional 
plane. The Sanga was finally eliminated from Kenya by the 
rinderpest epidemic of 1890, for it appears to be more 
susceptible than the Zebu. Humpless cattle now remain 
only in the cooler areas of Africa and in the tsetse belt 
of West Africa, where they appear to be more 
trypanotolerant than other types (Murray et a!, 1984a; 
1984b). The relationship between the two waves of Zebus, 
the humpless cattle of West Africa and the European breeds 
is thus not fully known. It may be that successive 
domestications of the wild ox followed by intensive 
selection separates all of these groups. 
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Recently, attempts have been made to exploit European 
cattle in Africa. These attempts have only been 
successful where intensive disease control techniques have 
been used. European cattle of the Bos taurus type are 
unable to survive in most of Africa without this type of 
management 
T!i _P 	!L _Y_! 	1! _2JflY 
The cattle found in Kenya today are largely of Zebu 
type. The small East African Zebu is the commonest form 
(Mason and Maule, 1960). These are stocky, shorthorned 
cattle, rather variable in size and colour. There is much 
local variation. The cattle owned by the Maasai tribe for 
instance, are larger and heavier than most. Even within 
the Maasai cattle there is great variation, which is 
presumably due, at least in part, to effects of nutrition 
and disease. 
The second major Zebu group in Kenya is the Boran. 
The Kenyan Boran is a rather highly selected animal used 
principally for beef production. It derives from cattle 
brought into Kenya by Somali traders and sold to European 
farmers, the Maasai and the Meru. The "improved Boran' is 
the result of intensive selection for beef production, and 
may contain some Bos taurus blood. The Boran appears to 
be generally more resistant to heat and drought than 
European breeds, but it is more susceptible to these 
factors and to some diseases than the small East African 
Zebu (Young and Dolan, personal communication). 
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Disease resistance characteristics of African cattle 
There is a growing body of opinion that there are 
real differences in the specific disease resistance and in 
resistance to heat, drought and exercise stress between 
the different types of cattle. 
For example, it has been established that Zebus are 
usually more resistant than European cattle to ticks, as 
judged by the numbers of female ticks engorging ( Seifert, 
1971; Wharton et al, 1973). It is also known that there 
is considerable heritable variation within a type 
(Seifert, 1971). 
It is also clear that there is considerable variation 
between breeds in their trypanotolerance. NDama cattle 
have been shown to be more trypanotolerant than Zebus as 
have West African shorthorns (reviewed by Murray et a!, 
1984a and 1984b). 
Frisch (1975) and Dodt (1977) showed that Bos 
taurus/Bos indicus crosses and pure Bos indicus animals 
suffer less often and less severely from infectious 
kerato-conjunctivitis than pure Bos taurus animals. Adams 
t al (1979) quote evidence that different breeds show 
different levels of resistance to brucellosis, babesiosis 
and tuberculosis. 
Clearly, there are major differences between various 
breeds of cattle in a range of characteristics. The 
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The African environment 
The environment faced by African cattle is likely to 
influence their performance and to exert a major selective 
pressure. The selective pressure exerted by the 
environment can be considered to have three major 
components; physical pressures due to climate, physical 
pressures due to management and exploitation, and disease 
pressures - which will be influenced by the first two. 
The climate and_veg2tation 
The climate and vegetation of East Africa is 
discussed in detail by Pratt and Gwynne (1977). It is 
characterised by large variations in temperature, 
rainfall, evaporation and vegetation. Rangeland, defined 
as "land carrying natural or semi-natural vegetation which 
St 
provides a habitat suitable for herds of wild ungulates 
(Pratt et al, 1966), represents 87% of Kenya's 569,260 
square km. Much of Kenya's surface is defined by Pratt 
and Gwynne (1977) as eco-climatic zone V. This is land 
which is too dry for agriculture or forestry, it is 
mostly the territory of pastoral tribes and is sparsely 
occupied. In Kenya, large areas have been taken over for 
the use of wild animals. The vegetation is mostly thorn 
bush-land, Cornmihora woodland and grassland and rainfall 
seldom exceeds evaporation. Most regions experience two 
peaks of rainfall, one in April and one in November. 
Day-time temperatures are consistently above 30 degrees 
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Centigrade and at niqht do not fall far below 20 degrees 
Centigrade. 
In North Western Kenya, there is an area (about a 
quarter of Kenya's land area) which is classified as eco-
climatic zone VI, semi-desert. This is a region of 
intense heat and desiccating conditions, annual rainfall 
seldom exceeds 300 mm, while evaporation is frequently 
greater than 3,000 mm. The mean daily maximum temperature 
of this region is between 32 and 37 degrees Centigrade. 
The dry season is associated with hot, drying winds. This 
land is occupied solely by pastoral tribes which survive 
by "nomadism and expediency" 
Apart from the small area of barren Afro-Alpine land 
(eco-climatic zone I) around Mount Kenya, the remaining 
quarter of Kenya's land is of eco-climatic zones II-IV. 
This is a much less demanding climate than that found in 
zones V and VI. Zone II is humid to dry sub-humid and is 
characterised by forest, grassland and bushland. Zone III 
is dry sub-humid to semi-arid which is not suitable for 
forestry but carries a vegetation of moist woodland, 
bushland or savanna. Large areas are under range-type 
cattle management: some areas are more intensively stocked 
and some are under crops. 
Zone IV land is of marginal agricultural potential 
carrying dry forms of woodland and savanna. Some regions 
carry high densities of wild-life and it will generally 
carry cattle at about half the stocking rate of zone III 
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land, that is, at about 4 hectares per stock unit. 
Traditional managgMEnt_2f cattle 
Cattle in East Africa fulfil a wide range of 
functions. This makes it very difficult to estimate their 
productivity in simple terms. The role of cattle in the 
traditional society is reviewed by Chavunduka (1976). He 
describes their spiritual role, their role as currency and 
their role as a source of traction. In addition to these 
functions they supply meat, milk and blood. Since most 
cattle are eventually eaten, beef production is part of 
their function, even when they are kept principally for 
milk (Mason, 1976). 
As a result of these considerations, cattle have 
rarely been selected in the same way in Africa as they 
have in Europe. Many pastoralists would rather have a 
large herd of small cattle than a small herd of large 
cattle, regardless of their performance. This serves as a 
means of insurance against catastrophic loss due to 
drought or disease and is also influenced by the 
traditional regard of wealth in terms of cattle numbers. 
European selection is characterised by heavy culling of 
less productive individuals, while in Africa an animal is 
rarely culled while it can walk. On the other hand, there 
is some selection by selective castration of bulls and by 
allowing only selected bulls to mate. The selection is 
normally done by choosing those bulls which produce good 
calves or whose daughters are good milk producers. How 
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thoroughly and consistently this is done is hard to judge, 
but it will certainly play a part in governing the genetic 
make up of a herd. 
Disease challeng2 
The disease challenge faced by African cattle is 
generally very much greater than that faced by European 
breeds. Little detailed information is available. 
However, it is clear that ticks, tick-born diseases and 
trypanosoiniasis are major constraints on cattle 
productivity in East Africa (Irvin et Al, 1981; Ristic 
and McIntyre, 1981; Murray et a!, 1984a ). 
45 
1. Introduction 
There is overwhelming evidence that the MHC plays a 
crucial role in the immune response of an individual. 
There is a great deal of work on the ruminant immune 
system presently being performed, much of it in African 
cattle because these animals are severely limited by a 
range of diseases (Morrison, 1985). Many aspects of 
this work require an ability to define BoLA products if 
they are to make further progress. 
African cattle have been under intensive and highly 
localised disease challenge for many generations and they 
have generally not been selected strongly by man. 
Therefore, Africa and particularly East Africa with its 
wide range of cattle types and environments, appears to be 
an ideal place to begin a search for associations between 
the MHC and fitness for a given environment, both because 
such information would have its greatest value here and 
because associations are expected to be easily seen. 
If MHC haplotypes could be identified which confer 
resistance (or which do not confer susceptibility) to a 
particular disease, they would be of enormous value in 
organising a breeding programme aimed at improving the 
productivity of African livestock. The large areas of 
East Africa which are unsuited to the production of crops 
and to intensie European-style cattle breeding are a 
resource which is presently under-used. Tourism is the 
only product of some areas while others are entirely 
46 
1. Introduction 
unproductive. Less arid land does carry cattle but their 
productivity is severely limited by environmental 
factors, particularly disease. An attempt to raise the 
productivity of this land by improving the performance of 
cattle under such conditions would be worthwhile and the 
MHC may well have a major part to play. Certainly it is 
the only known genetic marker with any hope of providing 
information on the performance of animals in the face of 
disease. 
Preliminary work on the serology of Kenyan Bos 
indicus breeds using sera produced in European cattle, 
showed that these sera were inadequate for the definition 
of the MHC in African cattle. Therefore, before any 
attempt to investigate the role of the MHC in African 
cattle was possible, it was necessary to raise new 
antisera, investigate anew the reactivity of the existing 
ones and to make a large scale attempt to use these 
reagents to characterise the MHC of East African cattle. 
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MATERIALS AND METHODS 
Cattle 
The cattle used in the study are described in table 
2.1. The results of BoLA typing a total of 1,678 cattle 
are reported here. They were from a wide variety of herds 
in a wide variety of climatic regions. Figure 2.1 shows 
the areas from which the Kenyan cattle came. 
Six hundred and sixty two Borans were BoLA typed. 
They were from one of two sources; 592 were from the 
Kapiti Plains Estate. This is a large ranch on the plains 
about 60 Km from Nairobi. The eco-climatic classification 
of this area according to Pratt and Gwynne (1977) is zone 
4 - semi-arid. The remaining 70 Borans were from a group 
in the Trans Mara district of Western Kenya. All of the 
Borans were of the type described by Epstein (1971) as 
"improved". The Trans Mara Borans were all bought from 
Rumuruti in central Kenya. The origin of the Kapiti herd 
is not fully known, but it probably also came in large 
part from the Rumuruti area. The Kapiti herd is probably 
rather in-bred but is large, containing 1000 breeding 
females and approximately 40 active bulls. 
A total of 606 animals of "Zebu type" were also BoLA 
typed. These were a much more mixed group than the 
Borans. Sixty two were from the Kafue flats in Zambia. 
They are certainly a representative sample from this area 
having been collected from a large number of different 
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herds. Another 148 Zebus were originally from the Orma 
tribes who live in the arid regions around the Tana River 
in Eastern Kenya. There is good evidence that these 
cattle, which live under a high trypanosome challenge, are 
more trypanotolerant than Borans (Ismail et al, 1985). 
Ninety Zebus were from the Galana Ranch in South Eastern 
Kenya. This is another arid region with a high 
trypanosome challenge. A total of 116 Zebus were from the 
Kaisut Desert in Northern Kenya. They were obtained from 
the local Samburu tribesmen and were from several 
different herds. This is a semi-desert region with low 
disease challenge but extremely hot and dry. Camels are 
tending to replace cattle as livestock for milk, meat and 
transport in this region. The remaining 190 Zebus were 
from the Trans Mara district of Kenya. They were Maasai 
owned and came from many different herds. 
Forty nine Sahiwal/Friesian crosses were tested. 
These came from the Trans Mara district of Western Kenya. 
They were kept under ranch conditions. 
Ten N'dama calves, brought to the International 
Laboratory for Research on Animal Diseases (ILRAD) from 
The Gambia as cryopreserved embryos, were also BoLA-typed. 
In Edinburgh, 351 Bos taurus animals were tested. 
They were of a wide variety of breeds. One hundred and 
fifty eight came from the farms of the A.F.R.C. Animal 
Breeding Research Organisation in Scotland. The largest 
single breed of these was Friesian (92) but included were 
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representatives of 18 other breeds of cattle. From Norway 
139 animals were tested, while the remaining 54 animals 
were from the English and Scottish Milk Marketing Boards 
(MMB and SMMB). They included eight Hereford bulls and 14 
bulls of five other European breeds. This is an excellent 
representative sample of the highly selected cattle 
currently being used in Europe for milk and beef 
production under intensive management systems. 
The classification and relationship of cattle is in 
some confusion. However, most authorities would classify 
all of the African cattle used in this study, with the 
exception of the N'damas, as being of Bos indicus type, 
and all of the European cattle as Bos taurus type 
(Epstein, 1971; Mason and Maule, 1960). This distinction 
is not sharp, and clearly they should not be considered to 
be the different species that these names imply, since 
they can and do interbreed. Certainly the Borans and 
Zebus form well defined races which are more closely 
related to each other than to the other groups. The small 
N'dama and Sahiwal cross populations are well separated 
from these and from the European cattle. The term Bos 
indicus is used in this study to refer to the Borari and 
Zebu cattle only, while the term Bos taurus refers to the 
European cattle. 
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Table 2.1 - The cattle 
Type Origin Number 
Improved Boran Kapiti Plains (Kenya) 592 
Improved Boran Rumuruti (Kenya) 70 
662 
Zebu Kafue Flats (Zambia) 62 
Zebu (Orma) Tana River (Kenya) 148 
Zebu Galana Ranch (Kenya) 90 
Zebu (Samburu) Kaisut Desert (Kenya) 116 
Zebu (Maasai) Trans Mara (Kenya) 190 
606 
Sahiwal x Friesian Trans Mara (Kenya) 49 
N'dama The Gambia 10 
Bos taurus Scotland 158 
Bos taurus Norway 139 
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Fig 2.1 The origin of the cattle 
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Serum 
Serum for use in the microcytotoxicity test was 
prepared as follows. Venous blood was collected from the 
jugular vein and allowed to stand overnight at room 
temperature. The serum was separated from the clot and 
centrifuged at approximately 1.500 x g for 35 minutes. 
The supernatant was collected and filtered through a five 
micron and then a 1.2 micron filter (Acrodisc, Gelman), 
and finally through a 0.45 micron filter (Millex). 	It was 
distributed into suitable aliquots and stored at minus 
35'C or minus 60'C. 
Immunisation 
All of the antisera prepared in Kenya during the 
course of this study were made by alloimmunisation. The 
antisera used are listed in tables 2.2 to 2.4. The 
European sera were mostly prepared by skin grafting. Some 
were made by innoculation of peripheral blood leukocytes 
(PBL) while the rest were from parous cows. Most 
immunisations were made between dam/calf pairs (Spooner et. 
a!, 1979b). 
The antisera raised in Kenya are listed in tables 2.3 
and 2.4. They were made in two separate groups. Those 
with the prefix KM were either made at the Veterinary 
Research Department of the Kenya Agricultural Research 
Institute at Muguga, or at Vipingo Estates near Mombasa. 
The sera with the prefix "ICK" were made at ILRAD using 
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Borans from the Kapiti. Plains Estate. 
The animals from the farm at Muguga were of extremely 
variable ancestry. The Bos indicus types would generally 
be considered to be of Zebu type. The Bos taurus types 
were either Friesian or Hereford, but may have had a small 
Bos indicus component. The immunisations performed at 
Vipingo were all between dam/calf pairs of "improved 
Boran". All were single immunisations by skin implant, 
the BoLA type of the animals involved was not known at the 
time of the implantation. 
All primary immunisations (except those made by 
TheileriaPEY infected lymphoblast innoculation) were 
made by skin implant according to the method of Pringnitz 
et ! (1982). Briefly, the immunisation procedure was as 
follows. Donor and recipient were lightly sedated with 2% 
Rompun (Bayer) given intramuscularly. The hair at the 
back of one of the donor's ears was shaved and the skin 
cleaned with soap and then alcohol. An area of skin at 
the base of the recipients neck was similarly prepared. 
Local anaesthetic (Lidothesin 1%, Pharmaceutical 
Manufacturing Co.) was infiltrated into these areas. An 
incision approximately two cm long was made through the 
skin in the recipient's neck. A pocket was made between 
the skin and the underlying muscle by probing with a 
scalpel handle. The loose skin at the back of the donor's 
ear was grasped with forceps and a piece of skin of 
approximately one square cm was removed. This skin was 
pushed into the pocket on the recipients neck. 
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Streptomycin sulphate powder (Pharmaceutical Manufacturing 
Company) was dusted into the wounds which were then closed 
by one or two sutures. 
Four typing sera resulted from immunisation on two 
occasions with Theileria 12arya infected cell lines. The 
BoLA-A locus phenotype of these lines was confirmed before 
use and they remained the same as those of the line 
donors. 
The titre of the recipient serum in the standard 
microcytotoxicity test against the donor's lymphocytes was 
measured after about 14 days. If it was found to be 
sufficient (above 1:4), a quantity of up to one litre of 
blood (depending upon the size of the animal) was taken, 
otherwise the immunisation was repeated. 	Occasionally 
the second immunisation was by subcutarus and 
intramuscular injection of PBL from approximately one 
litre of donor blood. PBL were collected and separated in 
the same way as PBL for absorption, except that the final 
resuspension was in five ml of RPMI 1640 (Gibco). 
Titres were found to be extremely variable following 
first immunisation. There was no obvious relationship 
between the BoLA compatibility of the donor and the 
recipient, and the titre of serum. A second immunisation 
always produced a serum with a titre of 1:32 or above. 
Table 2.5 shows the titres of sera following the 20 
immunisations performed at ILRAD of which six were 
boosted. It is not possible to draw conclusions about the 
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relationship between BoLA-type and response, as the donors 
selected usually had at least one undetected A locus 
allele and since the recipient was invariably the donor's 
calf the degree of matching could vary from complete 
matching of two MHC haplotypes (when the animals were 
inbred) to complete mismatching at all loci, without 
being distinguishable by BoLA-typing. 
The number of animals with which a serum reacted was 
always much more limited following a single immunisation 
than following two. Several sera are used as typing 
reagents with no absorption (see tables 2.3 and 2.4), and 
these all result from a single immunisation. A second 
immunisation often produced a "pan-reactive" serum which 
defied all attempts to render it operationally 
monospecific. For this reason second immunisations were 
avoided as much as possible. 
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Table 2.2 - The Edinburgh sera 
* 
Number of Lab performing Working Specificities 
Serum absptns immunisation dilution detected 
EDA001 2 Edinburgh 1:4 wi & w3 
EDA002 2 Edinburgh 1:4 w2 
EDA005 2 Edinburgh 1:4 w13 
EDA007 3 Edinburgh 1:4 wS 
EDA008 0 Edinburgh 1:4 wi 
EDA009 1 Edinburgh 1:8 w6 
EDA010 1 Edinburgh 1:4 w6 
EDA011 2 Edinburgh 1:8 w7 
EDA012 1 Edinburgh 1:4 ? 
EDA013 0 Edinburgh 1:8 w8 
EIJA014 0 Edinburgh 1:4 w9 
EDA016 1 Paris 1:8 w13 
EDA017 1 Paris 1:4 w7 
EDA028 4 Paris 1:16 
EDA030 1 Paris 1:4 
EDA038 2 Paris 1:8 w16 
EDA039 1 Paris 1:8 w3 
EDA040 1 Paris 1:16 EUI2 
EDA043 2 Paris 1:8 w16 
EDA047 4 Paris 1:4 w12 
EDA062 2 Edinburgh 1:16 w2 
EDA063 5 Edinburgh 1:16 w8 
EDA064 2 Edinburgh 1:4 w2 
EDA065 1 Edinburgh 1:8 w2 
EDA066 4 Edinburgh 1:4 w7 
EDA068 3 Edinburgh 1:8 w7 
EDA069 5 Edinburgh 1:4 wlO 
EDA071 2 Edinburgh 1:8 wlO 
EDA072 1 Edinburgh 1:4 
EDA073 2 Edinburgh 1:16 wil 
EDA074 1 Edinburgh 1:16 ? 
EDA075 1 Edinburgh 1:8 w6 
EDA076 1 Edinburgh 1:8 wil 
EDA077 U Edinburgh 1:8 7 
EDA078 2 Edinburgh 1:4 w20 
EDA080 4 Edinburgh 1:4 w8 
EDA081 1 Paris 1:8 
EDA082 1 Paris 1:8 w4 
EDA083 4 Edinburgh 1:4 wi 
EDA085 3 Edinburgh 1:4 
EDA086 2 Edinburgh 1:4 ? 
EDA092 1 Edinburgh 1:4 
EDA093 2 Edinburgh 1:4 
EDA094 3 Edinburgh 1:8 
EDA096 2 Edinburgh 1:16 wlO 
EDA097 2 Edinburgh 1:32 w6 
EDA098 3 Edinburgh 1:4 
EDA099 2 Edinburgh 1:4 
continued 
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Table 2.2 - continued 
* I 
Number of Lab performing Working Specificities 
Serum absptns immunisation dilution detected 
EDA100 0 Berne 1:16 
EDA101 4 Edinburgh 1:16 
EDA102 4 Edinburgh 1:8 7 
EDA104 3 Edinburgh 1:4 7 
EDA105 2 Edinburgh 1:4 7 
EDA107 0 Berne 1:8 7 
EDA109 5 Edinburgh 1:16 7 
EDAIIO 3 Berne 1:4 wil 
EDA111 4 Berne 1:8 ? 
EDA112 3 Edinburgh 1:4 7 
EDA113 1 Edinburgh 1:4 7 
EDA114 3 Paris 1:8 
EDA115 2 Edinburgh 1:8 w2 
EDA116 1 Edinburqh 1:4 ? 
EDA117 2 Edinburgh 1:4 7 
EDA118 3 Edinburgh 1:8 7 
EDA120 4 Edinburgh 1:4 7 
EDA121 2 Copenhagen 1:8 ? 
EDA123 4 Berne 1:32 7 
EDA124 4 Paris 1:4 ? 
EDA125 3 Edinburgh 1:4 ? 
EIJA126 5 Paris 1:4 7 
EDA127 4 Edinburgh 1:4 
EDA128 4 Paris 1:4 ? 
* Number of donors of PBL used in absorption.. 
Spooner et al, 1979a; Anon, 1982; 	INRA, 1982. 
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Table 2.3 - The Kenya Muguga Sera 
Serum Donor tissue Recipient Absptns Diltn Spcfcty 
KMA001 (x) w7/- (t) w7/w9 0 1:4 
KMA002 (t) w7/w9 (X) w7/- 2 1:32 7 
KMA003 (i) w4lwlO (i) -I- 3 1:4 wiC 
KMA004 (i) (i) 2 1:8 KM4 
KMA005 * (t) ? (t) ? 1 1:4 7 
KMA006 * (t) 7 (t) ? 2 1:4 7 
KMA007 V (j) ? (i) / 1 1:4 w7 
KMA008 V (i) / (i) 7 0 1:4 
KMA009 (i) / (1) ? 0 1:4 7 
KMA010 (i) w8/- (i) w8/- 1 1:16 KM18 
KMA011 (i) wil/- (i) 2 1:4 
KMA012 (i) W8/- (i) w8/- 2 1:4 ? 
KMA014 (i) (1) -I- 2 1:8 KK1 
KMA015 * (t) 7 (t) 7 1 1:4 7 
KMA017 (i) -I- (i) Will- 1 1:4 KM17 
KMA018 V (i) (i) 1 1:16 KM18 
KMA021 (i) Will- (i) -I- 2 1:4 7 
KMA022 !C(t) w6/w8 (t) w6/wl0 3 1:16 KM22 
KM.A023 (i) -I- (i) 7 1 1:8 ? 
KMA024 (i) (i) w4lwiO 4 1:16 KM4 
KMA025 !f(t) w6/w8 (t) w6/w8+ 3 1:8 
KMA026 * (t) ? (t) 7 1 1:4 
KMA027 (i) wlO/- (i) -I- 1 1:8 7 
KMA028 (i) -I- (i) wlO/- 2 1:16 7 
KMA029 (t) -I-- Ci) -/- 3 1:8 KM17 
KMA030 (i) -I- Ci) -I- 2 1:8 
KMA031 (i) -I- Ci) -/- 3 1:8 
KMA032 (i) -1- Ci) w9/- 4 1:4 ? 
KMA033 (i) w9/EU12 (t) w9/- 3 1:16 KM33 
KMA034 !f'(t) wll/w20 (t) willw20 4 1:2 7 
KMA035 new batch of KMA005 
KMA036 new batch of KMA026 
KMA037 (i) w8+/- (x) -I- 3 1:8 7 
KMA038 V (i) ? (i) / 3 1:16 w6 
KMA039 (i) - 1' - (i) 3 1:4 
KMA040 (i) w81- (i) -I- 5 1:8 ? 
(i) 	Bos indiEius 	type 
(t) Bos taurus type 
(x) 	Cross-bred 
* An absorption performed in Kenya upon 
a serum raised in Edinburgh. 
Immunisation with Theileria parva-infected 
lymphoblasts. Except for ' immunisation 
was by implant, sometimes boosted with PBL. 
£ Except for £ immunisation was between dam/calf pairs. 
V Immunisation performed at Vipirigo using Borans. 
Others were performed at Muguga. 
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Table 2.4 - The Kenya Kabete Sera 
Working 
Serum Donor tissue Recipient Absptns Diltn Spcfcty 
KKA001 (i) -/-;KMA014 (i) 0 1:4 KK1 
KKA002 (1) -/-;KMA014 (i) -I- 0 1:16 KK1 
KKA003 (i) -/-;EDA118 (1) -I- 0 1:4 KK3 
KKA004 £ 	(i) w101KM18 (i) KM18/- 2 1:16 KK4 
KKA005 (i) w6/- (i) w6/- 2 1:16 ? 
KKA006 (i) -/-;KMA014 (i) w6/- 1 1:8 
KKA007 (i) (1) wlO/- 1 1:4 ? 
KKA008 (i) wlI- (i) w4/- 1 1:4 
(i) Bos indicus type 
All immunisation was by skin implant, 
sometimes repeated. 
Except for £ immunisation was between dam/calf pairs 
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Table 2.5 - Maximum dilution of sera giving at least 40% 
killing of donor lymphocytes in the microcytotoxicity 
test. 
No of sera 
Titre 	1 immunisation 	2 immunisations 
<1:2 5 0 
1:2 2 0 
1:4 0 0 
1:8 7 0 
1:16 0 0 
1:32 1 0 
>1:32 5 6 
20 6 
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Absorplion of sera 
Before a serum could be considered to be 
operationally monospecific, and therefore a useful test 
reagent, it was absorbed with PBL from reacting animals. 
If this process removed activity for all animals then the 
serum could be assumed to have activity for the same 
antigen on all of these animals. The method used varied 
considerably depending upon the volume of serum being 
absorbed. Following absorption, the serum was always 
tested for cytotoxicity against cells from the animal 
which provided PBL for the absorption, to confirm that all 
activity for these cells had been removed. 
Cells for absorption were prepared as follows. Blood 
was collected into an equal volume of Alsever's solution 
(Gibco), and buffy coat cells were then collected 
following centrifugation for up to 40 minutes at 1200 x g. 
The erythrocytes were removed by a flash lysis with a 
large volume of distilled water, followed by sufficient 
Hank's balanced salt solution (HBSS, Gibco) at 10 times 
working concentration to restore isotonicity. The 
lymphocytes were pelleted by centrifugation and the 
supernatant was poured off. Cells were resuspended in 
fresh HBSS and centrifuged again. Then the supernatant 
was poured off and the cells were re-suspended in the 
serum to be absorbed. In most cases, a ratio of one 
volume of packed cells to three volumes of serum was 
sufficient to remove activity for the cells. The cells 
and serum were incubated at room temperature for 40 
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minutes with continuous gentle mixing. Then the cells 
were removed by repeated centrifugation followed by 
filtration as for the sera above. 
Monoclonal Antibodies 
Three mouse monoclonal antibodies (MoAbs) were used 
as typing reagents. They were made at ILRAD by I. 
Morrison, A. Teale and P. Lalor. The immunisations which 
lead to them are described in table 2.6. They were used 
in the form of mouse ascitic fluid (MA 4.1 and P3) or as 
tissue culture supernatant (MA 7.1). 
The extremely high titre in the cytotoxicity test of 
the ascites, greater than 1:100,000 in one case, created 
problems. The small amount of fluid carried between test 
wells by the dispensers was not significant with 
alloantisera which have titres of less than 1:300, but 
with monoclonal antibodies in the form of mouse ascites 
could cause cell death in the adjacent wells. This was 
avoided by, where possible, using care not to allow 
dispensers to touch the drop of reagent and by rinsing 
dispensers in 5M sodium hydroxide after they came in 
contact with such reagents. The absence of carry-over was 
ensured by placing negative control sera in the well 
following that containing a MoAb, if this well was not 
completely negative then carry-over was assumed to have 
occurred and the following wells were scored as untested 
until a negative was encountered. In practice such a 
situation was rarely encountered. Problems associated 
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with this carry-over of monoclonal antibodies have also 
been reported in HLA-typing (Bodmer et a! 1984). 
The MoAb (P8) was used to examine macrophage numbers 
in PBL preparations. This was prepared at ILRAD by P. 
Lalor and is specific for Inonocytes (Lalor et a!, 1985). 
It was used as mouse ascites at a dilution of 1:400. 
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Table 2.6 - The ILRAIJ Anti-MHC Monoclonal Antibodies 
Immunising Working 
Antibody Ig Class tissue Specificity dilution 
MA 4.1 IgGi (i) 	PBM 1(1(4 1:10,000 
(Ascites) wlO/KM18 * 
MA 7.1 IgG2A (t) 	PBM W10 & KM17 1:10 
(TC Sup) w7/w1O 
MA P3 IgG2A (i) 	PBM KM18,w2 1:1,000 
(Ascites) KM18/- 
(i) 	 Bos indicus 
(t) Bos taurus 
(TC Sup) 	Medium from an overgrown culture. 
(Ascites) Dialysed ascitic fluid from mice 
innoculated with hybridoma cells. 
* 	KMA003 & KKA004 positive 
KMA003 & KKA004 negative 
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Cell Lines 
Bovine lymphoblastoid cell lines, infected with 
Theilecia parva and used for some immunisations, were 
provided by other groups at Muguga. They were established 
and maintained according to Stagg et al (1981), and were 
grown in RPMI 1640 with 10% foetal bovine serum (FBS, 
Gibco). Before use they were BoLA-typed in the standard 
lymphocytotoxicity test using a low toxicity complement 
source. 
The source of complement for the BoLA-typing of PBL 
was commercial freeze dried rabbit serum (Cedar-Lane, Low-
Tox-H) Complement was pre-screened for cytotoxicity and 
complement activity. It was stored at minus 20'C, and was 
reconstituted with distilled water, mixed gently and 
placed on ice. Reconstituted complement was never re-
frozen or used after more than one hour. 
Lymphoblastoid cell lines were typed using a 
different complement source since they were found to be 
susceptible to lysis by the commercial complement. The 
complement used for this was prepared from pooled rabbit 
serum obtained from the ILRAD colony. It was absorbed on 
ice for one hour with bovine PBL collected as for serum 
absorption. Approximately one volume of packed cells was 
used to absorb three volumes of serum. It was then 
screened for cytotoxicity and complement activity against 
both cell lines and PBL. 
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All of the BoLA typing was performed using a standard 
procedure. The test used was a modification of that 
originally developed by Gorer and O'Gorman (1956) and is 
described by Teale et al (1963). 
Whore possible, lymphocytes were separated and 
tested within 24 hours, with 48 hours being the maximum 
time between collection and testing of unpreserved 
samples. Alternatively, the blood was cryopreserved. The 
cryopreservation process is described in chapter 3. 
Venous blood (either jugular or caudal) was collected 
into sterile vacutainers containing lithium heparin 
(Becton-Dickinson). Lymphocytes were separated from fresh 
blood as follows. 2ml of whole blood was layered onto 3m1 
of a mixture of Ficoll 400 (5.7% w/v) and sodium 
diatrizoate (9.0% wlv) (s.g.1.077, Ficoll-Paque, 
Pharmacia). The tubes were centrifuged at 1200 x g for 20 
minutes at approximately 15'C. The lymphocyte-rich 
interface between the plasma and the Ficoll-Paque was 
drawn off with a pasteur pipette and mixed with 
approximately 10 ml of HESS in a lOml polystyrene conical 
centrifuge tube (Sterilin). The tubes were then 
centrifuged at 130 x g for 5 minutes, at 15'C. The 
supernatant was poured off and 2ml of distilled water was 
added to the cell pellet while it was being mixed 
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vigorously. After approximately five seconds of mixing, 
2m1 double strength HBSS was added and mixing was 
continued for another five seconds. A further six ml of 
HBSS was then added to the tubes and they were again 
centrifuged at 130 x g for 5 minutes. The supernatant was 
poured off and the cell pellet re-suspended, then lOud of 
HBSS was added and the centrifugation repeated. The 
pellet was then re-suspended in imI 10% FBS in HESS (test 
medium) . The cells were counted in a Neubauer chamber 
under phase contrast to allow an estimate of viability, 
6 
and adjusted to 2.5x10 /ml in test medium. Only samples 
in which 80% or more of lymphocytes were viable were 
considered acceptable for testing. 
The resultant cell suspension was completely free of 
a 
erythrocytes as a result of the flash lysis. Platelet 
contamination was variable, and when it was considered 
excessive the cells were centrifuged at 100 x g for 5 
minutes and the platelet-rich supernatant was discarded. 
Granulocyte contamination was rarely over 5%. 
LYTR ~22cvte-preDaration - from-defibrinated blood 
Defibrin ation of blood samples provided a cell 
preparation completely free of platelets and with very low 
granulocyte numbers, but it was not always practical under 
field conditions, particularly when cattle were sampled in 
small and scattered groups. 
Defibrination was performed by collecting 
2. Materials & Methods 
approximately 6m1 of venous blood into a lOmi vacutainer 
(Venoect) containing approximately 2nd of small glass 
beads. The vacutainers were immediately placed on a 
rotary mixer and after 10 to 15 minutes of mixing a fibrin 
clot formed around the beads. Following defibrination, 
lymphocytes were separated in the same way as for 
heparinised blood, except that it was found that only one 
wash was required since there were negligible numbers of 
platelets in the preparation. 
The absence of macrophages in PBL prepared from 
defibrinated blood was demonstrated by the use of the 
monoclonal antibody P8 (specific for macrophages) in an 
indirect immunofluorescence test. PBL were incubated with 
P8 ascites at 1:400 in RPMI 1640 with 0.1% sodium azide 
and 1% FBS (FACS medium) at four degrees Centigrade for 30 
minutes. They were washed twice in cold FACS medium and 
incubated at the same temperature for 30 minutes with a 
1:10 dilution in FACS medium of a Fluorescein 
isothiocyanate-conjugated rabbit-anti-mouse immunoqiobul in 
serum prepared by staff at ILRAD according to the method 
of Brandtzaeg (1973). The cells were again washed twice in 
FACS medium and their fluorescence was examined on a FACS 
It cell-sorter (Herzenberg and Herzenberg, 1979). Figure 
2.2 is a plot of cell numbers versus fluorescence 
following this analysis. It shows negligible macrophage 
numbers in a defibrinated sample, and considerable numbers 














11010 	 200 
REL INTENS 
Fig 2.2 
FACS profile following incubation of heparinised 
and defibrinated PBL with a MoAb specific for 
macrophages 
'0. 
2. Materials & Methods 
The microcytotoxicty test, which was the basis of 
the BoLA typing was performed as follows. Terasaki 
plates (Nunc) were flooded with liquid paraffin, allowed to 
stand for ten minutes or more to allow air bubbles to 
leave and then all excess liquid was poured off. This 
left the wells completely full but without liquid paraffin 
between wells. 
The typing antisera were diluted in test medium to 
their appropriate working dilution in Terasaki monoclonal 
cluster plates (Costar). Then one micro litre was added 
to each well of the Terasaki plates using a Multi 
dispenser (Hamilton). The sera were arranged so that each 
plate carried six different reagents, one in each column. 
This was found to be superior to the more common "multi-
plate" arrangement (in which each plate carries a 
different reagent in each well), in a number of respects. 
It meant that the typing sera needed to be held at room 
temperature for short periods of time, and it minimised 
the chance of carry over as cells and complement were 
distributed. It had the disadvantage that it was wasteful 
of materials to test animals in other than groups of ten. 
However, this was not a major drawback. 
Following the distribution of antisera, the plates 
were stored at minus 60'C until required. They were never 
kept for more than two months before use. 
After the plates had reached room temperature, one 
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micro litre of cell suspension, prepared from heparinised 
or defibrinated blood as described above, was distributed 
into each well (2,500 cells per well) using a multi 
dispenser. Then one micro litre of complement, diluted 
50% in test medium was added and the plates were incubated 
at 37'C for 80 minutes. 
After incubation, one micro litre of 1.25% Eosin Y 
(Fisher) in HESS was added to each well. After three to 
four minutes, two micro litres of 40% formaldehyde (Kobian 
Ltd) buffered to approximately pH 7 with 0.15M di-sodium 
hydrogen phosphate (Sigma) was added. The plates were 
then stored over-night at four degrees C before being 
read. 
Reading was performed under phase contrast microscopy 
using a Nikon microscope at a total magnification of 150x. 
Dead cells were identified by their failure to exclude 
eosin. Scoring of the wells was as follows: 
Not tested 
0-10% of cells dead 	- 
11-20% of cells dead 2 
21-40% of cells dead 	4 
41-80% of cells dead 6 
81-100% of cells dead 	8 
Scores of - and 2 were considered negative and scores 
of 6 or 8 were considered positive. The partial killing 
scored as 4 was not often seen and was normally considered 
negative as a result of the analysis performed at the two 
BoLA comparison tests (Spooner et al, 1979a; Anon, 1982). 
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THE DEVELOPMENT OF A MEANS OF CRYOPRESERVINC3 LYMPHOCYTES 
IN WHOLE BLOOD 
Introduction 
Following the collection of blood, it was found to be 
necessary to separate and test the lymphocytes within 24 
hours in order to reliably obtain cells of sufficient 
viability to be of use in the cytotoxicity test. This 
placed severe constraints upon the collection of samples 
from areas more than a short distance from the laboratory. 
The road conditions in Kenya are such that a journey 
of 150 miles can take eight hours. During this time the 
samples are violently shaken and exposed to temperatures 
of up to 40'C in the shade. Direct sunlight very rapidly 
raises the temperature of a sample of blood sufficiently 
to kill every cell. It was found to be essential to 
minimise temperature fluctuations by storing the samples 
in an insulated box. 
Even with such precautions, the fact that a maximum 
of 50 samples could be tested in one day meant that to 
collect a useful number of samples from a given area 
required a series of expensive and time consuming 
journeys, many of which yielded 40 or less samples with a 
viability adequate for B0LA-typing. 
In an attempt to overcome this problem, a brief 
investigation of means of cryopreserving lymphocytes in 
the field was made. It was not an attempt to exhaustively 
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examine the effects of various parameters on the success 
of cryopreservation, it simply used an empirical approach 
to find a system which worked under the unusual conditions 
facing this study. In this it succeeded, and the work is 
reported by Kemp and Teale (1984). 
The requirements of such a technique were; that it 
should be fast and simple to perform, so that many samples 
could be processed rapidly; that it should require no 
electricity supply; and that it should require no 
equipment that could not be carried in a Land Rover. 
Since no means of separating lymphocytes was 
available in the field, it was necessary to freeze whole 
blood. Because the conditions required for the successful 
cryopreservation of lymphocytes destroy other cells 
(Mazur, 1976), this would certainly contaminate the sample 
with cell debris. It is likely that much of this debris 
is potentially cytotoxic, but it was hoped that by rapid 
freezing and then rapid dilution following thawing, that 
the cell loss due to this effect could be minimised. 
Many "recipes" exist which describe conditions for 
cryopreservirig a wide variety of cell types (for a review 
see Mazur, 1976). Most techniques require the controlled 
cooling of separated cells, in the case of lymphocytes, 
this is generally at a rate of about 1'C/minute. Tate and 
Cram (1982) described a method for the cryopreservation of 
bovine lymphocytes in whole blood by such a method. 
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An alternative to a controlled rate cooling technique 
is a two-step cooling such as that described by Knight et 
al (1977). Their method for the cryopreservation of human 
lymphocytes requires that samples of whole blood be held 
at -10'C for a maximum of two minutes, but this precise 
timing would not be feasible in the field. A two-step 
freeze has also been described for sheep lymphocytes by 
Stear et al (1982a) and was modified for cattle 
lymphocytes by Oliver et a! (1985). 
Materials and Methods 
Initial collection and treatment of blood_samR!21 
Venous or caudal blood was collected into vacutainers 
containing lithium heparin (Becton-Dickinson) . Two ml 
was transferred to a SmI polystyrene freezing vial (Nunc) 
which was placed into a bath of iced water. After five to 
ten minutes, two ml of ice-cold dimethyl sulphoxide 
(DM50. Sigma) at an appropriate concentration in HBSS, was 
added dropwise. The samples were mixed by inverting twice 
and immediately transferred to the next stage of the 
freezing process. 
Controlled-rate freezing 
The cooling of samples at a controlled rate was 
achieved by the use of boxes made of expanded polystyrene 
of a variety of wall thicknesses. Samples were packed 
into these, and then placed in a closed container of solid 
carbon dioxide. The temperature inside the box was 
monitored by means of a thermo-couple which was inserted 
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into one of the samples. 
Methanol bath 
A bath, well insulated with expanded polystyrene and 
containing approximately four litres of 50% methanol and 
50% water, was used for the first stage of a two-step 
freezing. The methanol/water was pre-cooled in a box of 
solid carbon dioxide, and its temperature maintained 
during the freezing process by the addition of small 
pieces of carbon dioxide, which also served to vigorously 
mix the liquid in the bath. 
9!_ 	A 
After freezing, the lymphocytes were separated as 
follows. The samples were rapidly thawed in a water bath 
held at 37'C, and then transferred to a lSml conical 
centrifuge tube containing 2mls HBSS with 25i.u./ml 
heparin (Novo). After mixing, a further 4m1 heparinised 
HESS was slowly added with mixing. The tubes were then 
centrifuged at 210 x g for 5 minutes. All but imi of the 
supernate was discarded and the cells resuspended. lOmIs 
of heparinised HESS was then added and the tubes were 
centrifuged at 150 x g for 5 minutes. The supernatant was 
poured off and the cells resuspended in ImI HESS. This 
suspension was layered on to Ficoll-Paque, and the 
lymphocytes separated and washed as described above for 
heparinised samples (Chapter 2; "Lymphocyte preparation 
from heparinised samples"). 
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Results 
With a final DM50 concentration of 10% the controlled 
freezing technique gave cell preparations which did not 
have a consistently acceptable viability. The explanation 
of the variability of this method may have been that the 
cooling rate was extremely variable. Samples at the edge 
of the box cooled much faster than those in the middle, 
and even when all samples were placed at the edge, the 
rate of cooling varied with the total number of tubes in 
the box. It was found that for a sample to reach a 
temperature of minus 40 , 'C could take over two hours, even 
when the polystyrene box was wafer thin. 
The two-step freezing technique, using a final DMSO 
concentration of 10% and a methanol temperature of minus 
25'C gave cell preparations with consistent but 
unsatisfactory viabilities, about 75%. 
The viability of the cells was relatively insensitive 
to variations in the temperature of the methanol bath. 
Varying this between -25'C and -40'C showed a slight 
improvement at the lower temperatures. The mean viability 
at -35'C was approximately 80%. 
Next, the DMSO concentration was varied using a 
methanol bath at minus 35'C. A dramatic increase in cell 
viability was seen when the concentration of DMSO was 
raised to 15%. At concentrations higher than this, most 
cells maintained a good viability, but some samples showed 
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significantly lowered numbers of viable cells. This 
presumably was the result of damage to the cells caused by 
the DMSO during the thawing process. Table 3.1 shows the 
result of freezing cells using these conditions. 
It was shown that the viability of cells was 
unchanged if they remained in the methanol bath under 
these conditions for up to two hours. 
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Table 3.1: The results of freezing cells by the two-step 
method, using a methanol bath at -35'C and a final 
DMSO concentration of 15%. 
Animal 	 % recovered * 	 % viable 
1 	 34 	 89 
2 52 90 
3 	 19 	 90 
4 68 87 
5 	 30 	 92 
6 46 69 
7 	 23 	 83 
* By comparison with cells prepared from two ml of fresh 




The two-step freezing method, using a methanol bath 
held at minus 35'C, and a final DMSO concentration of 15%. 
reliably gave cell populations with viabilities over 85%, 
which is more than adequate for BoLA-typing. Over three 
hundred cell samples were cryopreserved by this method and 
subsequently BoLA-typed, and the performance of the typing 
sera was unchanged with no evidence of an increase in 
background cell death. 
The slow, dropwise addition of HBSS to the sample 
after thawing was found to improve viability, presumably 
by reducing the osmotic damage as DMSO left the cells. 
This was a compromise between the desirability of first 
rapidly removing toxins resulting from cell death during 
freezing, and also of rapidly diluting out the DMSO which 
is itself toxic at room temperature, and of reducing the 
damage caused by rapid dilution. It seems likely that 
slow dilution following thawing becomes more critical as 
the DMSO concentration used in the freezing process is 
increased. 
The recovered cell preparation was completely free of 
platelets and erythrocytes. Macrophage numbers appeared 
unchanged by the freezing process. The destruction of the 
platelets may be significant in that they will release 
potentially toxic material into the preparation. For this 
reason defibrinated blood rather than heparinised blood 
might give even better results. 
Chapter 4 
STATISTICS AND COMPUTING 
Introduction 
There are two major statistical problems facing a 
study such as this. One is to define the tools of the 
analysis - the sera - and the second is to use these tools 
to analyse the distribution of the BoLA alleles. The 
first of these is a classical statistical problem which 
can be resolved, within limitations, by cluster analysis. 
Because of the complexity of the set of antigens which 
generate the antibody response, it is virtually unknown 
for two alloantisera to have identical reaction patterns. 
Even in the highly unlikely case of antisera which have 
only one population of cytotoxic antibodies directed 
against the same MHC antigen molecule, differences in the 
pattern of cross-reactivity would be expected. Therefore 
a study such as this generates a complex mass of results 
for each serum and it is almost never possible to 
immediately identify sera which are identifying the same 
antigens by a simple examination of the results. It is 
important that an analysis of the relationship between 
sera is not simply performed once, but that cluster 
analysis is used throughout the development of the 
reagents to suggest improvements that may be made by 
absorption or by further immunisation. 
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The subject of cluster analysis is reviewed by 
Everitt (1974). There are two stages in any clustering 
process. The first is the establishment of a measure of 
similarity or dis-similarity between individuals (in this 
case the individuals are the sera), and the second is the 
process of merging individuals into clusters on the basis 
of these measurements. 
The measurement of similarity 
The observations made in this study were considered 
to be of the binary type, that is, the reaction of an 
animal's PBL with a serum could take only one of two 
values - positive or negative. For a large number of 
observations on two antisera (designated si and s2) there 
are four possible outcomes and these are represented by a, 
b, c and d in the 2x2 contingency table: 
s2 
+ 
+ : a 	 b 
si 
-:c 	 d 
In the case of cluster analysis of antisera the value 
"a' will represent absolute numbers of animals whose PBL 
react with both serum si and serum s2; "b' will represent 
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numbers which react with si but not s2; "c" will represent 
numbers reacting with s2 but not si and; "d" those 
reacting with neither serum. Thus there are two types of 
result, matched results (a and d) and non-matched 
results (b and c). Two highly similar antisera will 
generate large values in the matched categories and 
relatively low values in the non-matched categories. 
However, because most serum/PBL reactions give a negative 
result, even two very dis-similar antisera will have a 
large number of matched negatives (value c) so that 
this figure is of little value in determining similarity 
between antisera. 
It is assumed that highly similar sera are detecting 
the same or closely related antigens, although sera with 
identical reaction patterns may of course detect entirely 
different epitopes on a given antigen molecule. The term 
"antigen" used here refers to a structure which probably 
has several antigenic sites (Lopez de Castro et a!, 1984) 
and a cluster of sera which detect the same antigen may 
well detect different sites. 
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The following similarity coefficients have been used 




(2(a+d) ) / (2(a+d)+b+c) 
a/(a+2(b+c)) 
a/(a+b+c+d) 
They all give different weighting to different 
conditions. For the purpose of the clustering of antisera 
it is appropriate to give more weight to matched pairs 
than to unmatched pairs as is done by (iii) and (iv) 
above. The difference between these two formulae is that 
(iv) gives the same weight to matched negatives (d) as to 
matched positives (a) whereas (iii) gives no weight to 
matched negatives but increased weight to matched 
positives. When considering the extremely sparse 
reactivity of many typing reagents where more than 95% of 
observations may be negative, weighting matched negatives 
as is done by(iv) would not be reasonable since the large 
majority of matched negatives will be due to chance, and 
the converse of this is the justification for weighting 
matched positives more heavily than unmatched 
observations. 
This suggests that the formula given in (iii) above 
is the best measure of similarity for clustering antisera 
and it is the formula chosen by Currie-Cohen et al (1980) 
in their analysis of BoLA-typing reagents. It has the 
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advantages of simplicity and intuitive appeal. It is 
superior to the correlation coefficient which is reported 
by many workers in the HLA and other MHC fields (de Weck 
et al, 1976 and Pickbourne et al, 1978). This is because 
the data generated by testing antisera against cells are 
very sparse and not suited to the treatment given by this 
test, which gives excessive weight to matched negatives 
and insufficient to matched positives. 
However, there can be no absolute rule as to which 
method of calculating similarity is the best for this 
purpose, because as Sokal and Sneath (1963) say, each set 
of data must be considered on its merits. A similarity 
index based on (iii) above was the measure used throughout 
this study. For convenience it was expressed as a 
percentage so that it was calculated by: 
% SIMTY 100(2a/(2a+b+c)) 
Clustering 
Having established a technique for measuring 
similarity it was necessary to decide how to merge 
antisera to form clusters. Everitt (1974) suggests that 
the so-called hierarchical clustering techniques are the 
most suitable to biological observations. These methods 
work by simply taking a set of distances or similarities 
between individuals and repeatedly merging those with the 
greatest similarity. The reverse procedure may also be 
used so that all individuals are considered to be part of 
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one cluster which is then progressively split. 
The crucial problem of the hierarchical techniques 
appears to be the way in which they handle the emerging 
clusters. The distance between a cluster and another 
observation may be taken as the maximum of the distances 
between each member of the cluster and the other 
observation, or some form of average value may be 
determined for the cluster. 
However, when clustering antisera the underlying 
hypothesis is that there is not a complete gradation of 
types of reagents, but that if the sera were perfectly 
monospecific the components of the clusters would coincide 
exactly. Thus, when two antisera are clustered together 
because they appear to detect the same antigen, it is 
invariably true that the most of the differences between 
the sera are not due to differences in the principle 
antibody population, but rather to the presence of extra 
antibodies (this is demonstrated by absorption studies of 
clusters, Spooner et a!, 1980). 	If a serum has 
specificity for an antigen detected by a cluster as well 
as for another antigen, it would not be unreasonable to 
incorporate it into the cluster, but it would clearly be 
wrong to then "shift the location" of the cluster towards 
another cluster which detected the same specificity as the 
second antibody population in this serum. This is exactly 
what is done in conventional clustering when the distance 
between two clusters is reduced as a result of 
incorporating an intermediate individual into one of the 
4. Statistics & Computing 
clusters. Such chaining of clusters could result in 
meaningless results. In this study for example, w7 and 
wiC in the Boran population would have been merged by such 
techniques. Cluster analysis of typing sera is not 
therefore an attempt to measure the degree of association 
of antisera but an attempt to identify the areas of 
overlap which are due to single antigens. 
The obvious solution to this problem is to use a 
technique which does not seem to have been formally 
described in the literature. When two sera are merged to 
form a cluster, the behaviour of that cluster may be 
characterised by considering those animals which are 
positive for both to be positive for the cluster, and all 
others negative. In this way the sera within the cluster 
may be collectively represented by a single "phantom 
serum". Further comparisons may then be made between the 
cluster represented by this phantom serum and other sera. 
This technique is more taxing in terms of the number 
of calculations to be made than are the conventional 
techniques because it requires that, after each merging 
of antisera or clusters, a new set of similarity 
measurements be made which incorporate the new cluster and 
treat it as if it were a new serum. 
The appeal of this technique is that it is easy to 
see how it relates to the antisera themselves. As each 
serum is added to a cluster, the definition of that 
cluster is narrowed to include only those animals which 
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are positive for both the new serum and the cluster. This 
is fundamentally different to the way in which 
hierarchical clustering works. 
A problem that is shared by both techniques is that 
they are poor at detecting sub-groups. It is common for 
the activity of one cluster to be entirely within that of 
another (Spooner et a!, 1980; Spooner and Morgan 1981). 
It is not always obvious how this relates to the 
underlying antigens. If most animals are positive for 
both clusters then usually the clusters will be merged so 
that the new cluster is limited to animals positive for 
the sub-group. However, if the sub-group is rare among 
the members of the larger cluster but entirely confined to 
them, it would certainly be wrong to merge the clusters. 
This is because it is likely that there are two genuine 
antigens, the presence of the rarer being entirely 
dependent on the presence of the more common one. 
There appears to be no simple solution to this 
problem. The computer algorithms that were used to 
perform the clustering in this study included a means of 
detecting such containment of one cluster within another 
(see Similarity Index programme below) but no attempt was 
made to use this information to influence the measure of 
similarity. 
It was because of this difficulty that the computer 
was not used to perform the clustering entirely unaided. 
Instead, separate programmes were written which first 
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calculated the similarity index using (iii) above. The 
results of this analysis were scrutinised and used to form 
the input to the second programme which merged sera to 
create "phantom sera'. Had these programmes been linked 
to perform a series of similarity index calculations 
followed by a merging of sera, the outcome would certainly 
have been different. It would have been necessary to have 
set thresholds of similarity at which to stop the 
clustering process. This would have forced the merging of 
some clusters which are probably true sub-groups, which 
would represent a major loss of information. For instance 
the wlO, KMA003, KK4 complex would have been joined very 
early in the process to form a single cluster. Such an 
approach would also have completely failed to identify 
rare subgroups, such as the containment of KMA025 within 
the activity of the w6-defining sera, because of the low 
measure of similarity between these reagents which is 
entirely due to the relative rarity of animals positive 
for the sub-group. 
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Conclusion 
Cluster analysis is an efficient way to extract 
information about antigens on FBL by examining the 
activity of alloantisera. Conventional clustering methods 
are unsuited to the analysis of typing reagents, but by 
formulating a new procedure to define clusters, useful 
information was extracted. A particular value of this 
method is its use during reagent development, perfect sera 
will be perfectly clustered by any method but the strategy 
described here, provides information which can lead to 
improvements. Even this approach does however have 
pitfalls and it is demanding of calculation time. In an 
attempt to minimise these problems, the analysis of the 
data, using the calculation of a similarity index and the 
clustering method described above, was performed by 
computer programmes whose output could be carefully 
scrutinised before proceeding. 
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Introduction 
The data which are collected during the course of a 
series of BoLA-typing studies rapidly become difficult to 
handle. Typing lymphocytes from one animal against a 
panel of antisera generates a set of over 130 results 
without including such data as breed and sex. This data 
was required for a number of purposes the most demanding 
of which was the cluster analysis described above. It was 
therefore decided to use a computer for data storage and 
analysis. 
The study had two major objectives; the investigation 
of the performance of the antisera and the antigens that 
they defined; and the study of the variations in BoLA 
antigens between different populations of cattle. The 
computer programmes were designed to assist these two 
studies. However a useful facility which the computer 
made available was the rapid storage and retrieval of data 
on individual animals. 
The programmes were first written in FORTRAN IV and 
run on a PRIME 750 mini-computer. They were subsequently 
re-written for an IBM PC XT micro-computer. The 
programmes for the IBM were considerably more useful than 
those on the PRIME and so only these will be described. 
It is worth pointing out that only five years ago, 
programmes of such complexity could not have been 
satisfactorily run on any but large computers such as the 
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PRIME, and that the sudden appearance of inexpensive 
micro-computers with sufficient power for applications 
such as this one may be expected to revolutionise the 
process of data collection and analysis. These "micros" 
make it possible to move away from large mini or main-frame 
computers which require teams of specialists to maintain 
and programme them. It also means that processes 
controlled by computers in the laboratory become 
practicable this is well illustrated in the field of the 
MHC by the appearance of a fully automated system for 
reading the lymphocytotoxi.city test (Bruning et a!, 1962; 
Naipal et a!, 1984). 
Hardware and commercial software 
The micro-computer used was an IBM PC XT with 640 K 
bytes of random access memory (RAM), a fixed disk of 10 M 
bytes capacity and a floppy disk drive of 360 K bytes. 
The large disk capacity enabled manipulation of the very 
large data files which the study accumulated (typically of 
the order of one M byte). In addition, the fast access 
time of the hard disk in comparison to a floppy drive 
allowed the programmes to run efficiently. The large RAM 
capacity was utilised by means of commercial RAM drive 
simulation software (Superdrive, AST Research Inc.) and 
print buffer software (Superspool, AST Research Inc.). 
An Epson FX-100 printer was connected to the 
computer, and the programmes which wrote their output to 
the printer (either directly or by first writing to a file 
92 
4. Statistics & Computing 
for subsequent spooling) provided the choice of a large 
number of print styles. This allowed a maximum of 233 
characters per line (often required by the printout 
programme) when using condensed print, or fewer and larger 
characters when less columns were required. The print 
buffer programme allowed applications which generated 
large amounts of print-out, such as the similarity index 
programme, to run continually without waiting for the 
printer to finish. 
Since the Pascal compiler could access only 128 K 
bytes of RAM, the large data arrays necessary for the 
clustering programmes could not be held in this space. One 
solution to this problem would have been to write assembly 
language routines to place the data in specific locations. 
This however would have been rather time consuming and 
tedious, so instead random access work files were written 
to the RAM drive. They were then written to and read from 
as if they were conventional arrays of data. 
Programmes were written using a word processing 
package (Wordstar, Micro Pro International) and compiled 
by the Prospero Pascal compiler (Version 1.1; Prospero 
Software). 
A listing of the source code of these programmes is 
contained in appendix two. 
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The BoLA-analyEjs_?L2gEaLnT2s 
The programmes for the IBM were written in Pascal 
(Wirth, 1976). Pascal has a number of advantages over 
FORTRAN for such an application. It allows the definition 
of extremely complex data structures which makes it easy 
to manipulate data which is grouped in mixed data types. 
The information on each animal was stored as a variable 
with the following type declaration: 
Rec_of_Resul tsRECORD 
Name:Packed Arraytl. .40] of CHAR; 
Details:Packed Array[Set_of_fields] of 
Packed ArrayEl. .8] of CHAR; 
Serums:Array[l. .240] of CHAR; 
END; 
Here the type"set -of -fields" was defined as: 
TYPE Set -of -fields 
(batch, date, sex, breed, 
location, subloctn,CBTS, Spare);. 
The identity of the animal was held in the 'name' 
field which allowed 40 characters, and thus could hold a 
great deal of information other than a simple identity 
number. The details of the test, the breed of the animal 
and the population from which it came, were held in the 
"details" field which was itself composed of eight fields 
each capable of holding up to eight characters. The 
reactions of the lymphocytes against each of the typing 
antisera was held in the "Serums" field which could hold 
up to 240 scores. This entire data structure occupied 344 
bytes so that data from more than one thousand animals 
would onto a single floppy disk of 360 K bytes capacity. 
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Pascal also allows the definition of files with 
particular structures. In the case of the BoLA 
programmes, the files which held the typing information 
were defined as being of type "Rec_of_results'. This 
allowed simple and rapid reading and writing of the 
complex data set defined above. Most of the programmes 
used a large number of sequential read and write 
operations. Since Pascal allows direct access to the file 
buffer, the programmes ran considerably faster than would 
have been possible under a language such as FORTRAN. 
The superiority of Pascal over FORTRAN for this 
application is well illustrated by the Pascal code shown 
in appendix two (programme "convert FORTRAN to Pascal") 
which is designed to read data from a file formatted for 
reading by the FORTRAN programme.]Because FORTRAN has no 
means of defining complex structures such as the 
Rec_of_Results" used here, each data type must be handled 
separately and some 35 lines of complex code are required. 
Having defined the variable Results" and the file 
Pasfil" as of type "Rec_of_Results', the same end result 
is achieved for Pascal data by the lines: 
WHILE NOT eof(Pasf ii) and (X<Copy) DO 
BEGIN 
Read(Pasfil ,Results); 
X: X+ 1; 
end; 
Whether or not this generates faster machine code depends 
on the compiler, but it is certainly much less prone to 
error. 
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The programmes required a number of control files 
containing further information. The most important of 
these was called the "Batch" file. This held a sequence of 
serum names which allowed the programmes to assign a given 
reaction to a given serum. The batch file was a text-file 
which allowed changes in the serum names or sequence, to 
be made using a text editing programme. The two other 
control files, which were also text-files, are described 
later. 
Eleven programmes were written, plus a simple "menu" 
programme to allow easy access to them. 
The data-entry programme: 
The data were entered using the "Entry" programme 
which collected data in a form that allowed direct reading 
of plates from the microscope onto the computer. It 
checked that the serum scores were within the set of valid 
scores. The NIH scoring scheme (Ray et. al, 1977) was used 
with the modification that negatives were recorded as "-" 
and unreadable wells as ".", which made a printout of the 
data easier to read. The programme identified the plate 
and the sera which were being recorded and gave several 
opportunities for data checking and correction. To 
improve the speed and accuracy of data entry, several of 
the keys had their meanings modified by the programme. 
The zero key for instance entered a series of six negative 
scores; the F9 key a series of six not tested scores; and 
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the "+" key became an extra RETURN conveniently placed for 
the number pad. 
The Update programme: 
One possible disadvantage of using a Pascal non-text 
file to store data is that it cannot be corrected or 
modified by a conventional text-editor. Using such an 
editor would have been a hazardous operation anyway, as 
an alteration to the length of any of the fields would 
have caused the programme to fail and it would also have 
been extremely difficult to locate a given serum score or 
identity field. 
Having decided to use a non-text data file, it became 
necessary to write a programme to maintain it. This 
programme, called "Update" also provided a review of the 
serum reactions and the identity of any of the animals in 
a file. It was used as much to provide rapid retrieval of 
information on individuals as to edit the data. Records 
were "deleted" from the data set by assigning the symbol 
for hexadecimal 23 to the first character of the name 
field by means of the update programme. Any such record 
was completely ignored by all of the programmes which 
performed analysis of the data. 
If the data file to be manipulated by this programme 
was held in the RAM-drive, execution was extremely fast, 
but this was only possible with files less than 360 K 
bytes in length. In many cases, therefore, the programme 
read the records from the hard disk and was therefore 
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rather slow to search a long file. Since this programme 
was not designed as a database application, no attempt was 
made to overcome this drawback. There are a number of 
ways to dramatically speed up the search of a data file. 
However, they all require the setting up, either in RAM or 
on disk, of some form of index. Since most searches of a 
data file were 'one off', it was not felt that this would 
be worthwhile in view of the significant time that would 
be required to prepare the index when the programme was 
first loaded. 
The "utility" programmes: 
Four short programmes were written to further manage 
the data. One of these converted data in the format used 
by the FORTRAN programmes to that used by the Pascal 
programmes while another reversed this process. The third 
simply copied a given number of Pascal records from one 
file and appended them to another, this allowed files to 
be split (by copying only some of the records) and joined 
as required. This was often necessary when transferring 
large files from the hard disk onto a series of floppy 
disks and vice versa. 
The fourth of these programmes re-ordered the serum 
reactions in a data file, so that data collected at 
different times using different serum sequences could be 
merged or compared. As new sera were added to the 
standard panel, this programme was used to maintain a 
single, standardised data file. Records of animals which 
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had not been tested with the new sera were automatically 
given the "untested" score for their reactions with these 
sera. 
The Selection programme: 
In order to compare the BeLA types of different 
populations it was necessary to be able to create files 
containing details of all animals with given 
characteristics. This was achieved by the "selection" 
programme. It allowed records to be copied from one file 
to another depending on either the presence or absence of 
any characteristics in any of the data fields. 
Thus, a file of Borans and a file of Sahiwals could 
easily be created. It was also useful to be able to form 
files containing data from animals with given serum 
reactions, and in conjunction with the "printout" 
programme, this provided a simple way of examining the 
correlation between different antisera. 
Up to 50 different character strings in any field 
could be selected for in one pass through the data. 
Selection could either be on the basis of an exact match 
with the string being searched for, or it could be by 
treating it as a sub-string so that records would be 
selected if the string in the relevant field contained the 
appropriate sub-string. This was a useful means of 
collecting data on groups of animals with common 
components to their identifying fields. It also allowed 
4. Statistics & Computing 
the space available for data storage to be used more 
efficiently, since several independent pieces of 
information could be stored in a single field provided 
that a convention was used to allow them to be 
distinguished. The simplest example of this was the use 
of the character string "LCL" in the name field to denote 
a cell line. 
The Printout programme: 
To display the information on individuals the 
printout. programme was used. It printed the condensed 
identity details of each animal, together with the 
reactions of its lymphocytes with up to 187 antisera 
(this was limited by the maximum number of characters the 
printer could write on one line). An example of the 
output of this programme is shown in Figure 4.1 
The order in which the serum reactions were displayed 
was determined by the second "control" file, the sequence 
file. As well as determining the sequence of the sera 
whose reactions were displayed in the output, this file 
also governed the positioning of both the headings for 
groups of antisera, and of the symbols used to divide the 
output into convenient groups of sera. This file was 
extremely simple to re-arrange, so sera could be "moved 
about" on the print-out at will. The programme provided a 
powerful means of judging the relationships between the 
reactions of antisera, which could then be tested by 
calculating a similarity index. It also gave a useful 
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summary of the BoLA types of individuals or groups of 
animals. 
The Similarity Index programme: 
A more precise means of comparing antisera was 
possible by calculating the similarity index (described 
above) between them. The similarity index of serum si and 
serum s2 was defined as % SIMTY100(2a/(2a+b+c)) where a, 
b, and c are values in the 2x2 table above. 
The programme treated all serum scores as positive or 
negative (or untested). However since the actual score 
recorded for the serum was available in the data file it 
was possible to choose to treat the partial score "4" as 
either positive or negative. In practice, this made 
little difference to the clustering as most antisera 
generated few such scores. 
The programme calculated these values for a given 
serum as si with each of the sera against which the 
animals in a file had been tested as s2. The minimum 
value of the similarity index to be printed out was chosen 
by the user, as was a minimum value above which the output 
was highlighted by a bold print face. The similarity 
index is rather poor at identifying antisera whose 
reactions are entirely within those of another (and 
correlation coefficient is considerably worse). If there 
are relatively few positive reactions against the less 
reactive antiserum (as happens in rare sub-groups) then 
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they will show low correlations. To overcome this, a 
series of simple tests was performed on the data by the 
programme. It established four levels of such 
containment: 
level 1 - no evidence of containment 
level 2 - either b Of C are less than 10% of a 
level 3 - level 2 and where a was greater than 10 
level 4 - level 3 and where b or c was zero. 
This programme required four random-access work files 
to hold the totals for each of the elements of the 2x2 
table for every combination of antisera. These files were 
declared as "FILE OF WORKTYPE'; where the type "WORKTYPE" 
was declared as; 
"WORKTYPE=ArrayCl. .240] of two byte" 
and; "two byte as the range 1..65534. This limited the 
number of animals that could be clustered to 65534. 
However, it seemed unlikely that this quantity would be 
approached, and it allowed the files to fit into the 
available RAM. Each file was initialised by the programme 
up to a maximum of 240 records, so that a complete 
clustering of 240 sera could be performed. 
The files were treated as large arrays, a particular 
record being found by the "SEEK" statement and its 
contents examined or altered by a statement such as 
"WORK_FILEEserum3:=WORK_FILE[serum)+1". These files 
were always located on the RAM drive, since hundreds of 
thousands of such statements were executed during a 
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programme run. A conventional drive would have been 
impossibly slow. 
The gene-frequency comparison programme: 
Another programme calculated antigen frequency, gene 
frequency and standard deviation for every antiserum in a 
pciou1ain. Gene frequency was defined as: 
11- /u._antigen frequency) (Mattiuz et al., 1970). 
This assumes Hardy-Weinberg equilibrium in the population. 
Standard deviation was conservatively estimated by 
5I:F Jf/2N where N is the number of indiviva1c in the 
ucpu1an ion (PicKbourrie eL al. 197 
The programme calculated these values for two 
populations and then calculated the chi-square value for 
their antigen frequencies, the null hypothesis being that 
there was no significant difference between them. It also 
summed the chi-squares of each antiserum to give an 
estimate of the difference in antigen frequencies between 
the populations. 
All sera were treated as if they were detecting 
single antigens. Obviously this is not true in many 
cases, but it provided flexibility by allowing clusters to 
be treated in the same way as single sera. 
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The Cluster programme: 
Finally, a programme was written which allocated 
extra reactions to the records in a file according to the 
reactions of clusters of antisera. That is, it added 
scores corresponding to the presence or absence of antigens 
detected by 'phantom sera". The phantom sera being 
defined in terms of real sera by the user, who made these 
decisions on the basis of the output from the similarity 
index programme. 
The programme could assign up to 40 clusters, each 
holding up to 40 antisera. It was used to compare the 
performance of the antisera by allowing a similarity index 
to be calculated between these clusters and the defining 
sera. The clusters were defined by a control file which 
was easily changed to investigate the effects of varying 
the way in which clusters were allocated. This programme 
also allowed the gene-frequency and antigen frequency of 
clusters of antisera to be calculated and compared between 
populations. 
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Conc lus ions 
The programmes described were used to analyse the 
data collected during the course of the study, and proved 
to be of immense value both in the characterisation of 
typing reagents and in the investigation of the BoLA 
antigens themselves. However, perhaps even more important 
than their use in the final analysis of the data was their 
value in the continuous process of serum preparation and 
refinement. They allowed the rapid and accurate 
identification of panels of animals to test absorptions, 
to make grafts and to test hypotheses. They also provided 
a data-base for work in such areas as T-cell killing, 
where details of the BoLA phenotype of experimental 
animals and cell-lines were needed. 
It is certainly true to say that a major contribution 
to this study (and to several others) was made by the 
programmes described, they are constantly being refined 
and their value is likely to increase. There are no 
reports in the literature of comparable tools, the 
analyses performed at the HLA comparison tests for example 
are performed on main-frame computers (Albert et a!, 1984) 
and in some ways are more powerful than those described 
here, but they are much less flexible and are not 
available to the worker as he develops his typing 
reagents. If simple programmes are available for constant 
use throughout the working time of a laboratory then the 
quality of the typing reagents will be raised and the 
complexity of the final analysis will be reduced. 
106 
Chapter 5 
SUB-GROUPS OF w6,_w8_AND_w1Q 
Introduction 
A major feature of the results of the BoLA-typing was 
the appearance of previously unknown sub-groups of 
existing specificities. The three specificities which 
showed this behaviour were w6, w8 and wlO. Such splits 
are an extremely common feature of HLA serology, where, 
for example, 13 of the 23 HLA-A locus products are splits 
of others (Albert et al, 1984), but with the exception of 
the w6 sub-groups, they have not been prominent in BoLA-
typing. 
It seems clear from the HLA data that a split is 
usually due to common determinants shared by several 
alleles, so that "splitting" a specificity amounts to 
distinguishing different, but serologically related, 
products (Lopez de Castro et a!, 1984). An alternative 
explanation for a split however, is the presence of 
closely linked loci and this was proposed by Spooner and 
Morgan (1981) as a possible explanation for the w6 
subgroups. Products of linked loci showing a sub-group 
relationship might be expected to be a more common 
phenomenon in BoLA-typing than in HLA-typing, because of 
the widespread use of artificial insemination in cattle to 
propagate a limited number of haplotypes throughout a 
herd. For such a sub-group relationship to persist in 
herds in East Africa, West Africa and Europe would however 
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require an extremely high linkage disequilibrium in a two 
locus model. 
The splits of w6 which were seen in this study were 
not unexpected, for although w6 is a common and well 
defined specificity, the first international workshop 
provided evidence that three antisera were detecting sub-
groups of w6. 
An extensive study of w6 was made by Spooner and 
Morgan (1981). They made a series of cross-absorptions of 
the four Edinburgh w6 defining sera, and showed that three 
of them were not operationally monospecific. EDA009 could 
be absorbed with lymphocytes from any one of a group of w6 
animals, and be left with reactivity for another group. 
EDA066 behaved in a very similar way, while EDA075 
appeared to contain different specificities. EDA010, on 
the other hand, contained only activity for the broad w6 
specificity ("w6-broad"). 
At the second workshop w6-broad was defined by 14 
antisera which reacted with cells from 39 animals. In 
addition, two sub-groups were defined, w6.1 and w6.2. 
w6.1 was defined by five sera from Edinburgh and France, 
while w6.2 was defined by three sera from Edinburgh and 
Texas. 
The European workshop (INRA, 1982) confirmed w6, w6.1 
and w6.2. Subgroups w6.3 and w6.4, as described by 
Spooner and Morgan (1961),..appeared to be present but could 
not be confirmed. 
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Another cluster which showed evidence of sub-groups 
in this -Ljiv was w8. Evidence that w8 does have sub- 
ken groups nas,pur rorward at the international workshops. At 
the second workshop it was suggested that a serum from 
Texas which appeared not to detect all of the w8 animals, 
was detecting a w8 sub-group, but the evidence for this 
was limited. Spooner et a! (1980) also presented some 
evidence for a w8 sub-group. The European workshop of 
1982 also suggested that w8 may contain a sub-group. This 
suggestion was based on the fact that there appeared to be 
some w8 cells which did not react with the serum EDA080. 
However, since all but two of the 15 defining sera showed 
non-w8 reactions, it is hard to draw such a conclusion 
from the absence of activity for two cells. 
wlO was defined at the first workshop by seven sera 
from five laboratories. There was good evidence of at 
least one sub-group. At the second workshop it was 
defined by five sera from three laboratories. Again, 
there was evidence of a sub-group. The European workshop 
confirmed wlO with four animals and four antisera. There 
was no evidence of a sub-group here, no American sera were 
tested and only sera from American laboratories have shown 
this activity in the past. 
Therefore, although Spooner et a! (1980) suggested 
that many of the BoLA specificities, in addition to w6, 
were supertypic, there was hitherto little evidence to 
support this. The appearance of new subgroups in two 
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important specificities is thus a significant development. 
Methods 
For the purpose of cluster analysis, the data were 
first divided into three sets. These were the results of 
typing 606 animals of "Zebu" type, the results of typing 
662 Borans and the results of typing 351 Bos taurus 
animals in Edinburgh. These groups are fully described in 
table 2.1. Not all of the available typings were used in 
the cluster analysis, since some were from populations in 
which few animals were typed and the numbers were felt to 
be too low to be useful for this purpose. 
All of these results were stored on the computer 
using the entry programme. The populations were separated 
by the selection programme and similarity index 
calculations made by the similarity index programme. 
The preliminary analysis did not make any assumptions 
about the way in which the sera would cluster. The 
similarity index between each serum and the entire serum 
panel was calculated. The threshold for recording the 
result of each calculation was set at a similarity of 10%, 
this allowed many small associations to be recorded but it 
ensured that no important results were missed. It was 
anticipated that there would be differences in the 
performance of the sera between the populations, so it was 
felt that it would sometimes be of value to record non- 
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significant results because they may reach significance in 
other populations. 
On the basis of this analysis. the European sera were 
formed into clusters and the cluster programme was used to 
add the clusters to the results of each animal. The 
similarity index programme was then re-run on this data. 
In this way it was possible to form an accurate picture of 
the performance and inter-relationships of the sera and 
the workshop clusters. 
Finally, serographs were prepared using the printout 
programme, with the serum sequences determined by the 
process described above. This gave a clear picture of the 
performance of the sera that had been clustered. 
It is not useful to select a given value of 
similarity index as the threshold between significant or 
non-significant. This is because the value reached is not 
influenced by the number of animals tested, and so offers 
no guidance on the reliability of the result. It is also 
relatively meaningless under a number of circumstances, 
notably in the case of rare subgroups. More useful in 
many cases are the raw values from the 2x2 table. The 
similarity index was therefore only used as a guide to 
associations which might be significant. During the 
analysis by the computer a cut-off-point for printing 
details of sera was set at 10% similarity, this together 
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with the alyorithras which searched for evidence of sub-
groups regardless of the similarity index ensured, that no 
potentially important data was missed. 
Something of the difficulty in extracting information 
from a similarity index value is illustrated by the 
histograms of Figure 5.1 which shows data from the Boran 
population. The first shows the number of sera in each 
class of similarity with KMA038, a typical good 
moriospecific serum detecting a well defined cluster - w6. 
Here, a cut-off of 90% would clearly allow the definition 
of a very close cluster because there are few non-w6 
reactions of KMA038 and few sera which react with w6 and 
other antigens. 
In contrast to this are the figures for the 
similarity indices of a poor and probably multispecific 
serum, EDA105. The similarity of this serum is not above 
70% with any other serum, and there is a spread of values 
from zero to this figure. However, this serum is useful 
in the definition of wlO, and a cut-off above 10% would 
have meant the loss of useful information. 
Even more disturbing are the figures for EIJA085. 
They were almost identical to those of EDA105 and yet 
EDA085 is monospecific but detects a supertypic 
specificity (common to three alleles; w4, w7 and wlO). 
This serum had no associations above 60%; into the 50-60% 







in the 40-50% class, and those detecting wlO were in the 
30-40% class. These differences result entirely from the 
different frequencies of the three alleles w4, w7 and wlO, 
and another allele confined to EDA085 positive animals 
could show any value from almost zero if it were rare. 
The similarity index was therefore no more than a 
useful guide. However, Figure 5.1 suggest that most pairs 
of sera with similarity indices less than 30%, and which 
do not show evidence of a sub-group relationship, are not 
sufficiently related to be useful for antigen definition. 
This could not, however, be considered to be a hard and 
fast rule, hence the decision to set the initial cut-off 
point for the analysis at a safe 10%. 
Nomenclature 
Throughout this and the following chapters, a number 
of conventions have been adopted to avoid confusion. 
An antiserum always has six characters in its name, 
for example KMA017. When a cluster is formed from the 
coincidence of two antisera, its name never has six 
characters but is derived from the name of the antiserum 
with the activity which most closely corresponds to that 
of the cluster. The term "phantom serum' and 'cluster" 
are used interchangeably and have the same meaning, a 
"phantom serum" being defined by a 'cluster" of 
alloantisera. For example, the cluster whose definition 
includes the antiserum KMA017 is called KM17. In 
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accordance with convention, a cluster name refers not to 
the reagents which detect a specificity, but to the 
specificity itself. Thus a cell expressing KM17 reacts 
with the sera KMA017 and KMA029. 
The tables showing similarity indices are all of the 
same form. For economy of space the key is given only for 
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The initial similarity index calculations on the w6-
defining sera showed a group of five extremely highly 
correlated sera in all populations. The correlation 
between all combinations of these sera was of the order of 
90%. 
The analysis was repeated using a cluster defined by 
the overlap of the four Edinburgh sera of this group: 
EDA009, EDA010, EDA066 and EDA075. Table 5.1 shows the 
results of the analysis following this assignment of w6. 
It shows the close correlation between the w6 defining 
sera in all populations. This cluster was unique in that 
there was no loss of specificity in its defining reagents 
in the African cattle. 
The serum EDA097 clustered well with the w6 sera in 
the European animals, but in both the Zebu and Boran 
groups it had a large number of reactions with non-w6 
animals. Most of these animals had the KM18 specificity 
(described below), but there remained some reactions of 
EIJA097 with animals which were neither w6 nor KM16. 
Serograph Figure 5.2 summarises this situation. 
The Kenyan serum KMA025 appeared to detect a 
previously unknown sub-group of w6. In the Zebu group, 
the only six reactions of KMA025 were confined to w6 
positive animals. These six animals, however, came from 
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one herd and there is a possibility that they were 
related. 
The sera which have been assigned by international 
workshops to the w6 subgroups are as follows; w6.1: 
EDA012, EDA092, EDA093; w6.2: EDA086, EDA081. Spooner and 
Morgan (1981) further define w6.3 detected by EDA087, and 
w6.4 to which EDA100 was provisionally assigned by the 
European workshop. 
These assignments cannot be upheld by the results of 
the Bas iridicus populations. In the European population, 
the similarity indices between the w6.1 defining sera were 
higher than with any other sera, and their activity was 
largely confined to w6 positive animals. The same applied 
to the w6.2 reagents with the addition that EDA113 was 
closely associated with this cluster. 
Following these initial calculations a further 
clustering was performed using the above definition of 
w6.1 and defining w6.2 as EDA081, EDA086 and EDA113. The 
results of this analysis are contained in tables 5.2 and 
5.3. 	w6.1 formed a cluster in the European animals, with 
EDA093 showing more activity than the other sera. The 
frequency of the specificity detected by this cluster was 
too low for useful comment in the Borans, and in the Zebus 
it was seen in nine animals. However, these sera 
clustered less closely in the African animals than in the 
European breeds. The cluster KM18. which is detected by 
the sera KMA010 and KMA018, clustered with w6.1 in the 
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Table 5.1: w6-broad 
	
1 	 2 	 3 	4 	5 	6** 
SERA NUMBER +VE SIMTY 
population 	Si 	S2 	 Si 	S2 S18S2 (%) 
Zebu 	 W6 	EDA009 	0 	12 	79 92.9 
W6 EDA010 0 5 79 96.9 
W6 	EDA012 	29 	13 	49 70.0 
W6 EDA066 0 7 79 95.8 
W6 	 EIJA075 	0 	7 	79 95.8 
W6 EDA097 2 57 77 72.3 
W6 	KMA025 	73 	0 	6 14.1 
W6 KMA038 1 5 78 96.3 
Boran 	 W6 	EDA009 	0 	5 155 98.4 
W6 EIJAO1O 0 1 155 99.7 
W6 	EDA012 	44 	9 iii 80.7 
W6 EDA066 0 11 155 96.6 
W6 	 EDA075 	0 	9 155 97.2 
W6 EDA081 23 8 132 89.5 
W6 	 EDA091 	53 	87 102 59.3 
W6 EDA097 1 42 153 87.7 
W6 	EDA098 	112 	30 	43 37.7 
W6 EDA105 38 255 117 44.4 
W6 	KMA038 	4 	4 146 97.3 
European 	W6 	EDA009 	0 	6 	62 95.4 
W6 EIJAO1O 0 4 62 96.9 
W6 	EDA012 	38 	1 	24 55.2 
W6 EDA066 0 5 62 96.1 
W6 	EDA075 	0 	3 	62 97.6 
W6 EDA081 30 4 32 65.3 
W6 	 EDA086 	33 	3 	29 61.7 
W6 EDA092 41 4 21 46.3 
W6 	EDA093 	37 	28 	24 42.5 
W6 EDA097 1 7 61 93.8 
W6 	EDA113 	33 	10 	29 57.4 
W6 KMA038 8 12 53 84.1 
** 
The name of the cluster or "phantom serum" - Si. 
2 	The serum with which it is compared - 52. 
3 The number of animals positive for the cluster but 
not the serum - value "b' in the 2x2 table. 
4 	The number of animals positive for the serum but not 
the cluster - value 'c' in the 2x2 table. 
5 	The number of animals positive for both - value "a" 
in the 2x2 table. 
6 	The similarity index between these two "sera". 
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Table 5.2: w6.1 
SERA NUMBER +VE SIMTY 
population Si S2 Si 52 S1&S2 (%) 
Zebu W6.1 EDA012 0 53 9 25.4 
W6.1 EDA092 0 20 9 47.4 
W6.1 EDA093 0 36 9 32.1 
W6.1 KM18 3 17 6 37.5 
Boran W6.1 OCCURS IN ONLY ONE ANIMAL 
European W6.1 EDA009 0 54 15 35.7 
W6.1 EDAUIO 0 52 15 36.6 
W6.1 EIJA012 0 10 15 75.0 
W6.1 EDA066 0 52 15 36.6 
W6.1 EDA075 0 50 15 37.5 
W6.1 EDA092 0 10 15 75.0 
W6.1 EDA093 0 37 15 44.8 
W6.1 EDA097 0 54 15 35.7 
W6.1 KMA010 3 7 12 70.6 
W6.1 KMA038 1 52 14 34.6 
W6.1 W6 0 47 15 39.0 
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Table 5.3: w6.2 
SERA 	 NUMBER +VE SIMTY 
population 	 Si 	S2 	 Si 	S2 	Sl&S2 (%) 
Zebu 	 W6.2 OCCURS IN ONLY ONE ANIMAL 
Boran 	 W6.2 OCCURS IN ONLY TWO ANIMALS 
European 	 W6..2 	EDA009 	1 	38 
	
30 60.6 
W6.2 EDA010 1 36 30 61.9 
W6.2 	EDA066 	1 	37 
	
30 61.2 
W6.2 EDA075 0 34 31 64.6 
W6.2 	EFA08I 	0 	5 
	
31 92.5 
W6.2 EDA086 0 1 31 98.4 
W6.2 	EDA097 	1 	38 
	
30 60.6 
W6.2 EDA113 0 7 31 89.9 
W6..2 	KMA038 	4 	39 
	
26 54.7 
W6.2 W6 	 2 33 29 62.4 
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Table 5.4: The w6 subgroups 
Numbers of animals 
(Total w6) 	 w6 +ve 	w6 -ye 
Zebu 	 (79) 	w6.1 	7 	 2 
w6.2 1 0 
Boran 	 (155) 	w6.1 	0 	 1 
w6.2 1 1 
European 	(62) 	w6..1 	15 	 0 



















Another cluster which showed an interesting behaviour 
was w7. In the European animals there was no evidence of 
an association between w7 and wlO. Although in both 
European and African cattle w7 and wlO occurred only in 
animals also positive for the serum E13A085. However, in 
the African cattle, particularly the Borans, two of the w7 
defining sera (EDA017 and EDA067) reacted without the 
other two in a large number of animals, the vast majority 
of which were also wlO (see Figure 5.3). 
The cluster 7&10 was created, which comprised EDA017 
and EDA067 together with the wlO-defining sera, in order 
to study this phenomenon. Table 5.5 shows the similarity 
indices of this cluster, and its relationship with w7 and 
wlO is summarised in serograph Figure 5.3. This cluster 
occurred in only one animal in the European population - a 




Table 5.5: 7810 
SERA NUMBER +VE SIMTY 
population Si S2 Si 52 S1&S2 (%) 
Zebu 7810 EDA017 0 92 8 14.8 
7810 EDA067 0 112 8 12.5 
7810 EDA069 0 28 8 36.4 
7810 EDA071 0 52 8 23.5 
7810 EDA085 0 279 8 5.4 
7810 EIJA096 0 242 8 6.2 
7810 EDA105 0 243 8 6.2 
7810 KMA003 3 2 5 66.7 
7810 W10 * 0 15 8 51.6 
Boran 7810 EDA017 0 80 32 44.4 
7810 EDA067 0 104 32 38.1 
7810 EDA069 0 59 32 52.0 
7810 EDA071 0 58 32 52.5 
7810 EDA072 0 295 32 17.8 
7810 EDA085 0 247 31 20.1 
7810 EDA096 0 202 32 24.1 
7810 EDA105 0 340 32 15.8 
7810 KMA003 3 17 29 74.4 
7810 KKA004 2 7 12 72.7 
7810 MA04.1 3 13 15 65.2 
7810 MA07.1 0 141 18 20.3 
7810 WiG 0 27 32 70.3 
7810 M4 	! 3 7 11 68.7 
European 7810 OCCURS IN ONLY ONE ANIMAL 
* wlO defined by EDA069, EDA071, EDA096. 
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Ev idence_for__ sub -gLqgRs_2f w8  
The initial analysis of the performance of the w8 
defining sera showed a dramatic difference between the two 
Bos indicus populations and the Bos tau rus animals. Two 
of the Edinburgh sera which have been assigned to w8 at 
the second international workshop, EDA013 and EDA063. had 
a similarity index of about 70% in the Bos indicus animals 
and 87% in the Bos taurus animals. However, EDA080 which 
has also been assigned to w8, showed no correlation with 
these two sera in the Bos indicus groups. In the Bos 
taurys animals this serum was negative for some cells 
which reacted with EDA013 and EDA063, but it still had a 
correlation of around 75% with them. 
KMA022, a serum made in Kenya, appeared to detect a 
sub-group of w8 which occurred both in Bos indicus and Bos 
taurus animals. This serum was made in a w6/wlO Friesian, 
innoculated with Theileria parva infected lymphoblasts 
from a Friesian which was w6; EDA013, EDA063 positive; and 
EDA080 negative. 
The cluster w8 was therefore defined as EDA013 and 
EDA063. Another cluster, w8+, was defined as EDA013, 
EDA063 and EDA080 in order to examine the relationship of 
EDA080 with the other two sera. A potential sub-group of 
w8 called KM22 was defined as EDA013, EDA063 and KMA022 in 
order to find any relationship between this sub-group and 
the other sera which appeared to be associated with w8. 
The similarity index analysis was then re-run with these 
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clusters, and the results of these analyses are summarised 
in tables 5.6, 5.7 and 5.8. 
The correlation between the w8 defining sera and w8 
was about 80% in the Zebus. In the Borans, EDA063 
clustered closely (96.1%) with w8, that is, there were 
very few EIJA063 positive animals which were not also 
EDA013 positive. In the Zebus, there was no correlation 
between EDA080 and w8, while in the Borans the 
relationship was weak, the majority of w8 animals being 
EJJA080 negative. 
The relationship between EDA080 and this cluster was 
very different in the European cattle, although EDA013 and 
EDA063 also correlated very highly (88% and 98% 
respectively) with w8. Most (20/36) w8 animals were 
EDA080 positive, which is in contrast to both Bos iridicus 
groups where most are w8 positive and EDAOÔO negative. 
This is summarised in Figure 5.4. 
There was a comparable proportion of EDA080 
positive/w8 negative animals in the two groups but a large 
excess of w8 positive/EDA080 negative animals in the Bos 
indicus animals. This suggests a fundamental difference 
between the w8 in each group. The picture was confirmed 
by the behaviour of the cluster w8+ (table 5.7). 
The cluster KM22 occurred in both w8 and w8+ animals 
in all three populations. Approximately half of the 
Borans with w8 were also KM22 positive, and approximately 
one third of the European w8 animals were KM22 positive. 
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Table 5.6: w8 
SERA NUMBER +VE SIMTY 
population Si 52 Si 52 Sl&S2 (%) 
Zebu W8 EDA013 0 62 121 79.6 
W8 EJJA063 0 55 121 81.5 
W8 EDA072 34 144 64 48.6 
W8 EDA074 41 151 76 44.2 
W8 EDA096 48 187 71 37.7 
W8 EDA101 21 332 97 35.5 
W8 KMA009 49 150 71 41.6 
W8 KMA022 52 4 66 70.2 
W8 W8+ 114 0 4 6.6 
W8 KM22 52 0 66 71.7 
Box- an W8 EDA013 0 134 186 73.5 
W8 EDA014 127 62 59 38.4 
W8 EDA028 123 88 63 37.4 
W8 EDA063 0 15 186 96.1 
W8 EDA072 38 177 148 57.9 
W8 EDA074 27 144 159 65.0 
W8 EDA080 134 25 51 39.1 
W8 EDA099 120 63 66 41.9 
W8 EDA101 51 331 135 41.4 
W8 EDA109 55 324 131 40.9 
W8 KMA009 61 95 123 61.2 
W8 KMA022 93 1 92 66.2 
W8 W8+ 134 0 51 43.2 
W8 KM22 93 0 92 66.4 
European W8 E1jAO13 0 14 53 88.3 
W8 EDA063 0 2 53 98.1 
W8 EDA074 1 89 50 52.6 
W8 EDA080 16 4 36 78.3 
W8 EDA105 31 15 22 48.9 
We KMA009 26 59 26 38.0 
W8 KMA022 33 11 19 46.3 
W8 W8+ 16 0 36 81.6 
W8 KM22 33 0 19 53.5 
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Table 5.7: 	w8+ 
SERA NUMBER +VE SIMTY 
population Si S2 Si S2 Sl&S2 (%) 
Zebu W8+ EDA001 0 101 4 7.3 
W8+ EDA013 0 176 4 4.3 
W8+ EDA063 0 169 4 4.5 
W8+ EDA080 0 4 4 66.7 
W8+ EDA101 0 422 4 1.9 
Wa-I- EDI01B 0 104 4 7.1 
W8+ EDA109 0 417 3 1.4 
W8+ W8 0 114 4 6.6 
Boran W8+ EDA013 0 268 51 27.6 
W8+ EDA063 0 149 51 40.6 
W8+ EDA072 3 276 48 25.6 
W8+ EDA080 0 25 51 80.3 
W8+ KMA022 23 65 28 38.9 
W8+ W8 0 134 51 43.2 
W8+ KM22 23 64 26 39.2 
European W8+ EDA013 0 30 36 70.6 
W8+ EDA063 0 18 36 80.0 
W8+ EDA074 1 104 35 40.0 
EIJA080 0 4 36 94.7 
W8+ W8 0 16 36 61.8 
W8+ KM22 24 8 11 40.7 
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Table 5.8: 	KM22 
SERA NUMBER +VE SIMTY 
population Si S2 Si S2 S1&S2 (%) 
Zebu KM22 EDA013 0 114 66 53.7 
KM22 EDA063 0 107 66 55.2 
KM22 EDA072 2 165 61 42.2 
KM22 EDA074 4 168 58 40.3 
1(1422 ED101B 34 78 32 36.4 
KM22 KMA022 0 4 66 97.1 
KM22 W8 0 52 66 71.7 
Boran KM22 EDA013 0 227 92 44.8 
KM22 EDA063 0 108 92 63.0 
KM22 EDA072 4 236 88 42.3 
KM22 EDA074 1 211 91 46.2 
KM22 KMA009 19 145 73 47.1 
KM22 KMA022 0 1 92 99.5 
KM22 W6 0 93 92 66.4 
1(1422 W8+ 64 23 28 39.2 
European KM22 EDA013 0 47 19 44.7 
KM22 EDA063 13 35 19 52.1 
KM22 EDA074 0 120 18 23.1 
KM22 EDA080 8 28 11 37.9 
KM22 EDA105 6 24 13 46.4 
1(1422 KMA022 0 11 19 77.6 
KM22 W8 0 33 19 53.5 
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5. Sub-groups 
The demonstration of wlO - sub-groups 
The initial analysis of the activity of the wlO 
associated sera showed a marked difference between the Bos 
taurus and the Bos indicus groups. In the Bos taurus 
animals, wlO was very well defined by EDA069, EDA071 and 
EDA096. However, in the Bos iridicus animals this was not 
so for the correlation of EDA096 with EDA069 and EDA071 
was low. Between EDA069 and EDA071, the similarity index 
was 50% in the Zebus and 65.6% in the Borans. There was 
also evidence that two reagents, KKA004 and MA 4.1, were 
detecting a sub-group of wlO, and that the serum KMA003 
was detecting another. 
It seems that wlO is best defined in all groups by 
the overlap of EDA069, EDA071 AND EDA096. This was the 
definition of the cluster which was used in the next stage 
of clustering. To investigate the subgroups, a cluster 
called M4 was defined by MA 4.1 and KKA004. 
Tables 5.9 and 5.10 show the performance of these 
clusters. In the African cattle, there was a clear 
relationship between the cluster 7810 and wlO, but none 
between w7 and wlO. Figure 5.3 summarises this. A 
proportion of wlO animals showed activity for EIJA017 and 
EDA067. Figure 5.5 summarises the occurrence of the 
proposed wlO sub-groups. 
Both EIJA096 and EDA105 showed a great deal of non-wiG 
activity in the Bos indicus animals, but this activity was 




There was good evidence for the existence of 
subgroups of wlO in the Bos indicus populations. This is 
summarised in Figure 5.5. The activity of the Muguga-made 
serum KMA003 was entirely within wlO in the Bos indicus 
animals. It reacted with only one animal in the Bos 
taurus population, and this animal was negative for all 
wlO defining sera. In the Borans, the activity of the 
ILRAD-made reagents KKA004 and MA 4.1 was largely confined 
to wlO animals. These sera were not tested in the Zebu or 
Bos taurus groups. 
The correlation between MA 4.1 and KKA004 was very 
close, and the one discrepancy could well have been an 
error. The similarity indices of the cluster M4, which 
was considered to be detected by these two reagents, is 
shown in table 5.10. Both reagents were made by 
immunisation with the same animal (8641, a wlO,KM3,M4/KM18 
Boran) 
Ten N'dama calves from The Gambia were tested with 
the wlO defining sera. Four of these were wlO, and all 
four also reacted with KMA003 and the M4 defining 
reagents. Forty nine Friesian/Sahiwal crosses were also 
tested, 14 of which were wlO, and none were M4 or KMA003 
positive. 
Another monoclonal antibody, MA 7.1, showed activity 
for all wlO animals and many others in the Borans (the 
only group in which it was tested). It was made by 
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immunisation with lymphocytes from a Friesian (C17; 
w7/wiO). It also had reactivity for all KMI7 animals, as 
well as reacting with many animals which were neither KM17 
nor wlO. However there is no correlation with any other 
serum. All proposed clusters (except for w16, seen in 
only one animal) have animals which are MA 7.1 positive, 
and more which are MA 7.1 negative. 
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Table 5.9: 	wlO 
SERA NUMBER +VE SIMTY 
population Si S2 	' Si S2 S1&S2 (%) 
Zebu W10 EDA069 0 14 23 76.7 
W10 EDA071 0 38 23 54.8 
W10 EDA085 2 266 21 13.5 
W10 EDA096 0 225 23 17.0 
W10 EDA105 1 226 22 16.2 
W10 KMA003 16 0 7 46.7 
W10 7&10 15 0 8 51.6 
Boran W10 EDA017 12 64 47 55.3 
W10 EDA067 23 100 36 36.9 
W10 EDA069 0 31 59 79.2 
W10 EDA071 0 31 59 79.2 
W10 EDA072 5 271 54 28.1 
W10 EDA085 2 221 56 33.4 
W10 EDA096 0 172 59 40.7 
W10 EDA105 0 311 59 27.5 
W10 KMA003 17 3 42 80.8 
W10 KKA004 2 4 15 83.3 
W10 MAQ4.1 7 7 21 75.0 
W10 MA07.1 0 131 28 29.9 
W10 7&10 27 0 32 70.3 
W10 M4 3 4 14 80.0 
European W10 EDA069 0 1 56 99.1 
W10 EIJA071 0 1 56 99.1 
W10 EDA085 0 55 56 67.1 
W10 EDA096 0 1 56 99.1 
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Table 5.10: M4 
SERA NUMBER +VE SIMTY 
population Si S2 Si S2 S1&S2 	(%) 
Zebu M4 NOT TESTED 
Boran M4 EDA017 5 21 13 50.0 
M4 EDA067 6 36 12 36.4 
M4 EDA069 4 18 14 56.0 
M4 EDA071 3 12 15 66.7 
M4 EDA076 17 0 1 10.5 
M4 EDA085 0 58 17 37.0 
M4 EDA087 12 2 6 46.2 
M4 EDA105 1 69 17 32.7 
M4 KMA003 4 3 14 80.0 
M4 KKA004 0 1 18 97.3 
M4 MA04.1 0 0 18 100.0 
M4 MA07.1 0 70 18 34.0 
M4 7&10 7 3 11 68.7 
M4 W10 4 3 14 80.0 
European M4 NOT TESTED 
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In this study, a striking feature of the results of 
the initial analysis was the consistency of the 
relationship between the w6 defining reagents. KMA038 was 
made in Kenya by a skin implant into a non-w6 Boran from 
its calf of unknown BoLA type. Its correlation with the 
Edinburgh w6-defining sera is remarkable. 
It is, however, clear that EDA097, which in Europe is 
an excellent w6-broad defining serum, is detecting at 
least two specificities, one of which (KM18) is unknown in 
European anim.ls. 
The definition of the workshop sub-groups of w6 was 
not clear in the African animals, and it may be that their 
apparent occurrence outside w6 is due to cross-reactivity 
with antigens unrelated to those which occur as sub-groups 
of w6 in European animals. 
One serum which showed good evidence of specificity 
for a w6 sub-group was KMA025, which was made by the 
immunisation of a w6 Friesian with Theileria parva 
infected lymphoblasts from a w6 Friesian. This is the 
type of immunisation that would be expected to generate an 
anti - w6-sub-group antiserum. It has not shown activity 
for any Bos taurus animals other than the donor. However, 
the donor came from a farm where no detailed breeding 
records were kept, and where Bos taurus and Bos iridicus 
animals of a wide variety of breeds are allowed to run 
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together. It is therefore possible that it had some Zebu 
blood. It seems likely that KMA025 is detecting a w6 sub-
group which is extremely rare in Bos indicus animals. 
Although the fact that the animals with the KM25 
specificity were all zebus from Northern Kenya, makes it 
possible that the reactions of KMA025 were due to a 
specificity independent of w6 but controlled by a single 
haplotype common to these animals 
In summary, w6 showed evidence that it was itself a 
split of the antigen detected by EDA097. This had not 
previously been observed because the other part of this 
split (KM18) is unknown in Europe. The existing w6 sub-
groups w6.1 and w6.2 were very poorly defined in the 
African cattle, and may not have occurred at all, and 
there is some evidence for a new and extremely rare sub-
group of w6, detected by KMA025. 
w8 
This study strongly supported the view that w8 is 
best defined by the sera EDA013 and EDA063. and that 
EDA060 detects a sub-group. This sub-group is common in 
Europe, less common in the Borans and rare in Zebus. 
EDA080 also appears to have some non-w8 activity which is 
of similar frequency in all groups. A second w8 sub-group 
is defined by KMA022 and is also of comparable frequency 
in all populations. It is possible that it detects a sub-
group for which the workshops have offered evidence. 
These sub-groups do occur together (including animals with 
other putative first locus alleles) so they may be 
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distinct from the apparently mutually exclusive w6 
subgroups, and more akin to the proposed wlO subgroups, 
KM3 and M4. 
In the European animals, approximately 20% (8 of 44) 
of the animals with reactions in the w8+/KM22 complex had 
KM22 reactions without w8+. In the Borans, over 55% of 
such animals had only KM22. In the Zebu animals, only one 
of the 69 animals of this type had both reactions, while 
94% have only KM22. The occurrence of KM22 in animals 
whose PBL did not react with EDA080 is therefore a case in 
which a gradation is seen between the European and Zebu 
animals, with the Borans being of intermediate type. One 
explanation of this pattern would be the occurrence of a 
specificity which reacts with both EDA080 and KMA022, so 
that there are three mutually exclusive sub-groups of w8. 
Immunisations and absorptions to examine this are under 
way. 
KMA022 does react in non w8 animals at a low 
frequency (there are 5/606 such animals in the Zebus, 
2/662 in the Borans and 11/351 in the European group). It 
is likely that this is due to extra antibodies and, 
absorption studies of this serum are required to confirm 
this. 
There can be little doubt however, that this study 
has demonstrated w6 sub-groups. The reason that they were 
not easily seen in European cattle is that the large 
majority of w8 animals contained a single sub-group, that 
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detected by EDA080. The second sub-group, KM22, does 
occur in Europe in a fraction of the w8 animals and could 
have been serologically detected, although apparently it 
has not yet been found. This is a good illustration of 
the value of new populations to the serology of BoLA. 
wlO 
There was apparent cross-reactivity between two w7 
defining sera (E1JA017 and EIJA067) and the wlO specificity. 
This cross-reactivity is seen in both African populations 
and is completely absent in European cattle. A possible 
explanation is that these sera react with an antigen 
associated with wlU in Africa, which is rare in Europe, 
and which shares determinants with the w7 specificity. 
This would require that the four w7 defining sera are 
detecting at least two epitopes on the w7 molecule, one of 
which occurs on wlO in Africa. Since w7 and wlO are 
related in that they are both splits of the EDA085 
determinant, this explanation does not seem unreasonable 
and amounts to a subtype of wlO which is unknown in 
Europe. 
There is also good evidence for the existence of two 
wiD sub-groups in the African cattle, KM3 and M4, both of 
these often occur together in the same animal and are 
clearly not allelic. Both appear to be entirely absent in 
the European cattle. The one reaction of KMA003 with Bos 
taurus cattle is likely to be either a false positive or a 
cross-reaction with a completely different antigen, 
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although further tests to confirm this are underway. 
MA 4.1 was not tested in European cattle during this 
study. However, KKA004 has since been tested in 
Edinburgh, upon 235 cattle of a wide range of Bos taurus 
breeds. It showed activity for three cattle none of which 
were wlO, although there were 46 wlO animals in the group 
(Spooner, personal communication). 
This study has shown clear evidence of wlO subgroups 
with a frequency which is very much higher in both African 
populations than in the European cattle. It would be 
valuable to compare them with the sub-groups detected by 
American reagents at both international workshops, and 
this will be done at the next BoLA comparison test. 
The cluster which detects M4 is unique in BoLA-typing 
in that it is the only example of a monoclonal antibody 
and an alloantiserum which show almost perfect 
correlation. This is seen even when they occur outside 
wlQ, and makes it highly likely that they are detecting 
the same epitope. Karr (1984) reports two anti-HLA-class 
II MoAbs which in population studies appear to detect the 
same specificity as alloantisera, but in biochemical 
studies, they precipitate different molecules. However, 
this is not directly comparable with MA 4.1 and KKA004 in 
that the structure of class-II molecules is different from 
that of class I and the association between the M4 
defining reagents in this study is very close. It is 
possible that the non-wlO, M4 animals have this epitope on 
an antigen which is completely distinct from wlO, so that 
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this activity should not be considered as cross-reacLive. 
An alternative explanation is that M4 is the product of 
another locus, although the fact that its association with 
wlO persists in West African N'damas makes this unlikely. 
The wlU sub-groups have also been investigated with 
MLC-generated alloreactive CTL (Teale, personal 
communication), which can be more discriminative than 
alloantisera (Lopez de Castro et a!, 1984). This work has 
shown that there are CTL which have activity for the wlO 
specificity of both European and African cattle, 
irrespective of the presence of KM and M4. There is also 
evidence that some CTL are specific for the M4 antigen, 
including that on wlO negative M4 targets (Teale, personal 
communication). 
It has also been shown that the serum KKA004 
precipitates a 44,000 molecular weight protein, from the 




THE DESCRIPTION OF PREVIOUSLY UNKNOWN BoLA ALLELES 
Introduction 
A number of sera raised in Kenya clustered together, 
and reacted with a small number of animals in such a way 
as to suggest that they were detecting previously unknown 
BoLA antigens. This detection of new BoLA antigens was 
not surprising, for although the internationally agreed 
specificities did occur in the African cattle, the 
frequency of some was extremely low and this suggests 
that there are specificities more common in African than 
European cattle. Racially characteristic specificities 
are well known in HLA-typing (Dick, 1978; Terasaki, 1980; 
Albert et a!, 1984). 
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Methods 
Initially, new specificities were detected by 
searching for Kenya-made antisera which clustered 
together, but independently of the Edinburgh reagents. 
The method of analysis and the criteria for significance 
were as described in chapter 5. 
Subsequently, single sera were considered as 
potentially detecting specificities. This is not as 
reliable as the use of clusters, because many reactions 
may be due to second or third specificities which 
clustering with another serum would help to identify. The 
criteria for a potentially useful single serum were; a 
relatively rare occurrence; a similarity index with all 
other clusters and antisera of less than 10%, and no 
evidence of activity for sub-groups of other clusters. 
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Results and Discussion 
KK1 
The serum KKA001 had a 100% similarity index with 
KKA002 in the one population in which it was tested. The 
acitivity of these two appeared to be entirely within that 
of KMA014. Both KKA001 and KKA002 were made by grafts 
between Boran dam/calf pairs. both the donors being 
positive for KMA014 while the recipients were negative. 
KMA014 has been successfully absorbed in very small 
quantities with PBL taken from an animal which was KP4A014 
positive, KKA001 and KKA002 negative. This created a 
reagent which had no activity for the absorbing cell, but 
which retained activity for PBL from two animals whose PBL 
reacted with KKA001 and KKA002. Unfortunately the animal 
which provided the absorbing cells died before further 
absorptions could be made. It seems certain, however, 
that KMA014 contains at least two antibodies, one of which 
is highly correlated with KKA001 and KKA002. 
A cluster was therefore declared called KK1, which 
comprised these three reagents. Table 6.1 shows the 
results of the similarity index analysis with this 
cluster. Only four KK1 animals were found (of 592 which 
were tested with all three sera) so spurious associations 
are to be expected. However the cluster appears well 
defined. The apparent association with four Edinburgh 
sera could well be due to chance. 
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Table 6.1: 	KK1 
SERA NUMBER +VE SIMTY 
population Si S2 Si 52 S1&S2 	(%) 
Zebu KK1 NOT TESTED 
Boran KK1 EDA065 0 34 4 19.0 
KK1 EDA120 0 19 4 29.6 
KK1 ECA121 0 19 4 29.6 
KKI EDA125 0 60 4 11.8 
KK1 KMA014 0 15 4 34.8 
1(1(1 KKA001 0 0 4 100.0 
KK1 KKA002 0 0 4 100.0 
European KK1 NOT TESTED 
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KK3 
This cluster is based upon the serum KKA003, the 
activity of which appeared to be almost entirely confined 
to animals positive for three other sera, EDA089, EDA090 
and EDA118. The cluster KK3 was therefore considered to 
be detected by these four antisera. 
Table 6.2 shows the performance of this cluster in 
the Borans. Ten positive animals were found. KK3 seemed 
to be a single antigen, and was well defined by KKA003 and 
EDAU9O. 
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Table 6.2: 	KK3 
SERA NUMBER +VE SIMTY 
population Si S2 Si S2 S1&S2 (%) 
Zebu KK3 NOT TESTED 
Boran KK3 EDA089 0 34 10 37.0 
KK3 E]JA090 0 2 10 90.9 
KK3 EDA118 0 26 10 43.5 
KK3 KKA003 0 9 10 69.0 
European KK3 NOT TESTED 
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KM3O 
Analysis of the activity of the serum KMA030 showed 
that it had a similar relationship with other antisera 
(but not a similar reaction frequency) in all three 
populations. It appeared to be closely related to EIJA030, 
and reacted only with animals positive for EDA091. The 
reactions of KMA011 were confined to animals which also 
reacted with KMA030. The cluster KM30 was defined by the 
overlap of these four reagents and table 6.3 shows their 
performance. There was good evidence for a single antigen 
detected by this group of sera. 
Three of these sera, EDA091, KMA030 and XMA011, were 
assigned to the specificity EUl by the European workshop, 
where EM appeared to include wi, w3, w7, wil and w12. 
This is clearly not the case with KM30, although EDA091 
does seem to have some association with wil and w16. The 
reasons for this difference of interpretation are not 
clear. EU1 was a poorly defined cluster, and the effect 
may have been due to the small sample size used at the 
workshop. The performance of the cluster KM30 was 
comparable in all populations. 
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Table 6.3: KM30 
SERA NUMBER +VE SIMTY 
population Si S2 Si S2 S1&S2 (%) 
Zebu KM30 EDA030 0 127 96 60.2 
KM30 EDA091 0 141 96 57.7 
KM30 KMA011 0 22 96 89.7 
KM30 KMA030 0 91 96 67.8 
Boran KM30 EDA030 0 98 55 52.9 
KM30 EDA091 0 128 55 46.2 
KM30 KMA011 0 18 55 85.9 
KM30 KMA030 0 56 55 66.3 
European KM30 EDA030 0 47 24 50.5 
KM30 EDA091 0 118 24 28.9 
KM30 KMA011 0 15 24 76.2 
KM30 KMA030 0 49 24 49.5 
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KM17 
Following initial similarity index analysis, the 
Kenyan serum KMA017 appeared to cluster with another 
Kenya-made serum, KMA029. Cluster KM17 was declared, 
which was considered to be detected by KMA017 and KMA029. 
Table 6.4 shows the result of this analysis. The 
association between the two sera was high, KMA017 having 
more positive reactions than KMA029. The frequency of the 
specificity was comparable in the two Bos indicus 
populations, but KM17 was entirely absent in the European 
cattle. 
In both African populations KM17 was entirely 
confined to animals positive for EDA105. In the Borans, it 
was almost entirely confined to animals also positive for 
FJJA072. The monoclonal antibody MA 7.1 was also positive 
for all KM17 animals, as well as for many non-KM17 animals. 
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Table 6.4: KM17 
SERA NUMBER +VE SIMTY 
population Si S2 Si S2 S1&S2 	(%) 
Zebu 10417 EDA105 0 235 21 15.2 
KM17 KMAQ17 0 23 21 64.6 
KM17 KMA029 0 6 21 87.5 
Bora.n 10417 EDA072 1 290 29 16.6 
KM17 EDA105 0 329 30 15.4 
KM17 KMA017 0 37 30 61.9 
KM17 KMA029 0 0 30 100.0 
KM17 MA07.1 0 144 15 17.2 
European KM17 DOES NOT OCCUR 
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KM4 
Reactions with the serum KMA024 were not common in 
either of the Bos indicus groups, and in the Bos taurus 
population it reacted with only two animals. It had a 
high correlation with KMAO04, which reacted with some 
KMA024 negative animals. Despite the extremely low number 
of animals which reacted with this pair of sera, there was 
no evidence of association with any other sera or 
clusters. This alone was evidence that they were 
detecting a BoLA allele. KMA024 and KMA004 were therefore 
assigned to the specificity KM4. 
The results of analysis with this cluster are shown 
in table 6.5. The correlation between the two was 
excellent, and it seems safe to assume that they were 
detecting a single antigen. 
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Table 6.5: KM4 
SERA NUMBER +VE SIMTY 
population SI 52 Si 52 S1&S2 (%) 
Zebu KM4 KMA004 0 4 ,9 81.8 
KM4 KMA024 0 0 9 100.0 
Boran KM4 KMA004 0 2 5 83.3 
KM4 KMAO24 0 i 5 90.9 
European KM4 ONLY ONE ANIMAL POSITIVE 
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KM18 
The reactions of the two Kenyan sera, KMAO1O and 
KMA018, appeared to cluster together. They correlated 
well in the two Bos indicus populations, KMA010 having 
activity for some animals which did not react with KMA018. 
In the Borans, they also showed associations with several 
other reagents; EDA113, EDA114, EDA115, EDA093 and MA P3. 
Unfortunately, none of these sera were tested in the Zebu 
group. EDA097, a w6 defining serum, was positive for all 
KM18 animals as well as w6 animals (Figure 5.2). EDA115 
and MA P3 also reacted with all KM18 animals, and many 
others. 
In the Bos taurus group, the situation was very 
different. Reactions of KMA010 were not uncommon, but 
EDA016 occurred in only three animals. The relationship 
with EDAO93 appeared to remain, and suggests that this 
serum is detecting the non-KM18 element of KMA010. EDA113 
was more closely related to KMA018 than to KMA010, and all 
three KMA018 reacting cells were EDA113 positive. 
EDA093 is a w6.1 defining antiserum. At the European 
workshop, KMA010 was assigned to w6.1, having complete 
correlation with this cluster. It seems that this 
activity is shown by KMAO1O only in European animals, and 
that it is distinct from the cluster defined by the two 
sera KMAO1O and KMA018. 
In an attempt to unravel this complex. KM18 was first 
defined as KMA016, KMA010, EDA097 and EDA093. Table 6.6 
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shows the results of this clustering. Clearly, the 
cluster KM16 was extremely rare in Europe. The reactions 
of MA P3 were all with KM18 animals. EDA093 correlated 
well with KM18 in the African animals, and not at all with 
it in Europe. There were 53 EDA093 reactions in Europe, 
and the similarity between this serum and KMA010 was 
41.1%. It seems that KMAO1O has an anti-w6.1 component, 
and that this is distinct from the KM18 component. Thus 
in European cattle, where there are few KM18 animals, 
KMAO10 appears to be a good w6.1 antiserum, and it appears 
to be a good KM18 antiserum in Africa where there are few 
w6.1 animals. 
That KM18 is a BoLA product is supported by the use 
of primary-MLC-generated alloreactive CTL, which have 
activity only for cells with the KM18 specificity (Teale, 
personal communication). It has also been shown that the 
MoAb MA P3 precipitates a typical class I molecule, of 
approximately 44,000 daltons moecular weight (Berisaid, 
personal communication) 
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Table 6.6: KM18 
SERA NUMBER +VE SIMTY 
population Si S2 Si S2 Sl&S2 (%) 
Zebu KM18 EDA092 12 19 10 39.2 
KM18 EDA093 0 24 23 65.7 
1(1418 EDA097 0 113 23 28.9 
KM18 KMA010 0 24 23 65.7 
KM18 KMA018 0 3 23 93.9 
Boran 1(1418 EDA093 0 10 16 76.2 
KM18 EDA097 0 176 16 15.4 
1(1418 EDA113 0 70 12 25.5 
KM18 EDA114 4 4 8 66.7 
KM18 EDA115 0 31 12 43.6 
KM18 KMA010 0 22 16 59.3 
KM18 KMA018 0 15 16 68.1 
KMI8 MA05.1 0 33 12 42.1 
1(1418 MA P3 0 5 6 70.6 
European KM18 OCCURS IN ONLY TWO ANIMALS 
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KM33 
In the European animals, reactions of EDA040 were 
seen in 14 animals. These reactions were largely confined 
to animals which also reacted with the serum EDA124. 
However, in the Zebus EDA040 reactions were common, 
88 animals being positive for this serum. EDA124 was not 
tested in this group. In the Borans, EDA040 reactions 
were rarer, nine animals being positive. There was no 
evidence of an association with EDA124 in these animals. 
However, both of the Bos indicus groups showed signs 
of a specificity entirely confined to animals positive for 
EDA040. The Kenyan serum KMA033 reacted with 21 of the 88 
EDA040 positive Zebus, and with only one EDA040 negative 
animal. In the Borans, this serum reacted with one of the 
nine EDA040 positive animals, and with only two others. 
K11A033 has never shown a reaction in Bos taurus animals. 
The European serum EJJA040 was assigned by the 
European workshop to the specificity E012, which appeared 
to be a BoLA-A locus product. It is clear from this study 
that EDA040 contains at least two specificities, including 
one which is rare in Europe. It is surprising that such a 
population of antibodies could be raised in a population 
which appears not to contain the KM33 specificity. One 
explanation is that the two specificities, EU12 and KM33 
are controlled by completely different alleles but that 
the determinant detected by EDA040 is common to the 
products of both. 
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There can be little doubt that the African animals 
which reacted with both EDA040 and KMA033 did not express 
the EU12 molecule. 	It is possible that the EU12 molecule 
was present in the animals which were KMA033 negative. 
There is therefore good evidence here of a specificity, 
KM33, which is rare or unknown in European cattle and not 
uncommon in Bos indicus. The frequency of the KM33 
specificity was another case in which the Borans seemed to 
be intermediate between the European animals and the 
Zebus. 
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Apart from the sera described above which formed 
clusters, a number of sera which were made in Kenya showed 
no association with any other sera or clusters of sera. 
The results of the initial similarity index calculations 
clearly showed these reagents and the frequency of their 
reactions in the different populations. 
Examination of these results suggested that the 
following sera might be detecting products of a single 
locus, because they had no significant associations with 
other antisera and because they reacted with lymphocytes 
from a small fraction of animals; KMAOO1, KMA008, KMA012, 
KMA021, KMA023, KMA027, KMA028, KMA039, KMA040. The 
frequency of the reactions of these sera is shown in 
Table 6.7 
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Table 6.7 
% FREQUENCY OF POSITIVE ANIMALS 
SERUM ZEBU BORAN EUROPEAN 
KMA001 3.49 1.84 3.29 
KMA008 14.40 12.15 0.58 
KMA0I2 2.67 13.08 0.58 
KMA021 2.01 0.46 0.87 
KMA023 1.50 1.69 2.05 
KMA027 0.63 0.31 0.58 
KMA028 1.18 0.77 4.97 
KMA039 1.03 1.40 0.00 
KMA040 1.55 0.93 0.58 
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Conclusions 
There was good evidence of several new specificities, 
although only those detected by clusters of reagents were 
well defined. Those defined by a single serum can only be 
considered tentative because the sera are unlikely to be 
monospecific. However, two of the most frequent of these, 
KM8 and KM12, have since been shown to cluster with other 
sera made independently, and appear to detect single 




THE GENETIC CONTROL OF THE NEW SPECIFICITIES 
Introduction 
The panel of antisera used in this study included 
sera which detect all of the internationally agreed BoLA 
specificities. Differences in the performance of these 
sera were expected when they were used in a new population 
such as the African cattle, since apparent losses of 
specificity are well known in the HLA field when sera are 
used in different populations (Dick. 1978). It could not 
therefore be assumed that, when all the sera of a cluster 
reacted with an animal, that the animal was positive for 
the antigen detected by that cluster in European cattle. 
The first task therefore in examining the results of the 
BoLA-typing, was to consider the activity of these well 
defined European reagents and to decide how far their 
operational monospecificity was changed in the African 
cattle. Having done this, it becomes possible to consider 
the genetic control of the new specificities which this 
study has proposed. 
Methods 
The similarity index programme provided a great deal 
of information about the way the defining sera were 
behaving. It was expected that a loss of specificity 
would not affect all sera of a cluster in the same way, so 
that cross-reactivity of the sera would be revealed by a 
reduction in the similarity between the members of a 
165 
7. Genetic control 
cluster. Such a reduction was seen in all clusters except 
w6. 
A useful way to determine whether or not antigens are 
controlled by the BoLA-A locus is to look for "triples", 
that is antigens which occur with two or more other BoLA-A 
locus products. If this happens, it is certain that 
either one of the antigens is not an A locus product, or 
that two clusters are detecting the same antigen. 
Therefore the selection and printout programmes were used 
to examine the way in which the clusters occurred. It may 
be significant that the similarity index analysis did not 
reveal any clusters which were associated with each other, 
except those considered to be subgroups. 
Results 
An initial examination of the internationally agreed 
clusters showed that some made triples, most of which 
involved w3, w4, w8 without its subgroups, w9 and w20. 
Triples were more common in the African animals than the 
European ones. 
w3 formed two triples (in addition to those caused by 
reactions with the w9, w20 and w8 sera) both of which were 
in the Borans. One of these animals was w3/w6/w13, and 
the other was w3/w7/w13. Since w3 is defined by a single 
serum (EDA039), it is not surprising that it occasionally 
formed triples. In Europe, all w3 animals are positive 
for EDA001 (Spooner et al. 1979a; Anon, 1982). Both of 
the African w3 triples were negative for EDA001 and this 
166 
7. Genetic control 
demonstrated that in the African cattle EDA039 was 
detecting a non-w3 antigen, and that the true w3 antigen 
occurred only in EDA001 and EIJA039 positive animals. 
The w4 defining serum (EDA082) made four triples, all 
in the Borans. Like the w3 reagent, this single serum 
seemed to detect a BoLA-A locus product and to have some 
cross-reactivity with other antigens. EDA117 has a high 
similarity index with the w4-defining serum in all 
populations. If the definition of w4 was restricted to 
those animals which were also positive for EDA117 then no 
triples were seen. Unfortunately, this serum was not 
tested in the Zebus, and w4 had therefore to be considered 
undetected in this population. 
w8 showed six triples in the Borans, eight in the 
Zebus and none in the European population. Of these 14 
triples, only six involved w3 or w4. It seems that in 
both African populations wô, as defined by EDA013 and 
EDA063, was detecting an extra antigen which was distinct 
from the European w8. If the definition of w8 was limited 
to those animals also showing EDA080 reactions or KMA022 
reactions (i.e. w8+ or KM22), then there were only three 
triples, all in Borans, and two of which involved w4 
animals which did not react with EDA017. This suggested 
that it was reasonable to define two antigens, w8+ and 
KM22, which appear to be the products of BoLA-A alleles. 
However, 1(1422 and w8+ are not allelic to each other. 
In all populations there are many w6+/KM22 animals with 
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other first locus alleles. The best explanation seems to 
be that there is a basic antigen defined by w8 which has 
sub-groups defined by w8+ and KM22. In Europe, w8 showed 
no triples, but in Africa it was impossible to define this 
antigen because of non-w8 reactions in the defining sera 
EDA013 and EDA063. 
In both Borans and Zebus, w9 showed many triples 
which included almost every other cluster. In the 
European animals, w9 was much less common and showed no 
triples. Clearly the w9 sera detected more than one 
antigen in the African cattle. Similarly, w20 showed many 
triples in both African populations. In the Borans, there 
were five animals with triples including w20. 
In view of this, w3 was re-defined as requiring 
reactions of EJJA039 and EDA001. This meant that if an 
animal was wl/w3 it was impossible to know if it was a 
genuine w3, because EDAOO1 is also a wi defining serum. 
w4 was re-defined as occurring only in EDA082 and EDA117 
positive animals. w8 was discarded as a useful cluster, 
so that only w8+ and KM22 were considered to be BOLA-A 
locus alleles. The definition of w4, w9 and w20 was 
considered to be inadequate for further analysis. 
None of the other internationally recognised clusters 
showed any triples. Some, of course, are extremely rare 
in the African cattle, and so triples would not be 
expected even if they were detecting more than one BoLA-A 
product or a non-BoLA-A product. 
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Having shown that, with the exceptions noted above, 
the internationally agreed clusters perform as products of 
alleles at the same locus, it was then possible to examine 
the way in which the unassigned clusters and sera 
performed. The reactivity of these sera was studied in 
relation to the known clusters described above. No 
attempt was made to compare their relationship with each 
other until this had been done. 
Table 7.1 shows the number of triples shown by each 
of these Kenyan sera, independently of the others, in 
relation to their frequency and the frequency of animals 
with two 'good workshop clusters (i.e. excluding w4, w9 
and w20 and restricting the definition of w8 to w8+ and 
KM22 and that of w3 to w3 with EDA001 reactions) in each 
population. 
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Table 7.1 - Observed and expected numbers of triples 
Expected number of triples were calculated by multipling 
the frequency of the antigens detected by the sera by the 
frequency of "good doubles" in a population. If these 
specificities were assorting independently of the workshop 
specificities, then this is the number of triples which 
would be expected. A number lower than this suggests 
that, at least part of the activity of a serum is directed 
against a specificity which is an allele of the BoLA-A 
locus. 
Expected number of : Observed 
triples if non- : number 
allelic to BoLA-A : of 	triples 
--------------- ---------------------- -Therefore: 
Boran Zebu European : Boran Zebu European 	:Allelic 	: 
KM17 	4 1 0 : 	0 0 	0 : 	Yes 
KM4 1 0 0 : 0 0 0 : ? 
KM18 	2 2 0 : 	1 	S 1 	& 0 : 	Yes 
KMA001 2 1 3 : 0 1 4 : No 
KMA00811 6 1 : 	3 1 	0 : 	Yes* 
KMA01211 1 1 : 0 0 0 : Yes 
KMA021 	0 1 1 : 	0 0 	0 : 	? 
KMA023 1 1 2 : 0 0 2 : 
KMA027 	0 0 1 : 	0 0 	0 : 
KMA028 1 0 5 : 1 0 3 : 	No 
KMA033 	0 1 0 : 	0 0 	0 : 
Observed number of 	"good" doubles: Boran 87/665 	= 	13.1% 
Zebu 40/606 = 6.6% 
European 99/351 	= 	28.2% 
$ Due to a w3/wl animal, w3 cannot be identified in this 
situation. 
& Due to a w6.1 animal. 
* three of the four triples are due to wlO without KMA003 
or KK4. 
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Discussion 
The cluster KK1, which was only tested for in the 
Borans, occurred in four animals, none of which formed 
triples. However, four animals is not enough to judge the 
significance of this result. 
KK3 was seen in ten Borans, and one of these formed a 
triple of the type w5/KM22/KK3. Again, it is not possible 
to draw many conclusions. 
KM17, which was seen in 30 Borans and 21 Zebus, did 
not form any triples. This cluster did not occur in any 
European animals. It seems likely from these results that 
KM17 is the product of a BoLA-A locus allele. 
KM4 occurred in five Borans, nine Zebus and one 
European animal, and did not form triples in any of these 
animals. 
KM18 occurred in 16 Borans. There was one possible 
triple in this group, an animal which was w1/w31KM16. 
However, since the animal is wi and therefore reacts with 
EDA001, it is likely that it is not a true w3. 	In the 
Zebus. KM18 occurred in 23 animals where it formed one 
triple of the type KM22/w6.1/KM18. There is an 
association between one of the KM18 defining sera (KMA010) 
and w6.1, and it is therefore possible that this was not a 
true KM18 animal. The evidence seems good that the KM18 
defining sera are detecting the product of an allele at 
the BoLA-A locus, except where w6.1 is present when cross- 
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reactivity may occur. 
The serum KMA001 reacted with a comparable proportion 
of animals in all populations. It created many triples in 
all. In the European animals triples were seen with an 
apparently random mixture of clusters, and in both African 
populations KMA001 positive animals were frequently 
positive for the w9 defining serum. The similarity index 
calculations suggested that this serum was associated with 
w9 in both Zebus and Borans, the similarity indices being 
16.8% and 22.4% respectively. In both populations the w9-
detecting serum showed activity for more animals than did 
KMA001, although there were some animals which were KMA001 
positive and w9 negative. 
One possible explanation of this situation is that 
KMA001 is detecting the product of a second BoLA locus. 
The w9 defining serum is known to show non-w9 activity in 
the African cattle, and it may be that KMA001 cross-reacts 
with the antigens responsible for these reactions. It is 
certain, however, that KMA001 is not detecting the product 
of a single BoLA-A allele. Whether its pattern of 
reactivity is due to activity for a range of BoLA-A 
products, or whether it is due to activity for the 
products of a small number of alleles controlled by a 
separate locus, cannot be determined without further 
study. 
There was a significant proportion of animals 
positive for KMA008 in both African populations, but its 
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activity was less common in Europe. A large number of 
triples would be expected to occur if this serum was 
detecting an antigen which is not allelic to the workshop 
specificities. In fact, there was only one in the Zebus 
and three in the Borans. It may be significant that all 
of these triples involved wlO. Of these four wlO triples, 
three were negative for KM3 and KK4. The fourth involved 
the rather weak cluster w13. This raises the possibility 
that EDA069 and EDA071 may be poor at defining wlO, and 
that in fact no true Boran wlO is negative for both KM3 
and KK4, or at least that the definition of wlO without 
these clusters is unreliable, this would be analogous to 
the w8 situation. 
Thus, there was excellent evidence that KMA008 was 
detecting the product of an allele of the BoLA-A locus. 
This serum may, however, contain a second antibody 
population which cross reacts with a w10-associated 
antigen. 
That the determinant detected by KMA008 was indeed a 
BoLA-A locus product was confirmed by family studies. The 
Boran Bull 54 is of BoLA-A phenotype w6/KM8. It has eight 
offspring which, together with their dams, were BoLA-typed 
in order to examine the segregation of the proposed KM8 
specificity. The results are shown in table 7.2. 
Clearly, the specificity detected by KMA008 is allelic to 
the bull's w6 allele. The KM8 determinant was passed to 
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Table 7.2: The inheritance of KM8 
The offspring of the w6/KM8 bull, number 54, showing the 
inheritance of the proposed KM8 determinant as a BoLA-A 
locus product. 
Sire 	 Dam Calf 
w6/KM8 	 w6/w8,KM22 w6/w8,KM22 







The KM8 determinant was passed to four of eight calves. 
In only one case is it impossible to exclude the 
possibility that both w6 and KM8 were inherited from 
the sire. 
174 
7. Genetic control 
four calves, only one of which was also w6, while the dam 
of this animal was of BoLA type w6/-. The bull appeared 
to pass w6 to the remaining four calves. 
The serum KMA012 reacted with a large number of 
Borans, fewer Zebus, and only two European animals. 
Despite the frequency of its reactions, it formed no 
triples. It seems likely therefore, that at least in the 
Borans, this serum is detecting the products of a BoLA-A 
locus allele. 
KMA021 reacted in very few animals, three Borans, 
three European animals and 12 Zebus. It formed no 
triples. It is not easy to draw any conclusions from 
these very limited observations. This serum may detect 
the product of a BoLA-A allele, or an antigen controlled 
elsewhere. 
Reactions of KMA023 were not common in any 
population. It reacted with 11 Borans, nine Zebus and 
seven European animals. Two triples were seen in the 
European cattle. It is not possible to draw any 
conclusions from these results at this stage. 
The reactivity of KMA027 was extremely rare in all 
groups. It reacted with two Borans, five Zebus and two 
European animals. No triples were seen. 
KMAO28 is another serum with activity for a small 
number of animals. It detected five Borans, seven Zebus 
and 17 European animals. Among the African animals there 
0 
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was one triple, while in the European animals there were 
three, all involving "good" BoLA-A locus clusters. 	It 
seems likely that this serum is operationally monospecific 
in the African animals in view of its low reaction 
frequency. It is possible that the greater number of 
reactions in the European cattle was due to extra activity 
for anticiens not seen in African cattle. However, it is 
certainly possible that this serum was detecting an 
antigen which is not controlled by the BoLA-A locus. When 
suitable animals are identified, family studies will be 
made to investigate this possibility.  
The activity of KMA033 was entirely confined to 
animals which also reacted with EDA040, the E012 defining 
serum. There were no KMA033 reacting animals in the 
European group. There were 21 Zebus which reacted with 
KMA033, and only one Boran (another example of Borans 
showing a greater resemblance to European animals than 
Zebus). There were no triples with workshop clusters, but 
KM33 formed many triples with an apparently random 
assortment of proposed BoLA-A specificities detected by 
Kenya made sera. Since the workshop specificities are not 
common in this population, and since the proposed 
specificities hold up very well in every other respect in 
every other population, it would appear that KMA033 is 
detecting an antigen which is not controlled by the BoLA-A 
locus. 
It is likely that the antigen detected by KMA033 
is completely different from that detected by EDA040 and 
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is not a sub-group of it. 
As a result of this series of analyses the following 
































If this scheme is applied to the results of the BoLA 
typings, the Zebus show 92 animals with two detectable 
BoLA-A locus products. In addition they show four 
triples, one triple included w6.1 and KM18, which may 
cross-react, and and one involves wlO without KM3. 
In the Borans there are 184 animals with two 
detectable A locus alleles. There are also seven triples, 
of which two are attributable to wl0 without KM3 or 
KK4. In the European animals there are no triples. 
The proposed non BoLA-A specificities are too rare to 
allow any conclusions. No animals form "second locus 
triples, but only one has two second locus specificities. 
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The evidence is extremely good that the proposed 
BoLA-A locus specificities are actually controlled by this 
locus. It may well be that the defining sera will show 
extra activity in other populations, as did many of the 
Edinburgh sera which had been exhaustively tested in 
Europe. 
Much less may be said of the other specificities. 
KK1 and KK3 appear to be highly specific, in that they 
react with very few cattle. There is only one triple in 
the Borans involving these clusters, a w5/KM22IKK1 animal. 
There is, of course, no reason to believe that the non 
BoLA-A specificities are controlled by the same locus, or 
even that they are controlled by loci linked to the BoLA-A 
locus. 
jb2_22pglation distribution of the BoLA alleles 
The gene frequency programme was used to calculate 
the gene frequencies of the proposed BoLA-A alleles in 
each population. The graph Figure 7.1 summarises the 
results. All of the Zebu groups were pooled to create the 
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A dramatic and consistent feature of the performance 
of the BoLA-typing antisera was their loss of specificity 
when used outside the population in which they were raised 
and tested. This is not surprising, and was clearly seen 
in the early days of the study of the HLA system (Dausset 
and Colombani, 1972). It does, however, suggest that 
there are a large number of antigens in both populations 
which are yet to be described. Such differences in the 
frequency of specificities in different racial groups are 
well known in HLA (Dick, 1978). 
It does not follow that the BoLA product which causes 
the appearance of these extra reactions in the new 
population, was present in the immunising animal. It 
merely suggests that two different products share a common 
epitope. The sharing of epitopes between products is a 
common feature of HLA-A and B antigens, and Lopez de 
-Castro et a! (1984) suggest that a given HLA class I 
antigen contains eight regions of variability which may 
correspond to antigenic sites. 	If this is so, then 
epitopes shared between different allelic products would 
not be surprising. 
However, the appearance of extra activity when sera 
are tested in a new group of animals, does imply the 
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existence of MHC alleles which are undetected in the 
population in which the serum was raised and tested. The 
sharing of epitopes further suggests an evolutionary 
relationship between these new BoLA products, and antigens 
present in the original population. 
Further evidence of differences between the HI-iC make-
up of the African and European groups was provided by the 
detectable BoLA-A locus alleles. Some were seen in both 
populations at very different frequencies, while others 
(w3, wil, w16, KM17, KM18) were extremely rare or 
undetected in one or other group. Differences in MHC gene 
frequency is not surprising in view of the number of 
generations for which these populations have been 
separated (Epstein, 1971). However, the fact that some 
specificities, notably w6 and w8, are present in widely 
diverse populations at similar frequencies while others 
are virtually unique to one or other, is evidence that 
BoLA antigens are exposed to selection. 
Of course, one crucial question in considering 
frequencies of BoLA antigens is whether or not the same 
products are being detected in different populations. The 
loss of specificity shown by many of the antisera makes it 
possible that this is not the case. However, many of the 
clusters comprise four or more sera, and in only one case 
was there a consistent 'shift" of activity in more than 
one of these defining sera (EDA017 and EDA067 occurring 
without si?). The overlap of several defining sera at a 
useful frequency indicates that the specificity detected 
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can be safely considered to be the same in all groups. 
There may be differences at a site which is not recognised 
by any sera of a cluster, but the probability of this 
decreases with the number of defining sera. 
New BoLA alleles 
This study provided evidence for the existence of 
five new BoLA-A locus alleles, which have been designated 
KM4, KM17, KM18, KM8 and KM12. There is particular clear 
evidence that two of these, KM8 and KM12. are indeed A 
locus products. Both occur in African cattle at a high 
frequency (12% and 13% respectively in Borans). New sera 
have recently been made which cluster extremely closely 
with the sera defining these specificities (Kemp and 
Teale, unpublished observations). The definition of the 
other three specificities is slightly less secure, 
although there seems little doubt that they do represent 
BoLA products. However, their low frequency makes their 
genetic control hard to determine by population studies, 
and reduces the confidence which can be placed in the 
similarity of the defining reagents. 
The identification of new and characteristically 
African specificities was one of the major objects of this 
study, and KM8 and KM12 alone account for 25% of the BoLA-
A locus products in Borans. Only w6 and w8 occur at a 
higher frequency, and these were both shown to be 
supertypic specificities. Their apparent occurrence in 
European cattle is so rare as to make it possible that 
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they do not truly occur (both KMAOUÔ and KMA012 reacted 
with approximately 0.6% of European cattle), but may be 
due to cross-reactivity in the defining sera which was 
undetected in Africa. It is important to improve the 
serological definition of these antigens and to examine 
their occurrence in Europe, and this work is currently 
under way. 
Further class I loci ? 
This study failed to provide solid evidence for 
alleles controlled by a second BoLA locus. When one locus 
is as well characterised as the BoLA-A locus, it is 
inevitable that the genetic control of new alleles will be 
more readily seen when they are also under A locus 
control. This is because allelism is easy to recognise 
when a useful fraction of the allelic products are already 
known. 
However, there were no clusters of sera which were 
clearly not under A locus control. The only potential 
candidates for B locus control (KM1, KM23 and KM33) were 
defined by single sera. This suggests that the BoLA-B 
locus, if it exists, may have poorly antigenic products. 
There is no evidence of such differential antigeriicity in 
any other species with polymorphic class I genes. The 
failure of the international BoLA community to demonstrate 
a second class I locus does however seem to be becoming 
significant. The distinction of HLA-A and -B was 
recognised early in the study of the human MHC, and the 
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definition of the C locus followed soon after that 
(Bodmer, 1978). The evidence that the BoLA system is 
different in this respect from the HLA system is mounting. 
It is possible that the cow has other class I loci, 
but that they are monomorphic. In man, the polymorphism 
of two of the class I loci is high, while the third (HLA-
C) has only eight alleles so far recognised (Albert et al, 
1984). There are species with monomorphic class I loci, 
including those with one polymorphic and one monomorphic 
locus (Streilein et. a!, 1984). 	If this were the case in 
cattle, then the proposed non-BoLA-A defining reagents 
might be detecting further splits of A locus products. 
Another possible explanation would be that the two 
loci have extremely low recombination frequencies, and so 
are not separable serologically. If this were the case, 
then a study such as this one would be expected to detect 
splits in existing clusters, because it is most unlikely 
that no recombinations have occurred since the separation 
of the European and African populations and their exposure 
to widely different environments. With one exception 
which will be discussed below, this was not the case. If 
some of the present clusters are due to the products of 
two loci then the linkage disequilibrium between them must 
be very high and must be identical in widely different 
populations. 
Studies based purely on serology, such as this one 
and that of Stear et a! (1982b), cannot be expected to 
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provide definitive evidence for multiple loci. These 
workers reported the use of low titre antisera. However, 
such sera have been shown to be extremely unreliable 
perhaps because of anti-complement activity (unpublished 
observations). Also, Stear et al, formed clusters based 
on sera with correlation coefficients as low as 0.212, 
which is far below normally accepted levels (de Weck et 
al, 1976). The results reported here provide considerably 
less evidence for further BoLA class I loci than those of 
Stear et al, and this may well be because of the high 
standard of sera which were initially used to define the 
internationally recognised specificities. These sera were 
exhaustively tested and refined at a series of 
international comparison tests, and they still showed 
polyspecificity when used in African cattle. Clearly the 
existence of triples cannot reliably demonstrate multiple 
loci. 
Biochemical studies of the molecules precipitated by 
the antisera, using an approach such as that described by 
Hoang-Xuan et al (1982a; 1982b), are capable of 
demonstrating multiple class I products, given suitable 
antibodies. Genetic studies using large families of full 
or half sibs to detect recombinations are another 
promising means of investigating the genetic nature of the 
BoLA class I products. Both of these approaches are 
beginning, using the sera developed during this study. 
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The sub-group relationship of some of the 
specificities described in this study could be explained 
by the existence of a second BoLA class I locus. One 
example is the apparent cross-reactivity with wlO shown by 
two of the w7 defining sera (EDA017 and EDA067). w7 and 
wlO are serologically related, in that together with w4, 
A 	 they only occur in animals which are also positive for the 
operationally monospecific serum EDA085. One possibility 
is that w7 is, in reality, two products controlled by 
separate loci but occurring together, and that in Africa 
there has been a recombination giving a product in linkage 
disequilibrium with wlO. However, the facts that these 
two sera never reacted with animals which were not either 
w7 or wlO, and that the same phenomenon is seen in both 
Bos indicus groups, makes this explanation unlikely. It 
seems more probable that in the African cattle there is a 
wlO sub-group which does not occur in Europe. It would 
not be surprising to find cross-reactivity between 
previously unknown wlO determinants and the related w7 
antigen. 
There is also evidence that the sub-groups of w6 
occur outside w6 more often in the African cattle than in 
the European breeds. Within or without, they certainly 
occur at a very much lower frequency despite comparable 
frequencies of w6-broad. It may be that these 
specificities are indeed controlled by a second locus, and 
that they are in high linkage disequilibrium with w6 in 
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European cattle, and a lower disequilibrium in African 
cattle. Such differences have been described in human 
populations (Bodmer and Bodmer, 1978). This 
interpretation is supported by the fact that the sub-
groups do occur outside w6 in European cattle, albeit at a 
very low frequency. 
However, the w6 sub-groups appear to have survived 
very well the rigours of international comparison tests 
when their defining sera were used on completely unrelated 
animals, and where recombinants might have been expected 
(Spooner et al 1979a; Anon, 1982). Another important 
observation is that of Teale et al (1985b), which appears 
to suggest that the sub-groups, rather than w6-broad, are 
the targets for primary MLC-generated alloimmurie CTL. 
This is very strong evidence that w6-broad does not 
represent a single BoLA class I allele but rather a 
determinant common to several. Thus the evidence of CTL 
appears to contradict the interpretation of the w6 sub-
groups as products of a second locus, which the serology 
suggests. 
The simplest resolution of these two contradictory 
sets of evidence would be if the non-w6 occurrence of the 
subgroups was due to cross-reactivity with other BoLA 
products. 	It is true that the clustering of the defining 
sera is not very close in any population. Perhaps the 
first step in an attempt to answer the question of the 
control of these sub-groups would be to attempt further 
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absorptions of the defining sera, together with further 
immunisations to raise new sera, and the latter approach 
is now being started. 
Another BoLA-A determinant which showed good evidence 
of sub-groups is w8. It seems clear that both EDA080 and 
KMA022 are detecting a fraction of the w8 animals, 
although in all populations these sera do react outside 
w8. This might be taken as evidence that the 
specificities which these sera detect are under the 
control of a second locus, although again, very high 
linkage disequilibrium would have to be postulated in two 
widely separated groups. Since these sub-groups were not 
recognised hitherto, no attempt has been made to remove 
non-w8 activity from the sera, or to absorb them to 
identify two mutually exclusive sub-groups. Until this 
has been done, further discussion is not useful. It is 
not known if w8-broad (as defined by EDA013 and EDA063) is 
a target for bovine CTL, and this is also be an important 
area for investigation. 
wlO is another cluster which showed evidence of 
subgroups. The sub-group M4 is defined by two reagents, a 
xenogeneic MoAb (MA 4.1) and an alloantiserum (KKA004). 
Their reaction patterns are almost identical, and they do 
react without wlO at a significant frequency. This might 
be taken as evidence that M4 is under second locus 
control. However, 10 N'damas from The Gambia were tested 
during this study and four of them were w10. Of these, 
all four were both KMA003 and M4 positive. Once again a 
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remarkable linkage disequilibrium must be postulated for 
M4 to be a second locus product. The picture in the 
European cattle is rather different. MA 4.1 was not 
tested in Europe during this study, but KKA004 has since 
been tested in Edinburgh against 332 Bgs taurus animals. 
KKA004 reacted with five animals, only one of which was 
wlO. There were 62 wlO animals in this group (Spooner, 
personal communication). Forty nine Friesian/Sahiwal 
crosses were tested in this study. They were of unknown 
relatedness but it may be significant that none were 
MA 4.1 or KMA003 positive, but 14 were wlO. 	It is of 
course possible that all of the wlO's came from the 
Friesian element in these animals, but this observation 
would suggest that further testing of pure Sahiwals might 
be informative. 
If the M4 specificity is under second locus control, 
then important questions are raised about its linkage with 
wlO in African cattle. N'damas are possibly no more 
closely related to Zebus and Borans than they are to 
European animals (Epstein, 1971). Such a close linkage 
between M4 and wlO in these animals and other African 
cattle would be strong evidence that there is a survival 
advantage in these determinants occurring together which 
is absent in European animals. 
There is, however, an alternative explanation which 
does not require linkage disequilibrium of such unlikely 
tenacity. M4 may simply be common to more than one BoLA 
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product. This explanation requires that a "very private" 
determinant (in that it is present on only a fraction of 
wlO animals) occurs on two distinct molecules. There is 
no reason why this should not happen, and such complex 
patterns of cross-reactivity are known between HLA 
antigens (Dausset, 1981b). There are a number of ways in 
which such a situation might occur, the simplest being an 
intragenic recombination (Bodmer, 1984) between wlO and 
another specificity carrying the M4 determinant. If this 
were so, then either this event occurred once and the 
wlO.M4 determinant was subsequently lost in European 
cattle, or it may have occurred independently in two 
widely separate African populations. Either explanation 
suggests that the M4 determinant might have significant 
survival value. This explanation does however seem more 
likely than that of two-locus control, and it is supported 
by preliminary evidence that KKA004 and an anti-wlO-broad 
antibody precipitate the same molecules in a wlO/M4 animal 
(Bensaid, personal communication). 
Another important fact is that the KM3 determinant is 
absent in European cattle and present in almost all 
African wiG animals. It seems likely that this is a 
determinant on the wlO molecule, and its total absence in 
Europe may reflect a survival attribute associated with 
wiG in the African environment. It may also be a purely 
chance 'loss" from the European wiG. 
wiG is serologically well defined in both Europe and 
Africa, but there appears to be a major difference between 
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wlU in the two populations. 	In Africa - in Boran, Zebu 
and West African N'dama - the vast majority of wlO animals 
are positive for both KMA003 and MA 4.1. In Europe, KM3 
may not occur and M4 appears to be completely independent 
of wlU. 
Cytolytic T-cells have been valuable tools when 
considering the nature of these sub-groups. In cattle, 
both alloreactive (Teale et a!, 1985a; 1985b) and 
autologous anti-The11i, (Morrison et a!, 1985) T-cells 
have been reported. Both have shown restriction of 
cytotoxicity to the serologically defined BoLA 
specificities, and some clones have provided evidence of 
specificity for subgroups of these antigens. This is 
analogous with experience in the human field, where such 
CTL have tended to split existing specificities (Lopez de 
Castro et a!, 1984). 
To take the example of HLA-A2, Wallace et a! (1985) 
showed allospecific T-cells which detected sub-types of 
A2, and those with specificity for broad A2. Even 
xenogeneic mouse-anti human CTL can distinguish these 
variants (Engelhard and Benjamin, 1983). However, these 
A2 variants have not so far been detected serologically. 
and this has prompted Wallace et a]. (1985) to suggest that 
there are epitopes detected by CTL but not alloantisera. 
There is no evidence for such epitopes in the bovine class 
I molecules, for while CTL have suggested splits of 
existing specificities, there has always been serological 
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evidence of such sub-groups. This may be a reflection of 
the advantages of the planned immunisations and 
absorptions which are possible in cattle but not humans. 
E2pulation analysis 
Two groups of African cattle were tested in useful 
numbers, Zebus and Improved Borans. These groups are 
certainly closely related. The Boran is simply a Zebu 
which has been selected for beef production under modern 
ranching regimes for perhaps 30 generations. There is 
evidence that they have a lowered resistance to East Coast 
fever and drought and have a reduced walking ability by 
comparison with the original Zebu stock (Young and Dolan, 
personal communication). 
The Zebu cattle came from an extremely wide range of 
areas and were very uniform in their BoLA profile. The 
Borans, in some respects, resembled European cattle more 
closely than the Zebus. It is important to refine the 
definition of BoLA in these groups in order to allow the 
identification of specificities which may have a changed 
frequency in the Borans, possibly the result of selection 
for high productivity under reduced environmental stress. 
The alleles which have not changed in frequency may be 
more important than those which have, in that they might 
be associated with tolerance to some diseases to which 
European animals are extremely vulnerable. Two obvious 
candidates for this are w12 and w16. These specificities 
are extremely rare in both African groups. The fact that 
192 
8. Discussion 
their frequencies are unchanged by selection could be 
chance, or it might indicate that they are unsuited to the 
African environment. Most authors (Epstein, 1971; Mason 
and Maule, 1960) admit the possibility that the Boran 
contains some Bos taurus blood. If this is so, then the 
w12 and w16 which might have been introduced has been all 
but lost. 
The major differences between the African and 
European cattle in the frequencies of the BoLA-A alleles 
are the relatively low frequency of w3, w12, w16 and the 
w6 sub-groups and the high frequency of KM18 in the 
African cattle. These clusters would therefore seem to be 
the most important to include in further studies of these 
cattle, with the aim of determining the characteristics of 
the animals which carry them. 
The future 
This study has succeeded in reducing the frequency of 
the null allele in African cattle, particularly Borans, to 
one which is comparable to that of European cattle. It is 
now possible to embark on studies of the immune system of 
these cattle without the need to confine studies to 
atypical examples with identifiable BoLA alleles. 
However, there is much remaining to be done. There 
may be more class I loci to be described, and there are 
certainly more BoLA-A locus alleles. It is important to 
extend the knowledge of BoLA further. Without the most 
complete understanding of this fundamental system. 
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important associations which may exist between BoLA and 
disease resistance are likely to be missed. 
This study has highlighted a number of areas where 
absorption analysis of the existing sera would be 
extremely valuable, particularly by absorbing with cells 
from cattle outside the population in which the sera were 
made. Simply using cattle from differing herds is clearly 
important, but the use of different races has been 
extremely revealing. There are a number of obvious areas 
where more sera could usefully be raised, particularly in 
an attempt to answer the question of sub-groups. 
Calves obtained by embryo transplant are likely to 
make an invaluable contribution to the understanding of 
the genetic control of BoLA, and allow the identification 
of further loci. This approach is the only one which 
would allow recombinants to be identified with certainty. 
Monoclonal Antibodies 
Monoclonal antibodies seem likely to have an 
important future in this work. This study describes the 
only such reagent presently available which detects a 
'private' BoLA product. 
The application of monoclonal technology to HLA-
typing is reviewed by Bodmer and Bodmer (1984b). It is 
clear that MoAbs are becoming of great value in tissue 
typing, but are still far from displacing alloantisera. 
At the ninth HLA workshop (Albert et al, 1984). MoAbs were 
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important in anLigen definition for the first time. They 
have generally exhibited the same patterns of cross-
reactivity as have alloantisera; they have suggested 
splits of existing specificities; and a MoAb-defined 
specificity has appeared (HLA-Aw69) (Fauchet et. al, 1984). 
However, it is also clear that there are potentially 
serious technical problems in the use of these tools. 
Bodmer et al (1984) cite two major hazards; carry-over and 
loss of reactivity. 
This study, and other preliminary investigations of 
the application of MoAbs to BoLA-typing (Morrison and 
Teale, personal communication) suggest that these problems 
can readily be overcome. The crucial stage in MoAb 
generation is the screening. Bodmer and Bodmer (1984b) 
suggest that the cytotoxicity test is not ideal for this 
purpose, as many useful antibodies do not fix complement. 
This however, seems an unrealistic approach. Culture 
supernatants can readily be screened in the cytotoxicity 
test within a few days of the initial fusion, and this 
allows the rejection of the vast majority as monomorphic 
or non cytotoxic. The major problems associated with the 
growth of MoAbs only become evident after this stage, and 
it seems more satisfactory to expend resources only on 
potentially ideal antibodies. Early screening may also 
reject MoAbs which give poor reproducibility in the 
cytotoxicity test. In this way a panel of high quality 
reagents may rapidly be acquired. 
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The problems associated with carry-over of MoAbs into 
adjacent wells do not seem insurmountable. The use of 
tissue culture supernatants rather than ascites, care in 
the dispensing of cells and complement and the monitoring 
of carry-over by intervening control wells, have proved 
entirely successful in this study. 
A typing panel based on MoAbs, while considerably 
more difficult than a conventional panel to generate, will 
have the great advantage of immortality. Most 
alloantisera are available in quantities of only a few ml, 
and this means that any laboratory working on BoLA must be 
continually maintaining its stocks of sera with the 
constant problem of not having standard reagents. 
Furthermore, it does not seem unreasonable to expect 
increased reproducibility from a panel of MoAbs by 
comparison with antisera, provided they are screened for a 
potential loss of reactivity in storage or transport. 
This is because, by using them at a titre well above their 
end-point, variations due to the complement source may be 
all but eliminated. 
It should be remembered, however, that the epitopes 
against which a mouse generates antibodies may not be the 
same as those seen by cattle, and for this reason 
alloantisera must be maintained in parallel with MoAbs. 
Human monoclonal human antibodies are now being 
investigated, but present some technical difficulties 
(Cole et. al, 1985). A bovine fusion partner would be 
highly desirable for preparing BoLA reagents. This 
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approach would be expected to be even more valuable than 
the use of murine antibodies, as it will reduce the 
relative number of monomorphic determinants which the 
immunised animal may recognise as non self. 
This study was considerably aided by the use of a 
micro-computer. In the past, the analysis of tissue typing 
data has been performed on a "one off" basis, where a mass 
of results has been given to computer technicians who then 
analysed it on a main-frame computer. This approach has 
many disadvantages, the greatest of which is that it is 
extremely difficult to use the computer in a 
'conversational" way, whereby a series of questions can be 
asked of the data, each question depending upon the answer 
to the last. 
The power and relative cheapness of the modern micro-
computer now means that the investigator himself can have 
unrestricted access to the data and, giv en good 
programmes, can have instantly available the results of 
thousands of tissue typings which can be examined and 
analysed in many different ways. 
The programmes developed during this study proved to 
be of immense value in answering spontaneous questions of 
the sort, "how many w3's are EDA097 positive in male 
Borans". The software is constantly being refined and it 
seems certain that the micro-computer in the laboratory 
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will greatly aid the developement of tissue typing. The 
fact that the investigator who understands the problems, 
rather than the professional statistician and software 
engineer, can now be responsible for data analysis, can 
only be beneficial. 
The modern micro-computer should not therefore be 
seen as an improvement on the main-frame, but rather as a 
new and valuable tool for the laboratory. Its uses are 
qualitatively different from those of the main-frame and 
its potential use in tissue typing is illustrated by 
reports of micro-computer controlled assay systems which 
appear to be accurate and reliable (Bruning et a!, 1982). 
Beyond this however, its potential for database management 
and simple analysis is considerable. 
The results of this study support the theory that MHC 
alleles are exposed to natural selection as a result of 
their role in the immune system. It is an increasingly 
accepted view that the so-called immune response (Ir) 
genes are actually the MHC class I and II genes themselves 
(Klein et a!, 1983). Cattle in Africa are certainly under 
powerful selection from a wide range of diseases. The 
African cattle in this study will have been exposed for 
many generations to tick and tsetse borne haematoprotozoa 
which do not occur in Europe. 




cattle seems to be important. Sophisticated regimes of 
prophylaxis and treatment are not always suited to the 
management systems of Africa. Attempts to "improve" the 
stock by blindly introducing exotic animals seem futile. 
The exploitation of innate resistance, which would be 




Previously undetected sub-groups of two 
internationally recognised BoLA specificities have been 
demonstrated. These are EDÔO and KM22, which are splits 
of wô, and KM3 and M4 which are splits of wlO. The 
behaviour of the sub-groups of w6 was examined, and their 
frequency was found to be considerably lower in African 
than in European cattle, while the frequency of the w6 
determinant was similar in all groups. 
Five new BoLA-A locus alleles were detected. The 
frequency of two of these (KM8 and KM12) was high in both 
African populations and extremely low in European cattle. 
Large differences were found between different populations 
in the antigen frequency of all specificities except w6 
and w8. The apparent specificity of the highly refined 
European BpLA-typing sera was dramatically reduced when 
they were used to type African cattle. 
No good evidence was found for the existence of 
further bovine class I loci, and this may suggest that 
such loci, if they exist, are monomorphic. 
A mouse monoclonal antibody (MA 4.1) is described, 
which has specificity for a split of wlO and which has a 
close correlation with an alloantiserum (KKA004). The 
future role of monoclonal antibodies in BoLA typing seems 
great. 
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A new means of cryopreservatiori of lymphocytes under 
field conditions was developed and it played a major role 
in providing material for this work. 
A series of computer programmes was written which 
allowed a micro-computer to store and analyse the data 
which were acquired. Algorithms were created which used a 
new approach to the clustering of antisera, allowing 
improved identification of sera with overlapping activity. 
Comparison with the HLA system suggests that the BoLA 
antigens are similar in many respects to those of the 
human. They show similar splits and are readily detected 
by cytolytic T cells. This study has succeeded in 
improving the definition of BoLA in East African cattle to 
the point where the frequency of undetected alleles is no 
greater than that in most European breeds. 	It is now 
possible to conduct population studies and specific 
experiments aimed at identifying MHC products which are 
associated with disease susceptibility or resistance. 
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Appendix 1: Suppliers 
AST Research, Irvin, California, USA. 
Bayer, Leverkusen,Germany. 
Becton Dickinson, Rutherford, Ney Jersey, USA. 
Cedar Lane, Hornby, Ontario, Canada. 
Costar, Cambridge, Mass, USA. 
Fisher, New Jersey, USA. 
Gelman, Ann Arbor, Michigan, USA. 
Gibco, Uxbridge, Middlesex, UK. 
Hamilton, Bonaduz, Switzerland. 
Kobian Ltd, Nairobi, Kenya. 
Micro Pro International, San Rafael, California, USA. 
Millex, Molsheim, France. 
Nunc, Denmark. 
Pharmacia, Uppsala, Sweden. 
Pharmeacut.ical Manufacturing Company, Nairobi, Kenya. 
Prospero Software, 190 Castelnau, London, UK. 
Sigma, St Louis, USA. 
Sterilin, Teddington, Middlesex, UK. 
Venoject, 3030 Leuven, Belgium. 
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Appendix 2: Pascal source code of BoLA programmes 
There follows a listing of the Pascal source code 
used to create the BoLA analysis programmes. This code 
was written for the Frospero Pascal compiler (version 1.1) 
(Prospero Software) and can only be compiled directly by 
this compiler running on an IBM-PC or compatible micro-
computer. However, Pascal is a particularly machine 
independent language and other compilers for other 
machines could be used if the code was slightly modified. 
The parts most likely to give problems are the file 
handling routines, routines designed to modify screen and 
printer i/o and the Prospero routines such as date. The 
bulk of the code will certainly be usable on other 
machines without modification. 
The screen and keyboard control routines require that 
the machine be started with a "CONFIG.SYS' file in the 
root directory, containing the line DEVICEANSI.SYS". 
222 
The source code for the BoLA analysis progammes is 
shown below. Many of the lines of the original programmes 
are too long to fit on the page and have therefore been 
broken. In general Pascal is very tolerant of line 
breaks, however it has sometimes been necessary to break a 
variable name in the middle and frequently it has been 
necessary to break a literal string (ie text within 
quotes). If used exactly as it is below the source code 
could not be successfully compiled because these two 
conditions would create errors. It has also been 
necessary to considerably alter the layout so the 
classical structuring of Pascal programmes into nested 
segments has been largely destroyed. 
THE MENU 
program BOLA MENU (input,output); 
var xiinteger; 
PROCEDURE Cl earecreen; EXTERNAL; 
begin 
CLEARSCREEN; 
wr i tel n; wr i tel n; 
write(' 
chr(1BH),'(7m' 	,'BoLA (by SJI< 2-10-84]'); 
write(ctir(IBH),'(Om',chr(lBH),'(lm'); 
for x:l to 6 do writeln; 
writeln(' Similarity index ............ ); 
writeln(' Print out data .............. 
writeinC' Update/review data ......... 
writeln( Reorder sera in a file ...... 
writeln(' Enter 	data.................. 
writeln(' Select 	data ................. 
writeln(' Compare serum frequencies.7'); 
writelnC' Assign clusters ............. 
writeln( Join 	B0LA files............. 
writeln(' Convert 1811 to PRIME .....  
writeln(' Convert PRIME to IBM .....  
wr i tel n; 
WRITELN( Quit ........................ 








(A HIGH SPEED VERSION OF SIMILARITY WHICH USES A RAM DISK 
TO HOLD THE TOTALS FOR THE 2X2 TABLE ALLOWING FOR MANY 
SERA TO BE COMPARED WITH ALL OTHERS IN A SINGLE PASS 
THROUGH THE DATA. THE NUMBER OF SERA THAT CAN BE 
COMPARED IS GOVERNED BY THE SIZE OF THE RAM DISK - EACH 
SERUM WILL OCUPY 480 BYTES ON EACH OF 4 FILES. 
THEREFORE NUMBER OF SERA = RAM DISK CAPACITY DIVIDED BY 
1920) 
CONST Allsera 	=240; 	(max number of set- a) 
Serum_length 6; (length of serum names) 
Name_length = 40; 	(length of animals name) 
Page_length = 35; (number of Lines printed 
per page) 
TYPE 	One-to _ten 	1. .10; 
One_to_eightl.. 8; 
One_byte 	-0-253; (integer range for 1 byte 
storage) 
Two_byte 	0..65533; (integer range for 2 byte 
storage) 
Maxno 	=1. .Allserm; 
Set_of_f ields(batch,date,sex ,breed,location, 
sublocation ,CBTS,spare); 
Set -of _scoresSET OF CHAR; 
Panel =Array[maxno] 
of packed array(l. .serum_length] of char; 
worktype= 	Array(maxno] of two_byte; 
Rec_of _resul tsRECORD 
Name:Packed arrayti. .Name_length] OF CHAR; 
Details:Array(set_of_fields] OF Packed 
array[One_to_sight] of char; 
Serums:ArraytMaxno] OF Char; 
END; 
BOLAfIIeFILE OF Rec_of_results; 




case x of 
1 :chain('sim); 	2 :chain(printout); 
3 :chainc'update 4 :chain(switch'); 
5 :chain(entry' 1; 	6 :chain('select'); 
7 :chain('chi-sq B :chain('cluster); 
9 :chainC'Pas-pa s'); 10: chain ( 'pas-for'); 





VAR 	Results: 	Rec_of_results; 
Test -serum: 	packed array 
(1. .serum_length] of char; 
Serum_panel: 	panel; 




No_pos: 	 Workfil.; 
(work files holding the counts) 
Array_filler: 	Worktype; 
drive: 	 String(2]; 
(to hold the SUPERORIVE drive designator) 
min,highlight, 
X,Count, 	 One_byte; 
Within, 
Found 1 Open.d : 	 Boolean; 
Eachserum, 
Panel _sizes 	 Maxno; 
Posecores: Sat _of_scores; 
Test, 	 Array(l. .2] of maxno; 
Message, 
printerfi lname, 
Ser af name, 
Datafname: 	 STRING(14]; 
Datafile: BOLAfile; 
printer, 
Serafile: 	 TEXT; 
bottom 1 ,bottom2, 
bottom,top,r,y,simx: 	LON(3REAL; 
FUNCTION VESNO (Default:CHAR; Plessage:STRING), 
BOOLEAN; EXTERNAL; 
PROCEDURE Clearscreen; 	 EXTERNAL; 
PROCEDURE Bleep; 	 EXTERNAL; 
PROCEDURE Bright; EXTERNAL; 
PROCEDURE Normal; 	 EXTERNAL; 
FUNCTION Caseup (ONECHAR: CHAR): CHAR;EXTERNAL; 
PROCEDURE Wipe(X: integer); EXTERNAL; 
FUNCTION Namecheck(filename:string): 
Boolean; EXTERNAL; 
BEGIN (MAIN PROGRAMME) 
ci earscreen; 
FOR X:1 TO 8 Do writein; 
wr i tel n ( ' 
writein' 	 Turbo Similarity Index 
writeln( ' *****************e**e 
writeln;writeifl;writeln;writeln;writeln; 
writeln( 'sjk 28/8/84'); 
For Eachser-um:=l to 240 do 
begin 
For X:=0 TO 252 do; 
end; 
cl earscreen; 
FOR Counts-1 to ailsera do 
begin  
For X:=l to Serum_length do Serum_paneitCount] (X]i 
end; 
For X:l To Serum_length do Test_serum[X],= 	; 
(open the work files on SUPERDRIVE) 
write('enter RAM drive designation (eg B:), 
readln(drjve) ;WRITELN; 
assign(One_pos, (concat(drlve,'workl')) ); 
assign(Two_pos, (concat(drive,'work2')) ); 
assign(Both_pos,(concat(drive, 'work3')) ); 
assign(No_pos, (cancat(drive,'work4')) ); 




(flow open the file with the data) 
REPEAT 
REPEAT 
write( 'File with BoLA data');bright; 
write(' I 	 ].DTA 
write(chr(1BH) , 
readln(datafname);writeln;nor-maj; 
UNTIL (namecheck (dataf name)); 
data-fname:concat(datafname, '.DTA'); 
IF NOT Fstat(datafname) THEN 
writein ('There is no file ',dataf name); 
Until (Fstat (dataf name)); 
Assign(datafile,datafname); writeln; 
(open the file holding the serum panel) 
REPEAT 
REPEAT 
write('Fils with serum batch');bright; 
write(' I 	 ].BCH 'I; 
write (chr (IBH), (160'); 
readln (seraf name) ;wri teln; normal; 
UNTIL (namecheck (ser- af name)); 
serafname: =concat (seraf name, '.BCH'); 
IF Not Fstat(seraf name) Then 
writeln ('There is no file ',merafname)p 
UNTIL (Estat (serafname)); 
Assign(serafiie,serafname); reset(serafile); writeln; 
REPEAT 
wri teln; Opened: TRUE; 
Write('Output file (printer 	"PRN'): 
Readln(Printerfilname); 
IF Printerfilnaine='prn' then Printerfilname:='PRN'; 
(simplify the next if ') 
IF (Printerfilname<>'PRN') AND Fstat(Printerfilname) 
THEN 
BEGIN 
IF Vesno('X','This file exists OK to erase it') 
Then Opened: =TRUE 
ELSE Opened: FALSE; 
END; 
UNTIL (Opened); 
assign (printer ,printerf ilname) ;rewrite (printer 
(3) 	 (4) 
IF (Yesno('x,'count 4 as -ye) )Then 
Posscorxs: =1 'B , '6'] 
ELSE Posscores: C 	, '6', 4']; 
REPEAT 
Wrlte('mLnlmum similarity index (X) for printing 	?:'); 
readln (mm); 
UNTIL ( (min>0) AND (min<.100) ); 
REPEAT 
write(minimum similarity index () for highlightng ?:'); 
readln(highlight); 
UNTIL ( (highlight>=ein) AND (highlight<=100) ); 
(fill the array serum_panel with the serum names in this 
file) 
Panel_size: 0; 
WHILE (Panel_size<Allsera) AND (NOT (eof(Sera_file))) DO 
BEGIN 
Panel _size: Panel_si ze+l; 
Count: =1; 
While NOT ealn(Sera_file) and (Count <6) DO 
BEGIN 
READ( Sera _file, 




END; 	(while panel size) 
(the serum names are in the array Serum_panel) 
(and the variable panel_size is equal to the number of 
sera in the panel) 
FOR Count:1 TO serum-length DO Test_ser-um(Count]:-' 
(now read the serum_names to be compared) 
REPEAT 




IF x1 then 
wrjte('enter the name of first serum: 
IF x2 then 
write('enter the name of last serum: 
Count: =1; 
While not (eoln(input)) 
and (Count<serum_length) DO 
BEGIN 
read (Test_serum(count]); 




(find the position of this serum in the panel) 
Eachserum: 0; 
Repeat 
Eachserum: Eachserum+l ; 
Until (serum_panel [Eachserum]=Testset-um) 
OR (Eachserum>=allsera) 
IF (serum_panel [Eachseruml=Test_ser-um) 
THEN Found:=TRIJE 




IF NOT (Test(l3<=Test[21) THEN 
writein ('Do not be silly - 
serum_panel(Test(21 ], is before , 
serum_paneltTest[l] 3,' in the panel'); 
UNTIL (Testti1<Test(21); 
for x:1 to alisera do array_4i1ler(x]i0; 
(set the files that will hold the totals of the 2x2 table) 






writeln( (Eachserum-Test( 1 3+1) :1, 
records written to 4 files'); 
end; 
cl earscreen; 
reset (datafi le); 
write(chr(IBH),'(2l;LBH','sera being compared'); 
write(chr(1BH) , 
write(chr(IBH), 	'(22;lBl-4',Serum_panel(TESTI1II,  
Serum_panel(TEST[211); 
write (chr(IBH) , 'IBm'); 
seen: 0; 
write(chr(1BH),'(21;40H','animals read); 
write(chr(I8H),'(7m'); (reverse video) 
(**** READ THE DATA FILE ****) 





seek (No_poe, 0); 
IF NOT (DATAFILE".NAME[l]C') THEN 
BEGIN (*5 IGNORE ANIMALS WITH C AS FIRST CHARACTER ***) 
seen: =seen+l 
IF (seen65533) then 
begin 
For X:l to 20 do write(printer,chr(07H)); 
(MAKE A LOT OF NOISE) 
For x:=1 to 10 do Writrin(printer); 
For x:=l to 10 do Writeln(printer, 
'TOO MANY ANIMALS IN FILE MAX:65535 RESULTS MEANINGLESS'); 
For x:1 to 10 do Writeln(printei-); 
end; 
write (chr ( 1BH) , ' (22; 401-I ' , seen: 1) 
For Eachserum:test[j] to test121 do 
begin 
IF NOT (DATAFILE. serums[Eachserum]-',') Then 
(5) 	 (6) 
BEG IN CE) 
For Count:t to panel size do 
begin(D) 
IF NOT (DATAFILE". s.rums(Count)=. ) THEN 
BEGIN(B) 
IF DATAFILE". serums(Eachserum] IN Pocscores 
Then 
Begin(A) 
IF DATAFILE". serumstCount) IN Posccores 
THEN both pos"tcount] :both_poc"tcount)+l 




IF DATAFILE". cerumslCount) IN Posccores 










END; (For eachserum) 
END;(if not £ 	) 
GET (DATAFILE); 
END; (WHILE NOT EOF) 
write(chr(1BH),(0m);(rever-se video off) 
For eachcerum:testtl) to testE21 do 
begin 
Writein; 
Writ.(Sl: ,serumPan.lEeachserum], 	52: ); 
seek (One_poe, eachserum-test(l)); 
seek(twa_pos, eachserum-test(l)) 








(set print style B) 
write(printer,from ,datafname); 
IF (41N Posscores)THEN 
Writeln(printer,' 	 4 is considered +ve) 
writeln(prtnter, 	 4 is considered -ve); 
writeln(printer,'minimum Sims printed: ,min:l, 
X 	minimum highlighted: 
highlight: 1, 7.); 
writeln(priot.r); 
writeln(printer, similarityicorr.lation); 
wr ,  i tel n (printer,
S2 	ci Only 	s2 only isl & s2 , 
nejthertotai 	index:coefficient 
writeln(printer- ); 
(*********e******* CALCULATE  
C' SIMILARITY INDEX AND CORRELATION FOR EACH SERUM 'a) 
FOR Count:=l to panel size do 	(LOOP FOR EACH SERUM) 
begin 
ite (Count: 3) ; write (chr ( 1 BH) (3D 
("CALCULATE SIMILARITY INDEX") 
y:=( one_pos"(count) + two_pos"(count) + 
(2*both_pOs"(count)) ); 
IF NOT (y<=B) AND (Count<>Eachserum) THEN 
(avoid error Z and comparing a serum with itself) 
BEGIN 
cimx: (200*BothposCcount]) / y; 
("a CALCULATE r **') 
tops= 	(both_pos"(count] * no_poc"(count]) - 
(one_pos"(count ]'two_pos"(countfl; 
bottoml = (both_pos"[count ]+one_pos"(count ) ) a 
( both_pos"tcount]+twopos(couflt)); 
bottom2: = (no_pos"(count)+two pos"(count] ) * 
one_pos(count]+ no_pos"(count)) 
bottom: bottoml*bottom2; 
(THE CALCULATION OF BOTTOM IS BROKEN UP TO AVOID 
OVERFLOWING INTEGER ARITHMETIC) 






(a HOW MUCH IS ONE SERUMS REACTIONS WITHIN ANOTHERS ?') 
Wjthin:= (both_pos"(cOunt]>(10*OnepO(COUflt]) I OR 
(both_pos"(count]>(lBetwoPos(count]) I; 
If Within then within:=( (one_pos"(countfl5) OR 
(two_pOs"(count]>S) I; 
Message:=- within ?; 
If Within and (both_pos"(count)>j) Then 
BEGIN 
If ( (one_pos"(count]=) OR (two_pos"(count]=B) 
Then Message:=*' WITHIN **• 
ELSE 	 Message:=- WITHIN ?; 
END; 
IF (simx>=mjn) OR Within then 
("if Sims > than min for printing***) 
begin 	(***or evidence of containment***) 
IF (simx>=highlight)then 
write ( printe - .chr(lBH) 9 ,chr(ord(24)) ); 
(if greater than min for highlighting then set 
printer to double strike) 
C" WRITE OUT THE RESULTS TO THE PRINTER e'*) 
Write (printer, Serum Panel (Each_serum], 
,serum_panel [Count] ,Onepos"Ccciunt], 
(7) 
(B) 
two_poe Icount J ,both_poe(count) ,no_pos"(Count], 
one pos ( Count ] +two poe " (count 1+ 
both pos[count 3+no pos"(count)) :4, 
,simx:lø:I,r:1:3); 
IF Within THEN writeln(printer,' 	',message) 
(if evidence of containment) 
ELSE writeln(printer); 
wr:te(printer,chr(IBH),',chr(ord(G)) ); 




IF (X=page_length) Then 
begin 
writeln(printev- ,chr(CH)); (formfeed) 
x 
end; 
end; (for Count 	) 
end; (for eachserum) 
writeln(printer);writeln(printer); 
wrlteln(printer);writeln(printer); 
writeln(Printer,' 	 KEY'); 
writeln (Printer, 
---------------------------------------------' ) ; 
writeln(printer, 
'within ' .... iøx one serum alone', 
• < both together and one serum alone >5); 
wri tel n (Printer, 
'WITHIN ?....and more than jg animals', 
• react with both together'); 
writeln (Printer, 




writeln(printer,'Total number of animals in ', 
datafname,' is ',seen:l); 
writeln;writeln('done'); 
writeln(prtnter,chr(CH)); 	 (formfeed) 








(input ,output , sourcef tIe, seraf i 1 e ,sequencef i 1 e,pr inter); 
CONST 
Max _per_page44; 	(lines of printout per page) 








(number of characters in the ID fields) 
Serum_length 6; (number of characters in the serum 
names) 
Allsera= 	24; 	(max number of sera in the sourcefile) 
Partname 15; (the number of characters in the name 
to be printed) 





setofcodeeSET OF printcodes; 
Maxno 	1. .Allsera; 
Cando 1. .Printable; 
Set -of -fields=  
(batch,date,sex ,breed,location,sublocation,CBTS,spare); 




PACKED ARRAY (1. .Field_lengthl OF CHAR; 
Serums:ARRAY(Maxno] OF CHAR; 
END; 
Order_Array Array[Cando] OF Plaxno; 
Heading array=Array[Cando]OF CHAR; 
Panel=Array(Maxno) OF 
PACKED ARRAY(1. .Serum_length) OF CHAR; 
PS_arrayPACKED ARRAYC1. .Serum length) OF CHAR; 
BOLAfile=FILE OF Rec_of_results; 
VAR 
Results: 	Rec_of_results; 




Serum_panel z Panel; 
To_print: 	Cando; 
Opened ,Found: 	BOOLEAN; 
Print _serum: PS-array; 
Eachserum: 	Maxno; 
poel,pos2, (first and last characters in the name) 
X ,line, 
yy,dd, 	 (to hold the date) 





Sequencef ii e, 
Printer: 	TEXT; 




FUNCTION YESNO (Default;CHR; Meseage;STRINI3): 
BOOLEAN; EXTERNAL; 
PROCEDURE Clearecreen; EXTERNAL; 
PROCEDURE Bleep; 	EXTERNAL; 
FUNCTION Caseup (letters CHAR) sCHAR;EXTERNAL; 
PROCEDURE pasdate(VAR year,days INTEGER; VAR month:STRING); 
EXTERNAL; 
FUNCTION len (var posi,pos2:Integer; 
TestString: PA):Boolean; 
(returns positions of first (post) and last (pos2) 
non blank characters in an array) 




(FIND REAL LENGTH OF STRING13 
(first find position of first non blank) 
not _blank:false; x : =1; 
While (X<40) and not (not -blank) do 
begin 
If (Teststring(x)<> .) 
Then not_blank:True Else xsx+l; 
end; 
IF (x41) then len:mfalse 
ELSE posl:x; 
(FIND LAST NON BLANK) 
x:40;not_blanktfalse; 
while(x>mi) and not (not-blank) do 
begin 
if (TeststringCx]<> ') 






FOR X:l TO B DO Writelri; 
writeln( 
writeln( 	 BoLA DATA PRINT-OUT ); 
wri tel n C 
writeln;writeln;Writeln; 
writeln( complaints and comments to sjk); 





wr I tel Ii; 
write( File to be printed: 	1; 
readin (sourcename) 
IF NOT rstat(sourcename) THEN 
Wrsteln( There is no file ,sourcename); 
UNTIL (Fetat (sourcename)); 
Assign C Sourcef lie, Sour cename 
reset (sourcefile); 
REPEAT 
wr i tel n; 
write(fiie with serum names(the batch): ); 
readin (seraf name) 
IF NOT Fstat(seraf name) THEN 
Writeln( There is no file ,serafname); 
UNTIL (Fstat(serafname)); 
Assign(seraf:le,seraf name); 
reset (serafi le); 
REPEAT 
wri teln; 
writeYfile with print sequence; 
readln(seqfname); 
IF NOT Fstat(seqfname) THEN 
Writeln(There is no file ,seqfname); 




wri tel n; Opened: =TRUE; 
Write(Output file (printer = "PRN) ); 
Readln(Printerfilname); 
IF Printerfilnamuprn then Printerfilname:PRN; 
(simplify the next if ) 
IF (Printerfilnarne<>'PRN) AND Fstat(Printerfilname) 
THEN 
BEGIN 
IF Yesno(X,This file exists 01< to erase it) 
Then Opened:TRUE 
ELSE Opened: FALSE; 
END; 
UNTIL (Opened); 
Assign (printer , 'PRN ) ; Rewrite (printer 
(Printer is assigned to the printer) 
(at this stage no matter what o/p ) 
(file is chosen - it is reassigned ) 
(to printerfilename before data is written) 
(fill the title array) 
for x:=l to printable do title(x]s 	; 
writeln(printer); x:1; 
Writeln(Enter the title for the printout (up to , 
printable: l, characters) '); 
write('Title: 	); 
while not eoln(input) and (x<printable) do 
begin 
read(titlelx)); 
x I x + 1; 
(11) 	 (12) 
end; Count:-0; F0undiFALSE; 
readin; WHILE (Count((Eachserum-l)) AND NOT (Found) DO 
FOR To_prnt:l TO Printable DO BEGIN 
Heads[To_print] i' 	'; Count:Count+l; 
(set the headings to blanks) If Print serum = Serum_panel(Count) THEN 
FOR Countil TO ailsera DO (if the 2 names match) 
BEGIN BEGIN 
FOR X:=l TO s.rumlength DO serum_panel(Count](x]:=' 	; Order(To_print)iCount; 
END; (then this is the next heading) 
(The 	DIVIDE 	symbols) Found:=TRUE; 
FOR Count:1 TO Serum_length DO Serum_Panel (240] [Count] END; 
• 	; END; 	(all serum names compared) 
FOR Count:l TO Serum_length DO Serum_Panel (2393 [Count] IF NOT Found THEN BEGIN 
Writeln(Prjntserum,' not found); 
Eachserum:=1; To_printi=To_print-l; 
WHILE NOT eof(ser- afile) AND (Eachserum<=(Allsera-1)) 	DO END; 
BEGIN END; 
Count:=l; To_print:=To_prjnt+l; 
WHILE NOT EOLN(SERAFILE) AND (COUNT<SERIJPI_LENSTH)DQ END; 
BEGIN To_printt=To_print-l; 
Read(seraflle,Serum_panel[Eachserum](count]); (The sequence of printing has now been established in the 
Serum_panel [Eachserum](Count]: array ORDER and the headings are in the array HEADS) 
caseup (Serum_panel [Eachserum](Count]); Writeln 
Count:Count+l; (' 	PRINT 	STYLE 	(for EPSON FX-80 & FX-100 printers)'); 
END; Writeln; 
Readln(serafile); Writeln(to_print:l, 
Eachserum:=Eachserum+l; sera and dividers plus 
END; TAB:l,' 	columns for id details.'); 
To_print.l; Writeln(' TOTAL of 	', 
WHILE NOT eof(sequencefile) AND (To_print<=Printable) DO (To_print+TAB).l,' columns required.'); 
BEGIN Writeln(' 	 Code 
For Count:l TO Serum_length DO Print_serum(Count]i=' 	; Writeln(' 1 strike 	2 strike 	'); 
Count:=l; Writeln('Condensed 	4 	20 	allows 	233 columns.'); 
While not eoln(sequenceftle) Writeln(Elite 	 1 17 allows 	163 columns.'); 
AND (Count<=Serum_length) DC) Writeln('Pica 8 	24 	allows 	136 columns.'); 
BEGIN Writeln('Enlarged 	32 48 allows 	68 	columns.'); 
Read(sequencefile,Print_serum(Count]); Writein; 
Print_serum(Count]:caseup(Print_serum(Count)); Writeln('For a demonstration of each style enter 0.'); 
Count: Count+ 1; REPEAT 
END; Write('choose the print code (0-63). 
READLN(SEQUENCEFILE); Readln(Count); 
IF 	(Print_serum(l]'*) or 	(print_serum(1]=':') 	THEN BEGIN 
(the divide symbols) writeln(printer,chr(tBH),D',chr(ord(20)), 
BEGIN chr(ord(0)) 	);(sets the tab) 
if print_ser-um(l)='*' then Order(To_print).=239 For X:0 TO 56 Do 
else order(to_print].240; BEGIN 
Count:To_print; IF(X IN Unique_codes)THEN 
FOR X:=2 TO Serum_length DO BEGIN 
BEGIN Writeln(printer); 
IF Printserum(X]()' 	THEN Wrtteln(Printer,chr(IBH),'',chr(ord(X)), 
Heads(Count).=Rrintserum(X]; (sets the print mode) 
Count.=Count+1; 'Mode 	9 X:3,chr(O9H),'sampl. text 	SAMPLE TEXT'); 
END; END; 
END END; 
ELSE BEGIN (the heading is a serum name) END; 
(13) 	 (14) 
UNTIL ((Count>=l) AND (Count<=63)); 
	
begin the printing with the headings 	 ) 
Assign(Printer,Printer+ilname); Rewrite(Printer); 
Writelo (printer ,chr ( 1BH) , 	, chr Cord (Count)) 
chr(1BH),D,chr(ord(TAB)),chr(ord()) 	); 







Writeln(printer,chr(BCH)); 	 foc-mfeed 
Writeln(printer) ;Writeln(printer); 
Page: Page+l; 




Write(Prtnter,Serum batch is 	',serafname,chr(ØDH)); 
Wri tein (Printer, - 
Write(Prtnter,Using serum sequence ,meqfname,chr(ØDH)); 
Wri tel n (Printer, - 
write(printer,chr(ord(137)) ); (TAB) 
for countsl to printable do write (printer,title(count] ); 
writeln(printer); 
write(printer,chr(ORD(137)) ); (Tab) 
For Count:=l TO To_print DO Write(Printer,Heads(Count]); 
Writeln(printer); 
FOR Count:l to Serum_length DO 
BEGIN 
If Count-serum-length then 
write (printer 
NAME 	 DATE BREED 	LOCTN SEX* ); 
write(printer,chr(ORD(137)) )p (Tab) 
FOR Eachserum:=l TO To_print DO 
Write (Printer, Serum_panel Corder (Eachserum]] [Count]); 
writeln(printer); 
END; 
write(printer,chr(ORD(137)) ); (Tab) 
For Count:l To To_print DO Write(Printer,-'); 
Writeln(printer); 
(now read the file and print it out 	 ) 
WHILE NOT eof(Sourcefile)AND (line<=Max_pec -_page) DO BEGIN 
Read(Sourcefile,Results); 
Results.Serums(24]: 	; Results.Serums(239]:= 	; 
IF NOT (Resu1ts.Name(i)'C) THEN 
BEGIN 
WITH Results do 
begin 
Found:len(pos1 • pos2,name)  
(find the first and last characters in the name) 
For x:posl to (posl4-partname) do 
Wr ite (Pr inter , Namelx 1) 
(write the first partname characters) 
If (pos2>(pos1+partname)) then 
write(printer,>) else wr:te(printer,V); 
(if are more than partname characters in the name then 





,details[sex ]( 1] , details[ sex ] (2]) 
Write(printer,CHR(ORD(137)) ); 






END; 	(while not eof) 
write('..') 
UNTIL (eof(sourcefile)); 
Wr- iteln(printer,chr (BCH)); 	 (formfeed) 
write (printer,chr(07H),chr(07H),chr(07H)); 
(ring the printers bell 	) 
Writein (printer,chr (IBH),); 




(15) 	 (16) 
PROGRAM NEWUPDATE (INPUT,O(JTPUT,INFIL,OUTFIL,batchfile); 
CONST ALLSERA 	 =240; 
NAMELENGTH 	40; 
Serum _length 6; 
Detail _length 	-8; 
Selectable 	50; 
(max number of sera which can be selected for) 
TYPE 




PA 	 Packed Array(l. .name_length] of char; 




of packed array Cl. .detail_length) of char; 
Serums:Arraytmaxno) of char; 
END; 
Srmname 	 Packed Array(l. .serum_length) OF CHAR; 
Panel ArrayCmaxno] OF Srmname; 
(holds panel sera names) 
BOLAfile 	=File Of Rec_of_results; 
ok_scores SET OF CHAR; 
COMMON Serum _Panel: 	Panel; 
(this array is needed by procedure REVISE) 
(it holds the names of the panel sera 	) 
Panel _size: 	Maxno; 
(so is this it holds the number of sera in panel) 
VAR 
ID-field: 	Arraylsetoffields) 





posnl,posn2t arrayti. .seiectable) of integer; 
Choice: 	 char; 




Found, serumonl y, 
Out ,Opened: 	BOOLEAN; 
test: 	 arrayCi. .selectable) of maxnop 
Wanted: Arrayll. .selectable) OF Boolean; 
Select: 	 Packed Arrayti. .ser-um_length] OF char; 
(names of selecting sera) 
Pos_scores: 	OK_scores; 
S_name: 	 arrayl:l. .selectable] of PA; 
S_field: arrayll. .selectable) of PAS;  
(as S_name for the id field) 
batchfi iname, 
inf i iname, 
Outfilname: 	string(121;(the names of the files on disk) 
Screen; 	 File 04 Char; 
(gives one chracter- entry without <CR>) 
Batchfii: 	TEXT; 
Inf ii : BOLA4iIe; (the pascal non text files) 
OK choice: 	SET OF A.. 1; 
FUNCTION YESNO (Default:CHAR; Message:STRING)iBOOLEAN; 
EXTERNAL; 
FUNCTION Caseup (letter: CHAR):CHAR;EXTERNAL; 
Function len (var posl,pos2: Integer; 
TestString: PA) :Boolean; 
(returns positions of first (posi) and last (pos2) 
non blank characters in an array) 
Var X 	: integer; 
not _blank: boolean; 
begin 
len: true; 
(FIND REAL LENGTH OF STRINGI) 
(first find position of first non blank) 
not_bl ank: =4 al cc; x: =1; 
While (X<=40) and not (not-blank) do 
begin 
If (Teststring(x)<) 	) Then not_blank:=True Else xzx+l; 
end; 
IF (x41) then len:false 
ELSE posl:x; 
(FIND LAST NON BLANK) 
x : =40; not_blank: fal cm; 
while(x>=l) and not (not-blank) do 
begin 
if (Teststringlx]<> ') 








(returns true if sub is within test) 
var sofar,y,x:integer; 
out,match,f cii :bool.an; 
begin (subin) 
out:=false; yz=pos3; 
(the first character in the test string) 
REPEAT 
Match:false; 
While(y<=pos4) and not match do 
begin 
If (sub[posl)=Testty]) then match:=true else y:=y+l; 
end; 
(17) 	 (18) 
Sofar: = y; 
If not match then begin subin:=lalse;out:=true;end 
(first character of sub is not in test so no match) 
ELSE 
BEGIN 
IF (poslpos2) then begin subin:=true;out:=true; end 
ELSE 
Begin 
Sofar:y; x:1; fail:=false; 
REPEAT 
If sub(posL+x)<testtso4ar+x] then failg=true 
else x:x+l; 
UNTIL ( 	(( posl+x)> pos2) or fail); 





Until ( (Sofar>=pos4) or (out) I; 
END; (subin) 
Function lenD (var posl,pos2:Integer; 
TestString: PAD) :Booiean; 




(FIND REAL LENGTH OF STRINGI) 
(first find position of first non blank) 
not_bi ank:=f alse;x: -1; 
While (X<=8) and not (not -blank) do 
begin 
If (Teststringlx)<> 	.) 
Then not-blank.-True Else xix+l; 
end; 
IF (x9) then lenR:mfalse 
ELSE posl,x; 
(FIND LAST NON BLANK) 
x:8; not_blank: false; 
whiie(x>l) and not (not -blank) do 
begin 
if (Teststringtx]<>' ') then 








(returns true if sub is within test) 
var sofar,y,x:integer; 
out ,match ,fai 1 ibool can; 
begin (subin8) 
out:=false; y:=pos3; 
(the first character in the test string) 
REPEAT 
Match: false; 
Whi1e(y(pos4) and not match do 
begin 
If (sub[posi)=Testty]) then match:=true else y:y+l; 
end; 
Safari y; 
If not match then begin subinB:false;out:=true;end 
(first character of sub is not in test so no match) 
ELSE 
BEGIN 
If (poslpos2) then begin subinDs=true;out:=true;end 




Sofar:=y; x:1; fail.-false; 
REPEAT 
If sub(posl+x)<>test[sofar+x] then fail:-true 
else x:=x+l; 
UNTIL ( (( posl+x)> pos2) or fail); 





Until ( (Sofar>=pos4) or (out) ); 
END; (sub mB) 
(a set of procedures for modifying the screen output) 
(their names should be self-explanatory 	 ) 
Procedure Unline 	;EXTERNAL; 
Procedure Bright ;EXTERNAL; 
Procedure Normal 	;EXTERNAL; 
Procedure Cl earscreen; EXTERNAL; 
Procedure Reverse 	;EXTERNAL; 
Procedure Bleep ;EXTERNAL; 
procedure revise (var results:rec_of_results); 
CONST Name length 4; 	(number of characters in 
the NAME field) 
Field_length= 8; 	 (number of 
characters in the ID fields) 
Serum_length 6; 	 (number of 
characters in the serum names) 
Alisera 	240; 	 (max number of sera in the 
sourcef jim) 
TYPE 	Set -of _scoresSET OF CHAR; 
VAR ID-field 	: 	ArrayCeetoffields) 
of packed 
arrayli. .detail_length] of char; 
Nowfield 	 Set_of_fields; 
carry_on, 
changed,Found : 	BOOLEAN; 
Eachserum 	: Max no; 
X,Count 9 	 Integer; 
Online 	 z I..10; 
(19) 	 (20) 
	
detail - correction: 	packed 
array[l..fieldlength)OF CHAR; 
NEWname, 
temp_name 	: 	packed 
arrayli. .name_length]OF CHAR; 
chksrm 	 : 	packed 
arrayll. .serum_length) OF CHAR; 
Pas _scares, 
OK Scores 	 set_of _mcores; 
onechar : 	char; 









ID_f Reldlspare) ;'Spare 
OK_scores:1'B','6', '4','-','2',. ,'7'); 
Pas _scores:=t '8', '6', '4', '7']; 
Assign (Screen , 'CON') ; reset (screen) 
(write out the details of the animals id) 
write(ANIMAL '); bright; writeln(results.name);normai; 
writeln;writeln('DETAILS:-'); 
for Nowfield:batch to spare do 
write(zd_field(Nowfield),' ); 
wri tein; 
writelo ( '- -------------------------------------- — - -- 
--------- — -------- -  -------' ) ; 




If count-2 then posscores:E'. ') 
else 
beg i n 
writeln; 
wri telri ( 
end; 
online: 
IF Countl then writeln(' 
	
SERA WITH 
SCORES >= 4) 
ELSE Writein 
UNTESTED SERA'); 
For x;1 to Panel -size do 
begin 
If (Results.serums(xi in poe_scores) then 
begin 
If(Resultsser-umstx]'B') then bright; 
write(serum_paneltx),' ',Results.serums(x))p 
normal; 
Online: 0n1 ine+l; 
(21) 




end else write(' 
end; 
end; 
wri tel n ( ' ------------- 
Count: count+1; 
UNTIL (Count-3); 
IF yesno(',c','Do you wish to change the ID details') THEN 
BEGIN 
REPEAT 
writelri( ' -------') 	wrlteln( name; ',Reeulte.naa.); 
write ('enter correct name (<CR> leaves as is) 
FOR X:i TO name-length DO NEWnameIX);-' 
Count; =1; 
While not eoln(input) and (Count<nam.length) DO 
BEGIN 
read (NEWnameccount]); 
NEWname(cotjnt) : -cameup (NEWnamelcount)); 




While (Count<-namelength) and not (changed) do 
BEGIN 
IF NOT (NEWnametcount)-' )TI'EN Changedi-True; 
Count: =Count+1; 
END; 
IF changed THEN Results.name;-NEwname; 




WRITE ('Enter correct ',ID_Field[Nowfjeld),'( <CR> 
leaves as is) : 
FOR Count:=i TO 8 DO Detailcor-rectjon(Count];' 
(reset the array) 
Count: 1; 





Count; Count+ 1; 
END; 	(while not) 
Readi n; 
IF NOT (Detail _Correction-' 	 ') THEN (if 
correction is not blank) 
Results.DetajjmCNowfjeid];.a,etai 1_Correction; 
(If correction IS blank the field remains unchanged) 




BEGIN Assign (Screen • CON); 	Reset (screen); 
REPEAT ID fieldiBatch] := Batch 
FOR Count:=l TO serum_length DO CHKSRM(Count]:' 	; lDfieldlDate) 	:='Date 	; writeln('which serum reaction do you want to check ?: IDfieId[sexl :sex 
ID field[Breed] 	:=Breecj 	; Count:=l; IDfield[Location] 	:Location'; 
While not(eoln(input)) and 	(Count(-s.rum_length) DO IDfieIdCSublocation):Subloctn'; 
BEGIN ID+Ield[CBTS] 	:=C$TS 
Read(chksrmtcount)); IDfie)dlSpare] :=Spare 
chksrm(count]:caseup(chksrmCcount]); REPEAT (A LOOP AROUND THE ENTIRE PROGRAM) 
Count: count+l; Clearscreen; 
END; writeln;writeln; 
readin; writeln('This programme allows you to modify the input'); 
carry_on:false; writeln('file. 	The animals to be modified are chosen in'); 
count:I; wrtteln('exactly 	the same way as the selection program'); 
repeat writeln('chooses animals to be 	copied. 	USE THE'); 
IF chksrmCcount]<>' 	'THEN carry_onstrue; writemn('PROGRAMME WITH CARE - 	ONLY RUN IT ON 	FILES'); 
count:count+l; writeln('THAT HAVE BEEN 	BACKED UP. AN ERROR CAUSED BY'); 
UNTIL 	(carry_on) or (count>"serum_length); writeln('POWER FAILURE ETC 	CAN DAMAGE THE FILE BEYOND'); 
IF carry_on THEN writeln('REPAIR. 	AFTER "UPDATE" CHECK THE 	INTEGRITY'); 
BEGIN write[n('OF THE OF THE MODIFIED FILE BY RUNNING IT'); 
Eachserum:0; writeln('THRQUGH 	ANOTHER B0LA PROGRAMME. 	Never exit'); 
REPEAT writeln('by "C or "'Break after the input file 	has been'); 
Eachserum:Eachserumi-1; writein ('opened. '); 
Until 	(serum_panelCeachserum]chksrm) OR writeln;writeln; 
(Eachserum>=allsera); open the input file) 
IF (serum_panel Ieachserum]=chksrm) THEN REPEAT 
BEGIN write 	('Input file: 
REPEAT readln(Infilname); 
writeln(serum_panel(eachset-um],' reaction is IF Not 	(Fstat(Infjlname)) 	Then writeln('no file 
results.serums(eachserum]); ',Infilname); 
write('enter correct reaction: 	'); UNTIL 	(Fstat(Infilname)); 
onechar:' 	'; Assign(Infil ,Infilname); 	Update(Infil); 	writeln;writeln; 
read(screen,onechar); writein; (open the batch file) 
IF 	( onechar(chr(ord(l3))) 	) 	(<CR)) REPEAT 
THEN onechar:resuits.serums(eachserum]; write 	('Batch file: 
IF NOT (onechar in OK-scores) THEN bleep; readln(Batchfilname); 
UNTIL (onechar IN OK_scores); IF Not 	(Fstat(Batchfjlname)) 	Then writeln('no file 
Results.serumsteachserum:honechar; ',Batchfilname); 
END UNTIL 	(Fstat(Batchfilname)); 
ELSE Writeln(chksr., 	not found'); Assign(Batchfil,Batchfilname); 	Reset(Batchfil); 
END;(if carry On) FOR Count:=l to ailsera do 
UNTIL NOT (carry_on); begin 
END; For X:-1 to Serum_length do Seruin_panel[Count] CX] 
end;  
BEGIN 	 (MAIN PROGRAMME) end; 
Clearecreen; FOR Count:l to serum_length do select(counth=' 
FOR X:l TO B Do writein; (fill the array serum panel with the serum names in this 
writein (' 	 ****sae*****e****e**'); file) 
writeln(' Update 	'); Panel_size:=1; 
wrjteln(' 	 *******4************'); WHILE 	(Panelsize<=Allsera) AND (NOT 	(eof (Batchf ii))) DO 
writeln;writeln;writeln;writeln;writeln; BEGIN 
writeln('sik 26/1/84'); Count:=l; 
For X:1 TO 70000 do; While NOT eoln(Batchf ii 	) and (Count <6) DO 
OK_choice;C'N','T','D','X','B','L','S','C','P',R'); BEGIN 
(23) 	 (24) 
READ( Batchfil ,Serum_panel (Panel_size) 
[Count] ); 
Count: Count+ 1; 
End; 
READLN(Batchf ii); 
Panel size: Panel _size+l; 
END; 	(while panel size) 
Panel_si ze: =Panel _si ze- 1; 
(the serum names are in the array Serum_panel) 
(and the variable panel_size is equal to the number of 
sera in the panel) 
clearscreen; Wri teln;Writeln; Writeln; 
write(' 	); 
Writeln(Vou may select animals for updating by up to 
,selectable:l, strings); 




Write V 	 N);normal;Writeln( umber'); 
Write V 
Ba ) ;bright; write (*t) ; normal; writeln( ch 
bright; 
Write V 	 D);normal;writeln('ate ); 
normal; 
Write V 	 Se);briqht;writeln('x'); 
Write V B);normal;writeln('reed'); 
Bright; 
Write V 	 L');normal;writeln('ocation); 
Bright; 
Write V 	 S');normal;writeln('ublocation); 
Bright; 





Write (' Or by Serum 
');bright;write( 'r');normal;writ.ln( 'eaction ); 
writeln;writeln; 
writeln('choose the field upon which to base your 
selection ');writeln; 
write(* 	Choice (',chr(lBH),'(s',(stores cursors 
position) 
repeat 
wrxte(chr(1BH)'(u');(return cursor to stored position) 
bright ;read (screen ,choice) ;normal; 
Choice:Caseup(choice); 
Until (Choice IN OK_Choice); 
writeln; 
IF (ChoiceN') Then (select by Name) 
Begin 
counts l; 	out:true; 
While out and (Count(seLectable) do 
begin 
tloForName: true; 
Write( Enter id number ',count:l,' to be selected: 
For x:=l to namelength do s_name(count)(]: 	; 








(if empty string is entered then leave the loop) 
count: count+l 
end; todo: count-2; 
end (+ choice-N) 
ELSE (if choice<>N) 
Begin 
6oForName:false; 	serumonly:false; 





L' :field: =location; 
S':field:sublocation; 
'Cifield:=cbts; 
'P's field: Spare; 
'R' : serumoni ys true; 
end; (case) 
IF (not serumonly) then 
Begin 
Count:l; out:true; 
while out and (Count<sel.ctabl.) do 
begin 
for x:1 to detail_length do s_4ield(count](x]i 
Write('Enter ',ID_Fteld(field],' ',countit,' to be 
selected: '); 




x : x + 1; 
End; 
readln; 
OUT: =(lenB(posnl(count) ,posn2(count) ,s_field[count]) 
I; 
(until blank string is entered) 
Count: Count+ 1; 
end; todo: =count-2; 
END 
ELSE (selection by serum reaction) 
BEGIN 
(25) 	 (26) 
(now read the serum -names to be selected) 
x:l; out:false; 




FOR Counts-I TO serum_length DO Select[Count]:= 
wri tel n; 
write ( enter the name of serum  
Count: =1; 




Select[Count]a- caseup( Select[Count] ); 
Count: Count+ 1; 
END; 
read in; 
IF select<> 	 then 
begin 




Until (serum_panel tEachserua]=select) OR 
(Eachserum>=al isera) 
IF (serum_panel CEachserum)=select) THEN Found:-TRUE 
ELSE writeln(select, not found in ,batchfilname); 
end else outaTRUE; (if select is empty) 
UNTIL ( (Found) or (out) ); 
IF not out then 
BEGIN 
Test(s): Eachserum; Opened: true; 
Repeat 
opened: -true; 
write(select animals pas or neg for ,select,? (+/ 
) a 
read (screen,choice) 
case choice of 
+ wanted (5 ] : true; 
awanted(x]afalse; 
otherwise opened: false; 
end; (case) 
until (opened); 
5: x + 
END;(if not out) 
END; 
todo: x-l; 
writeln;writeln(selection will be by those ',todo:i,' 
sera); 
wr i tel n; 




clearscreen; moved:=; seen:; 
writeln;wri teln;wra teln; 
if not serumonly then 
begin 
write( 	 selecting by ,todo:i, strange an 
the ); 
IF goforname then writeln(name) else 
writeln(id_4ie)d[field], field 
end 
(****** START READING THE FILE ****e*) 
else writeln( 	 selecting by ,todo: 1, serum 
reactions); 
continue: =true; 
writeln;write( wait ); 
While not eof(inf ii) and continue do 
begin 
ok:false; seen:-seen+l; 
write('.'); 	 (ii**** SELECTION 
BY NAME *****) 
If GoForName then (if selection is by name) 
begin 
If (len(pos3,pos4,infil.name) ) then 
(if name from file is not empty) 
begin 
count: =1; 
While (Count<=todo) and not ok do 
begin 
I4(subin(posni(courst),posn2(count],s_name[couot], 
pos3,pos4,infil.name) ) then 
begin 
Cl earscreen; reverse; 
write( animal number ,seen:4, in 
,infilname, 
,moved:4, animal(s) updated 	this is number 
(moved+l) :4> ;writeln; 
normal ;writeln; 
revise(infil); moved:moved+l; ok:true; 




If continue then write('wait); 
end; (if subin) 
count: =count+l; 
end; (while count) 
end; (if len) 
if not ok then Put(infil);(no change has been made-
advance to next record) 
END 	 (if go for name) 
Else 
begin 
IF not serumonly then 
(**** SELECTION BY DETAIL FIELD ****) 
BEGIN 
(27) 	 (213) 
If (ienB(pos3,pos4,in4il".details(field)) )then 	 chain( E40LA); 
begin 	 END. 
Count:1; ok:fa1se; 
While (Count<todo) and not ok do 
begin 
If (subin8(posnl(count],pomn2[couot] ,sfield(count), 
pos3,pos4,inhii'.detai1s(4ield]) ) then 
begin 
clearscreen; reverse; 
write(animal number ,seen:4, in 
• ,infilname, 
,moved:4, animal (3) updated - this is number 
, (moved+l) :4) ;writeln; 
normal ;writeln; 




If continue then write(wait); 
end;(if subin8) 
Count: count+l; 
end; (while count) 
end; 	(+ lenS) 




(**** SELECTION BY SERUM REACTIONS ****) 
repeat 
if infil.serums(test(x]) in p05_scores then 
begin 
if wantedtx) then ok:true else ok:4 mime; 
end 
else begin if not wantedix] then ok:=true else 
ok:false;end; 
x : 
until (not (ok) or, (xtodo+l)); 
if ok then 
begin 
ci earecreen; reverse; 
write(animai number ,seen,4, in ,infilname, 
,movedz4, animal(s) updated - this is number 
, (moved+i) :4) ;writeln; 
normal ;writeln; 
revise(infil); moved:moved+l; okstrue;put(infil); 
ci earscreen; 
Continue (yesno(x,keep searching)); 
If continue then write(wait); 





UNTIL (NOT Yesno(X, 	make another selection) ); 
(29) 	 (3) 
Re-order serum reactions 




Serum length 6; 
Detail length 	B; 
TYPE 	Maxno 	 1. .Allsera; 
Set -of -fields 
=(batch,date,sex,breed,location,sublocation, 
CDTS,Spare); 
Recof _resul tsRECORD 
Name:Packed Array(l. .name_length] of char; 
Details:Array(set_of_fields) of packed array 
(1. .detail_length) of char; 
Serums:Array(maxno) of char; 
END; 
Snames = Array(Maxno] OF Packed 
Array(l. .serum_length] OF CHAR; 
BOLAfile 	=File Of Rec_of_results; 
VAR 	Eachserum , Neweachserum 
Count: 	 Maxno; 
X: 	 Integer; 
Results: 	Rec_of_results; 
Found,Opened: 	BOOLEAN; 
order 	s 	ArrayMaxno] OF integer 
OldPanel, (holds the names of the 
old panel sera) 
NewPanel: 	Snames; (holds the names of the 
new panel sera) 




Indatafile, Outdatafile: 	BOLAfile; (the 
pascal non text files) 
Oldpanelfile, Newpanelfile: 	TEXT; 	(the 
two panel files) 
FUNCTION VESNO (Default:CHAR; 
Message: STRING) : ROOLEAN;EXTERNAL; 
FUNCTION Caseup (letter, CHAR):CHAR;EXTERNAL; 
PROCEDURE Cl earecreen; EXTERNAL; 
BEGIN 
Cl earscreen; 
Writeln('This program re-orders the reactions in the input 
file'); 
Writeln('o that it coresponds to the NEW PANEL') 
(open the file to be added) 
REPEAT 
write ('file to be read:'); 
readln(Indatafilename); 
IF Not (Fstat(Indatafilename)) Then writeln('n o file 
',Indatafilename); 
UNTIL (Fstat (Indataf i lename)); 
(31)  
Asslgn(Indatafjje,Indatafjlename); Reset(lndatalile); 





IF Fstat(Outdatafilename) THEN 
BEGIN 
IF Vesno('X','This file exists 01< to append to 
it') Then Opened:=TRUE 




(open old serum panel file) 
REPEAT 
write ('Old serum panel filet ); 
readln(Oldpanelfilename); 
IF Not (Fstat(Oldpanelfil.name)) Then writ.ln('no file 
',Oldpanelfi lename); 
UNTIL (Fstat(Oldpanelfilename)); 
Assign (01 dpanel fi le,Oldpanelfi lename); 
Reset (Oldpanel file); 
(Open new serum panel file) 
REPEAT 
write ('New serum panel file: 
readln(Newpanelfi lename); 





FOR Count:=1 TO allsera DO 
BEGIN 











WHILE NOT EOLN(NEWPANELFILE) AND (COUNT<SERUtl_LEN13TH)DO 
BEGIN 
Read (Newpanelfi le,Newpanel (NEWEachserum)(Count)); 
Newpanel [NE WEachserum] (Count], = 












WHILE NOT EOLN(OldpanelFILE) AND (COUNT<=SERUM_LENGTH) DC 
BEGIN 
Read (01 dpanelf ile,Oldpanel [Eachses' -um] (Count]) 







For Count:l TO NEWEachserum DO 
BEGIN 
X:'1; Found:-FALSE; 
WHILE (X<Eachserum) AND NOT FOUND DC) 
BEGIN 
IF Newpane1CCount]0ldpanel(X] THEN 
BEGIN 
order CCount]:X; 






IF NOT Found THEN 
BEGIN 




For XsNeweachserum TO Ailsera DO order[X]t=240; 
write('wait'); X:1; 
WHILE NOT eof(Indatafile) DO 
BEGIN 
Resu1ts:Indatafile; write('.'); 
FOR Countsl TO Alisera DO Results.Serums(Count]:= 
Indatafile".serums(order(Count)]; 




Writeln((x-1):l,' Records copied'); 
chain('BOLA'); 
END. 
PROGRAM READ IN_TENS 
(INPUT,OUTPUT,OATAFILE,SERAFILE,RSVFILE,NOTHING); 
CONST a11sera=24; 	( max number of sera) 
Totplate=40; ( max number of plates) 
Name length=4; ( length of the name field) 
Kbd_Buffer=15; 	( number of characters 
in keyboard buffer) 
TYPE One_to_ten=1.. 1; 0ne_to_eight1. .8; 
Maxno=1. .Allsera; 
Set_of _f ields= (batch ,date, sex ,breed 1 ocat i on 
sublocation,CBTS,Spare); 
Set_of _scores=SET OF CHAR; 
Recof _Resul tsRECORD 
Name:PACKED ARRAY(1. .Name length) OF 
CHAR; 
Details:ARRAY(Set_of_fields] OF 
PACKED ARRAY(1. .8] OF CHAR; 
Serums:ARRAY(maxno) OF CHAR; 
END; 
Allten=ARRAY [One -to-ten] OF Rec_of_Results; 
Field= ARRAY [Set-o4-fields) OF PACKED 
ARRAY(1. .8] OF CHAR; 
Panel= ARRAY (Maxno] OF PACKED ARRAY(1. .6] OF 
CHAR; 
Allplate=l. .Totplate; 
BOLAfjle=FILE OF Ref_of _Results; 
VAR Eachanimal,Wrongone; 	One_to_ten; 
Results: 	 Aliten; 
Eachfield: Set_of_fields; 
ID_field: 	 Field; 
Name-correction: 	 PACKED 
ARRAY(I. .Name_length)OF CHAR; 
Detail-corrections 	 PACKED ARRAY(1. .8) 
OF CHAR; 





Opened ,00psed,Data_oks 	BOOLEAN; 
Serum_panel: 	 Panel; 
ASCII, 
X,Counts 	 INTEGER; 
Screen, 
Directs 	 FILE OF CHAR; 
Nothing: CHAR; 
RSVfile, 	(HOLDS the data as it is entered) 
Dataf lie: BOLAf lIe; (holds the data) 
Serafile: 	TEXT;(holds the list of sera) 
RSVf name, 
Dataf name, 
Serafname: 	 STRING(14); 
Setl,Set2: STRING(20); 
(33) 	 (34) 
Backplate, SERUNS[Eachserumi:=chr(ord(ASCII)); 
SO_far,Eachplate,Maxplate: 	Aliplate; If ASCU70 then ASCII:65 else ASCII:ASCII+l; 
OKscores: 	 Set_of_scores; end; 
Eacheerum, END; 	(With Results) 
Panel -size: 	 Maxno; END; (for eachanimal) 
FUNCTION YESNO (Default:CHAR; For Count:=l TO allsera DO 	 (initialise the 
Message:STRING):BOOLEAN;EXTERNAL; array which will) 
PROCEDURE Bright;EXTERNAL; BEGIN 	 (hold the serum 
PROCEDURE Normal;EXTERNAL; names) 
PROCEDURE Clearscreeo; 	EXTERNAL; For X:l TO 6 00 Serum_panel[Count] (X]: 	; 
PROCEDURE Bleep;EXTERNAL; END; 
FUNCTION Caseup 	(Letter: CHAR)gCHAR;EXTERNAL; (open a file to hold the data 	and set it for APPEND) 
FUNCTION namecheck(filename:string):Boolean;EXTERNAL; REPEAT 
BEGIN 	 (main program) Opened;-true; 
clearscreen; REPEAT 
FOR X:1 TO 9 DO writeln; write( 'file to hold the data); 
writeln( 	 ***************); bright;write( 	I 	 J.DTA,chr(1BH),(15D); 
writeln(' DoLA DATA ENTRY); Readlo(Datafname);writeln;normal; 
writeln( 	 **************4); UNTIL(namecheck(datafname)); 
writeln;writeln;writeln; datafname:=concat(datafname,.DTA); 
writeln( 	 by sjk B884); IF FSTAT(Dataf name) 	THEN 
FOR X:l TO 90 	DO; BEGIN 
Assign(direct,CON.DIR);reset(direct);(allows input IF Yesno(X,This file exists - Ok to append new 
without holdup) data) THEN Opened:TRUE 
Assign(screen,'CON); 	reset(screen); ELSE 
write(chr(IBH), 	Cø;67; .......... ; 13p); Opened:FALSE 
(SETS F9 = ...... (CR> ) END; 
ID_fieldtBatch) 	: Batch 	•; UNTIL Opened; 
ID_fieldtDate) :Date ; Assign(datafile.,Datafname); 	Append(dataflle); 
ID_f ield(sex) 	1-sex 	•; (NEXT: open for reading the file holding the names of the 
ID_field[breed] :Breed ; sera 
ID_fieldlLocation) 	:Location; REPEAT 
ID_fieldCSublocatin]:=Subloctn; REPEAT 
ID_4ieldlCBTS) 	c=CBTS 	; writein; 
ID_f ield[Spare] :=Spare • write(file with serum sequence); 
OXscores:=C-,B,64,.,2,7]; bright;write(' 	I ].BCH,chr(IBI-4),115D); 
(this set is used for checking serum scores as they are readln(serafname);writeln;normal; 
entered. 	It contains all the valid scores) UNTIL (namecheck(seraf name)); 
Clearscreen; serafname:=concat(serafname, .BCH'); 
FOR Eachanimal:1 TO LB DO If not (Fstat(serafname)) then writeln(lhere is no file 
(initialise the arrays which will hold) ,serafname; 
(the details of theanimals ID) UNTIL 	( Fstat(seraf name) 	); 
BEGIN Assign(serafile,serafname); 	reset(serafile); 
WITH Results(eachanimal) DO Panel_size:B; 
BEGIN WHILE 	(Panel_size<=Allsera) AND (NOT (eof (Seq-a_file))) DO 
FOR Count:l TO Name_length DO Name(Count):= 	•; BEGIN 
FOR Eachfield:=Batch TO Spare DO Panel_size:Panel_size+l; 
BEGIN Count:=l; 
FOR Count:l TO B DO Details[eachfield] (Count): 	; While NOT eoln(Sera_file) and 	(Count <=6) DO 
END; 	(For Eachfield) BEGIN 
(fill 	the serum fields with A..F) READ(Sera_file,Serum_panel[Panel_size]lcount)); 
(to mark unread plates) Count:Count+l; 
ASCII:65;(A) End; 
FOR Eachserum:=l to allsera 	do READLN(Serafile); 
begin END; 	(while panel size) 
(35) 	 (36) 
(the serum names are in the array Serum_panel) 
(next calculate the number of plates in the set) 
IF (Panel - size DIV t,)(Panel_size/h) THEN 	 (if it is 
a multiple of 6) 
Maxplate:=Panel_size DIV 6 
ELSE tlaxplate:=((Panel size DIV 6)+1); 
WRITELN(lhere should be ,maxplate:2, plates in this 
set. 	); 
WRITELN; 
(F7 IS NOW SET TO ANY STRING) 
WRITE(ENTER STRING FOR P7: ');READLN(SETI); 
SET2:CDNCAT( '(B;hS;',SETl, ';l3p); 
WRITE(CHR(1BH) ,SET2); 
wri teln; 
IF Vesno('X','Is this the start of a new set of plates) 
THEN 
BEGIN 	 (It is a new set - start from the beginiog) 
SO_far:=l; (the plate at which to begin reading) 
REPEAT 
Opened: true; 
write (file to hold temporary data: ); 
readln(rsvf name); 
IF NOT FSTAT(rsvf name) THEN assign(rsvfile,rsvfname) 
ELSE 
BEGIN IF (yesno(x,File exists ok to delete it)) 
THEN assign(rsvlile,rsvfname) 




(open a file to hold data as it is entered ) 
( 	- a safeguard against power cuts!I 
Cl earscreen; 
FOR Eachanimal:l TO 10 DO 
BEGIN 	 (record animal numbers) 
WRITELN (ENTER ANIMAL NUMBER ,Eachanimal:2); 
Count: =1; 
WHILE (NOT eoln(input)) AND (Count<=Name_length) DO 
BEGIN 
READ (Results(Eachanjinai ).Name(Count)); 
ResultsCEachanjmal ).Name(Count]: 
Caseup(Results(Eachanilnal].Naine(Count)); 	(convert 
to upper case) 
Count: Count+1; 
END; (while not eoln) 
READLN; 
END; 	 (numbers recorded) 




writeln( Number ,eachanimal:2, 
,results(eachanimal).name); 
normal; 
FOR Eachfield:.Datch TO Spare DC  
BEGIN 
IF (Eachanimal > 1) THEN 
WRITELNVANIMAL NUMBER •,Eachanimal:2,: ENTER 
	
,ID_fieid(eachfield]:B, 	Default is: 
,Results(Eachanimal-l).Oetajls(Egchfield]) 
ELSE 	 (this is the 1st animal - no 
default) 
WRITELN (ANIMAL NUMBER ,Eachanimal:2, 
: ENTER ,ID_fieldIEachfield); 
Count: l; 







END; 	(while not eoln) 
Readin; 




ResultsCeachanimai-I ]. Detai iscEachfieldj; 
C sets each field = to that of the last animal if a null 
is entered) 
END; (for eachfield) 
END; (for eachanjmai) 
C ID details recorded I 
For Count:=l to Kbd_buffer do read(direct,nothing); 
(absorbs any extra characters typed in response to above) 
(prompts no hold-up if no extra character.) 
REPEAT 
(now write out the numbers and identities) 
clearscreen; 
FOR Eachanignal:=1 TO 10 DO(write out the names in full) 
BEGIN 
Read (direct,nothing); 
(throw away anything entered while identities are 
being written out) 
WRITE (Eachanimal:2, - ,ResultslEachani.al).Name); 
IF(results(eachanjmal].name(l)='() THEN 




WRITELN('ROW BATCH 	DATE 	SEX 	BREED LOCTN 
SUBLOC 	CBTS 	SPARE'); 
FOR Eachanimal:=l TO 10 DO 
BEGIN 
WRITE (Eachanimal:2,' - 




(37) 	 (38) 
END; 	 C of writing out details ) 
wri twin; 
IF NOT Yesno('X,'DATA OK') THEN 	(if data not ok) 
BEGIN 	 (correct the error) 
Data_ok:FALSE; 	(there is an error) 
REPEAT 
WRITE('enter number of row to be corrected: 
READLN CX); 
UNTIL (X<li) AND (X>ø);(untii answer is in the 
legal range of wrongone) 
Wrongone: =X; 
WRITELN('Animal,Wrongone:3, Number is: , 
Resul ts(Wrongone) .Name); 
WRITE ('Enter correct number (return leaves as is): ); 
FOR Count:-1 TO Name length DO 
Name_correction(Count):' p (reset the array) 
Count: =1; 
WHILE (NOT eoln(input)) AND (Count<Name_length) DO 
BEGIN 
READ (Name _correctionlCount]); 
Name _correctionCCount Ix - 
Caseup(Name_correctionlcount]); 
Count: Count+ 1; 





IF NOT (Name-correction[Count]=' ') THEN CHANGE:-TRUE; 
Count: Count+ 1; 
UNTIL (Change) OR (Count>Name_length); 
IF (Change) THEN (if correction is not blank) 
Resu1ts[Wrongone).Name:Name_Correction; (change name) 
(If correction is blank old name remains unchanged) 




WRITE ('Enter correct ,ID_Field(Eachfield],: 'I; 
FOR Count:-1 TO a DO Detail -correction(Count)c=''; 
(reset the array) 
Countzl; 





END; (while not) 
Readln; 
IF NOT (Detail -Correction=' 	 ) THEN (if 
correction is not blank) 
Resul ts(wrongone). Detail stEachf id d] : - 
Detail Correction; 
(If correction IS blank the field remains unchanged) 
END; (For eachfield) 
END 	(if not yesno) 
ELSE 	(Data is correct) 
Data_ok: =TRUE; 
UNTIL Data_ok; 	 (until data is correct) 
(Now the information is written into the file RSVfiIe) 
WRITELN('wait this data is being stored in the temporary 
file ',rsvfname); 
FOR Eachanimal:=l TO 10 DO 
write(RSVfile,Results(Eachanimal]); 
CLOSE(RSVfile); 
( 	 details written to RSVfile 
END (if a new set) 






write('temporary file holding part read test: 
readln (rsvf name) 
IF NOT Fstat(rsvfname) THEN Writeln('There is no file 
,rsvf name) 




WRITELN('This file will continue to be used for temporary 
storage'); 
FOR Eachanimal:1 TO 10 DO 
BEGIN 
Results(Eachanjmal ]: RSVfi le; 
get (RSVfi le); 
END; 	(for eachanimal) 
CLOSE(RSVfile); 
(find how much was read) 
Eachplate; ; Eachseruin: -a; 
REPEAT 
Eachserum: =Eachserum+6; 
Eachpl ate: Eachpi ate+ 1; 
UNTIL(NOT(Results[l).seruins(eachserum) IN OK -Scores)); 
Eachpl ate: eachpl ate-i; 
(now eachplate is the number of plates read) 
(write out what has been read from the RSVfile) 
ci earscreen; 
WRITELN('ROW BATCH 	DATE 	SEX 	BREED 
LOCTN 	SUBLOC 	CBTS 	SPARE'); 
FOR Eachanimal:=l TO 10 DO 
BEGIN 
WRITELN(' 
WRITE (Eachanimal12,' - 
FOR Eachfield:=Batch TO Spare DO 
WRITE (' ,ResultslEachanimal).Details(Eachfipld):B); 
END; 	 C of writing out details ) 
WRITELN(' 
(39) 	 (4) 
FOR Eachanlmal:1 	TO lB DO 	(write out the names in full) 
WRITELN 	(Eachanimal:2,' 	- 	',ResultsCEachanimal).Name); 
WRLTELN; 
WR[TELN(Eachplate,' Plates read'); 
UNTIL Yesno 





C 	 BEGIN 	READING 	SERUM SCORES 
Oopsed: 4al me; Data_ok: =true; 











IF 	(Results(Eachanimal].name(l]<>'E') 	THEN 
BEGIN 
(program function keys) 
write(chr(IBH),'148;"------";13p' 	); 	(B 	= --- <CR> ) 
write(chr(1BH),'(43;l3p'); 	 (+ 	= <CR> ) 
WRITE( 'Plate: ',Eachplate:S,' 
Row: 	,Eachanimal:3, ': 	'); 
FOR Count;l TO 7 DO Temp_score_holder(Count):=' 	; 
(reset the array) 
Gopsed: FALSE; 
Data _ok: TRUE; 
Count: =1; 
WHILE (NOT eoln(input) AND (Count<7)) AND (NOT Qopsed) DO 
BEGIN 
READ (Temp_score_holder(Count]); 
IF Temp_score_holder(Count]= 'C' THEN 
Oopsed: 	TRUE; 
Count: Count+l; 




IF ((Temp_score_holder(7)<>' 	') OR 
(Temp_score_holder163' 	')) AND (OOPSED=FALSE) 






ELSE 	 (six were entered - check them) 
BEGIN 
IF NOT Oopseci THEN 
BEGIN 
FOR Count:1 TO 6 DO 
BEGIN 




WRITELN(Temp_score_holder[Count],' is not a legal score ' ); 
Bleep; 
Data _ok: =FALSE; 
END; 	(if not in okacores) 
END; (for count) 
	
END; 	(if not oopsed) 
END; (else) 
UNTIL Data _ok OR OOPSED; 
(if ok write scores to results array) 
IF NOT OOPSED THEN BEGIN 
FOR Count:1 TO 6 DO 
Results(Eachanimal).Serums(((Eachplate-l)56)+Count):= 
Temp_score_holder (Count]; 
END; 	(if not oopmed) 
UNTIL ((Eachanimal>lB) OR OOPSED); 
(reset function keys) 
write(chr(1BH),'148;48p'); 	(B ) 
write(chr0BH),'(43;43p'); (+ ) 
end;(:4 not backcheck) 
(NOW CHECK THE DATA FOR EACH PLATE) 







FOR X:1 TO 6 DO 
BEGIN 	 (write out the serum names) 
WRITE(' 




END; (for Eachanimal) 
WRITELN; 
WRITELN(' 	 A B C D E F 
WRITELN(' --------------------V); 
FOR Eachanimal:l TO lB DO 
BEGIN 
WRITE(' 	',Eachanimal:3,' 	'I; 
FOR Counts-1 TO 6 DO 
WRITE(' 	', 
ResultstEachanimal ].Serums( ( (Eachplat.-l)46)+Count3); 
WRITE(' 
If (Eachanimal5)then writeln(' 	PLATE ',eachplate:3) 
Else 
(41) 	 (42) 
beg: ii 
If (Eachanimal,) then writ&n( 	 - 
else writein; 
end; 




IF NOT Yesno(X, 	Data Ok') THEN 
BEGIN 
REPEAT 
If BackCheck then FirstLook:=FALSE; 
WRITE('line at which to begin correcting ?'); 
READLN CX); 
UNTIL C (X<I) AND (X>) AND 
(resultslX).name( 11<> C ) ) 
( cant correct a £ animal) 
Eachanimal :X-1; 
(because Eachanimal will have one added at the start of 
the loop) 
Data _ok: FALSE; 
END (if not yesno) 
ELSE Data _ok: =TRUE; 
END (if not oopsed) 
ELSE (was oopsed) 
BEGIN 
REPEAT 
WRITE('line at which to begin correcting ? (max 
is,Eachanimal:3,'): '); 
READLN CX); 
UNTIL ( (X<Eachanimal) AND (X>) AND 
(results(X].name[1)<>f') 
(must be at or before the line that 
was oopsed and not a £ animal) 
Eachanimal : X-l; 
Data _ok: FALSE; 
END; 
UNTIL (Data_ok); 
(data for one plate is correct - store it in RSVfile) 
update(RSVfile); 
FOR Eachanimal:1 TO 10 DO 
BEGIN 
RSVfile':=Results[Eachanimal); 
put (RSV+ i id; 
END; 	(for eachanimal) 
close(RSVfile); 




write('Carry on ? (y/n/b (=back)  
read(screen,nothing);writeln; 
case nothing of 





If backcheck then eachplates=sofar; 
(if was backcheck then pick up at plate before backcheck) 
backcheck: false; 
If Carry_on or (eachplatemaxplate) then 
begin 
Carry_on:=true;(if last plate this allows backcheck) 
If (Nothing'B') or (Nothingb') or 
(eachpi ate=maxplate) then 
begin 
If (eachplate=maxplate) then 
backcheck:=NOT(Yesno(X', 	LAST PLATE - ALL OK')) 
else backcheck:=true; 
If backcheck then 
REPEAT 
write('plate to check: );readln(backplat&; 
UNTIL (backplate>Ø)and(backplate<=egchplate); 
end; 
If not backcheck then Eachplate:=Eachplate+i 
else 
begin 
sofar:=eachplate; (remember where you got to) 




UNTIL ( (Eachplate>maxplat& OR (NOT Carry_on I ); 
(then fill in the not tested wells maxplate to Totplate) 
IF Carry_on THEN 	(if got here by finishing the 
reading) 
BEGIN 
WRITELN( 'filling in remaining results'); 
FOR Eachanimaj:=1 TO 10 DO 
BEGIN 
FOR Count:=(((Eachplate-j)*6)+1) TO Alisera DO 
Results(Eachanjmal].Ser-umsCCount):.'; 
END; 	(for eachanjeal) 
(then write all the details to data file) 
FOR Eachanimal:=1 TO 10 DO 
BEGIN 
IF (ResultsEachanimal).name(j](>C') THEN 
WRITE(DATAfi1C,Results(Eachanimal)); 
END; (for eachanimal) 
WRITELN('results written to file ,datafname); 
Writeln; 
END; 	(if not carry on) 
wr1te(chr(lBH),'(;67;;e7p'); (RE-SET F9) 
write(chr(iBH,'[ø;6;ø;65p); (RE-SET El) 
CHAIN( 'BOLA'); 
END. 	(main program) 
(43) 	 (44) 
Selection 
PROGRAM SELECT 
INPUT ,OUTPUT, INFIL ,OUTF IL ,Rejectf ile,batchf it e) 
CONST ALLSERA 	 =240; 
NAMELENGTH 
Serum _length 	=6; 
Detail length =8; 
Selectable 	5; (max number- of sera which 
can be selected for) 
TYPE 	Maxno 	 =1. .Allsera; 
Set -of -fields 
= (batch ,date,sex ,breed , location ,sublocat jon 
CBTS,Spare); 
PA 	 =Packed Array(l. .name_length] of char; 
FAa 
	
=Packed Arrayll. .detail_length] of char; 
Rec_of _resul ts=RECORD 
Name: PA; 
DetaUs:Array(set_of_fjelds] of packed array 
(1. .detail_length) of char; 
Serums:Array[maxno] of char; 
END p 
Srmname 	 Packed Arrayll. .serum_length] 
OF CHAR; 
BOLAfile 	=File Of Res: _of_results; 
ok_scores= SET OF CHAR; 
VAR 	seen,todo, 
eachserum • moved, 
Pos3, 
Pos4,Count,X: 	integer; 
posnl,posn2: arrayCi. .selectable] of integer; 
response, 
Choice: 	 char; 
Field: Set _of_fields; 
Panel _sizes 	Maxno; 
Results: 	Rec_of_results; 
Exact _match: 	Arrayti. .selectable] of BOOLEAN; 
Reject, 
GoForName,ok, 
Found, serumon 1 y, 
Out ,Opened: 	BOOLEAN; 
test: 	 arraytt. .selectable) of maxno; 
Wanted: Arrayli. .selectable) OF Boolean; 
Serum-Panel: 	Array(maxnol OF Sr.name; (holds 
panel sera names) 
Select: 	 Packed Arrayli. .serum_length) OF 
char; (names of selecting sera) 
Pas _scares: 	OK_scores; 
S_name: 	 arrayti. .s.lectable) of PA; 
S_field: arraytl. .selectable] of PA8; 
(as S_name for the id field) 
ID-Field: 	Arraylset_of_fields) OF STRINBIB]; 
(the NAMES of the fields) 
rejectf i 1 name,  
batchfi lname, 
Infi lname, 
Outfilname: 	string(121;(the names of the files 
on disk) 
Screen: 	 File Of Char; (gives one chracter 
entry without <CR>) 
Batchfil: 	TEXT; 
Reiectfile, 
Infil, Outfit: BOLAfile; (the pascal non text 
files) 
OK-choice: 	SET OF 'AS.. 
Function len (var post,pos2:Integer; 
TestString: PA) :bool man; 
(returns positions of first (post) and last (pos2) 
non blank characters in an array) 




(FIND REAL LENGTH OF STRINGI) 
(first find position of first non blank) 
not_blank: f alse; xi =1; 
While (X<=40) and not (not-blank) do 
begin 
If (Teststringlx]<>' ') Then not_blank:=True Else 
xi 
end; 
IF (x41) then len:=false 
ELSE posl:=x; 
(FIND LAST NON BLANK) 
x : 4S; not_blank: =false; 
while(x>=l) and not (not -blank) do 
begin 

















While(y<=pos4) and not match do 
begin 
If (sub[post]-Test[y] then match:-true else y:=y+l; 
end; 
Sofari y; 
(45) 	 (46) 
If not match then begin subin:fa1se;out:.true;end 
(first character of sub is not in test so no match) 
ELSE 
BEGIN 
IF (poslpos2) then begin subin;true;out:true; end 
ELSE 
Begin 
Sofar:y; x:1; fail:false; 
REPEAT 
If subtposl+x1<>test(so4ar+3 then fail:true 
else x:x+l; 
UNTIL ( (( posl+x)> pos2) or fail); 





Until ( (So4ar>pos4) or (out) ); 
END; (subin) 
Function match(posl ,pos2: integer; 
sub: PA; 
pos3,pos4! integer; 
test:PA) :Bool can; 
(returns true if sub matches test ignoring leading and 
trailing blanks) 
var x:integer; 
matched: bool can; 
BEGIN 
If (pos2-posi )<>(pos4-pos3) then matchtfalse 
(if there are not the same number of characters in the 
strings 
then they cannot match) 
ELSE 
begin 
x:=0; matched:=true; match:true; 
While (X<=(pos2-posl) ) and matched do 
begin 
if (sub1posi+x3<>test1pos3+x1) then matched:-false; 





Function match8(posl ,pos2: integer; 
sub iPA8; 
pos3,pos4: integer; 
test:PA8) : Bool can; 
(returns true if sub matches test ignoring leading and 
trailing blanks) 
var x:integer; 
matched: boot can; 
BEGIN 
If (pos2-posl)<>(pOs4pOs3) then match8:false 
(if there are not the same number of characters in the 
strings 
then they cannot match) 
ELSE 
begin 
x:=6; matched: true; match8: =true; 
While (X<=(pos2-posl) ) and matched do 
begin 
if (sub(pos1+xJ<>test(pos3+x.1) then matched:false; 





Function lenD (var posl,pos2:Integer; 
TestString: PAD)-.Boolean; 
Var X 	: integer; 
not -blank: boolean; 
begin 
I enD: =true; 
(FIND REAL LENGTH OF STRING1) 
(first find position of first non blank) 
not_bi ank: fal se; x: =1; 
While (X<8) and not (not -blank) do 
begin 
If (TeststringCx]<> 	) Then not_blank:True Else 
x : 
end; 
IF (x=9) then len8:false 
ELSE posl:x; 
(FIND LAST NON BLANK) 
x :8; not_blank: false; 
whjle(x>1). and not (not-blank) do 
begin 









(returns true if sub is within test) 
var sofar,y,x:integer; 
out ,match,fai 1 iboolean; 
begin (subin8) 




While(y<pos4) and not match do 
begin 
If (sublposi]=Testty]) then match:true else y:y+L; 
end; 
Sofar: y; 
If not match then begin subin8:false;out:true;end 
(47) 	 (48) 
(first character of sub is not in test so no match) 
ELSE 
BEGIN 
If (poslpos2) then begin subin8:=true;out:=true;end 




Sofar:=y; x:l; fail:false; 
REPEAT 
If sub[posl+x)<>test[sofar+x] then fail:=true 
else xax+l; 
UNTIL C (( posl+x)> pos2) or fail); 





Until ( (Sofar>pos4) or (out) ); 
END; (subinO) 
FUNCTION YESNO (Default:CI-4AR; 
Message: STRING) : BOOLEAN;EXTERNAL; 
FUNCTION Caseup (letter: CHAR) :CHAR;EXTERNAL; 
Procedure Unline 	;EXTERNAL; 
Procedure Bright ;EXTERNAL; 
Procedure Normal 	;EXTERNAL; 
Procedure Cl earscreen; EXTERNAL; 
Procedure Reverse 	;EXTERNAL; 
PROCEDURE WIPE(X: integer); EXTERNAL; 
(runs cursor x spaces back down a line erasing as it goes) 
BEGIN 
Clearscreen; 
FOR X:1 TO 8 Do writein; 
writeln C ' 
writeln(' 	 Selection 
wri tel n C ' 
writeln;writeln;writeln;writeln;writeln; 
writeln('sjk 6/10/84'); 
For X:=l TO 70000 do; 
OK_choice: 	'N' , 'T', D, X, 'B', 'L', '5', 'C', P', 'R' 








ID_fieldtSpare] 	:= Spare'; 
REPEAT (A LOOP AROUND THE ENTIRE PROGRAM) 
Cl earscreen; 
writeln;writeln; 
Writeln('This program creates an output file by'); 
Writeln('selecting animals from the input file'); 
Writeln('according to specified criteria. Note that'); 
Writeln(when searching a field a match will be'); 
Writeln(assumed if the string in the field CONTAINS'); 
Writeln('the string being searched for to select only' 
Writeln('records which completely match the string'); 
Writeln('enter the character"@" before the first'); 
Writeln('character of the string Animals not selected' I 
Writeln(may be written into a REJECT file'); 
wri teln;writeln; 
(open the input file) 
REPEAT 
write ('Input file: 
readln(Infilname); 




wr i tel n; 





IF Fetat(Outfilname) THEN 
BEGIN 
IF Yesno('X','This file exists OK to modify it' 
Then Opened:TRUE 
ELSE Opened: FALSE; 
END; 
UNTIL (Opened); 
Assign(Outfi 1 ,Outfi lname); 
if fstat(outfilname) then 
begin 
Repeat 
write('over-write ',outfilname,' or append to it? 
(0/A) ');read(screen,choice); 
writeln; 
case choice of 
'a', 'A' : Append (outf il) 
'o', 'O':rewrite(outfil); 





(open the batch file) 
wri tein; 
REPEAT 
write ('Batch file: 
readln(Batchfilname); 
IF Not (Fstat(Batchfjlname)) Then writeln('no file 
',Batchfilname); 
UNTIL (Fstat(Batchfilname)); 
Assign (Batchfil ,Batchfilname); Reset(Batchf ii); 
wri teln; 
Reject:=yesno('X','Save the rejects'); 
(49) 	 (50) 
If reject then 
begin 
(open the REJECT file) 
REPEAT 
Opened: = TRUE; 
Write(Reject file: 
Readin (rejectf i iname); 
IF Fstat(rejectfilname) THEN 
BEGIN 
IF Yesno( 	This file exists OK to modify it) 
Then 	Opened:=TRUE 




if fstat(rejectfilname) then 
begin 
Repeat 
write(overwrite ,rejectfilname, or append to it? 
(0/A) ) ;read(screen,choice); 
writeln; 








end; (if reject) 
FOR Count:l to alisera do 
begin 
For X:1 to Serum length do Serum_panelCCount] (X] r 	; 
end; 
FOR Count:1 to serum_length do select(count):= 
(fill the array serum_panel with the serum names in this 
file) 
Panel_si ze: =0; 
WHILE (Panel_size<Allsera) AND (NOT (eof(Batch+il))) DO 
BEGIN 
Panel _si ze: Panel_si ze+l; 
Count: =1; 
While NOT eoln(Batchf ii ) and (Count <=6) Dl) 
BEGIN 




END; 	(while panel size) 
(the serum names are in the array Serum_panel) 
(and the variable panel_size is equal to the number - of 
sera in the panel) 
clearscreen;Writeln;Writeln;Writeln; 
write( 
unl i ne;  
Write(Vou may select animals by up to ,selectable:1, 








Write ( 	 D);normal;wr- iteln(ate ); 
normal 
Write ( 	 Se) ;bright;writ.ln( x); 
Write ( 8);normal;writeln('r-eed); 
Bright; 
Write ( 	 L);normal;writeln(ocatfon); 
Bright; 
Write ( 	 S);normal;wc- iteln(ublocatjon); 
Bright; 
Write ( 	 C)1normal;writelo(9T9 No  
Write ( 
5);Bright;write(p');normal;wr - jte(are 
Writein; 
writeln; 
Write ( Or by Serum 
);bright;write( r);normal;writelneaction ); 
writeln;writeln; 
writeln('choose the field upon which to base your 
selection ) ;writeln; 
write(' 	Choice V,chr(IBH),(s,(tor-es cursors 
position) ]'); 
repeat 
write(chr(lBH), (u); (return cursor to stored position) 
bright; read (screen,choice) ;normal; 
Choice: =Caseup (choice); 
Until (Choice IN OK-Choice); 
writein; 
IF (Choice-'N') Then (select by Name) 
Begin 
count:=l; 	out:-true; 
While out and (Count<=selectable) do 
begin 
GoForName: =true; 
Write(Enter Id number- •,count:l, to be selected: ); 
For x:=t to namelength do s_name(count)(x):- 	; 
X­ 1; 
read (screen ,response); 
(response may be the first character of the string or It 
may be the symbol to show that an exact match is wanted) 
If (response<>) and (response<>chr(ord(lO)) ) then 
begin 
WI pm ( I) ; Writein; 
write (response); 
response: caseup (response); 
Exact _match(count): FALSE; 
x:2; s_name(count](1]:=response; 
(51) 	 (52) 
(convert response to the first 
character of the name) 
end Else 
begin 
write (chr (LBH) ' C iD'); (backspace) 
if (response<>chr(ord(13))) then begin 
write(' going for an exact match with the string'); 
writeln; 
end; 
Exact_match(count] z TRUE; 
(the symbol "" Shows that an exact match is wanted) 
end; 
If <reeponsechr(ord(13)) ) then 
begin 
writein(' END'); 
out:=false;x:=44; (<CR> has been entered as first 








x : x + 1; 
end; 
readin; 
(find position of first and last characters - assigning 
to OUT is meaningless) 
OUTz(len(posnl(count],posn2(count),snaee (count)) ); 
end; 
count count+l; 
end; todo count-2; 
clearecreen; wri teln; 
writeln( 'choosing 	 exact 
match ?'); 
for xs1 to todo do 
begin 
write(sname(x),' 
if (exact_match(x]) then writein('yes') else 
writeln( 'no'); 
end; 




end (if choice=N) 
ELSE ( if choic.<>N) 
Begin 
GoForName;-faise; 	serumoniy;=faise; 
Case Choice of 
'1': field; batch; 
'D':field:date; 
'X';fieldisex; 
'B' ,field, -breed;  
L':field:=location; 





If not serumonly then 
Begin 
Count:l; out:=true; 
while out and (Count<selectable) do 
begin 
for x:-1 to detail _length do s_f ieid[count](x):=' 
Write('Enter ',ID_Field(field),' ',count:i, 
to be selected: 
read (screen ,response) 
(response may be the first character of the string or 
the symbol "i" to show that an exact match is wanted) 





response: caseup (response); 
Exact _match (count]: FALSE; 
x:=2; s_field(count]( i]:=response; 
(convert response to the first character of the name) 
end (if response)Eise 
begin 
write (chr ( 1BH) ' C 1D'); (backspace) 
if (response<>chr(ord(l3))) then begin 
write(' going for an exact match with the string'); 
wr i tel n; 
end; 
Exact _matchEcount] : =TRUE; 
(the symbol "s" shows that an exact match is wanted) 
end; (else response) 
If (response=chr(ord(13)) ) then 
begin 
writein(' END'); 
out:=false;x:44; (<CR> has been entered as first 
character so EXIT) 
s_fjeid[count](l]:=' 
end (if response)eise 
begin 




x : =x + 1; 
End; (while x) 
read in; 
OUT:=(leneposnhlcount,posn2count],s_fjeld(couflt)) ); 
(until blank string is entered) 
end; (else response is not <CR>) 
(53) (54) 
Count: Count+l; 





writeln( 'choosing 	 exact 
match ?'); 
for x11 to todo do 
begin 
write(s_fieldtx),' 
if (exact_match(x]) then writeln('yes') else 
writeln('no'); 
end; 
Writeln;Write('press any key to continue....); 
read (screen ,response); 
wipe(30) ;writeln; 
END(i+ not seruinonly) 
ELSE (selection by serum reaction) 
BEGIN 
(now read the serum -names to be selected) 
x:l; out:fa1se; 




FOR Count:1 TO serum_length DO Select[Count]:=' ; 
writeln; 
write( 'enter the name of serum ',x: 1,': 
Count: =1; 
While not(eoln(input)) and (Count<=serum_length) DO 
BEGIN 
read (Select(count]); 




IF select<> 	 then 
begin 




Until (serum_panel (Eachser-um)=select) OR 
(Eachserum>=allsera) 
IF (serum _panel CEachserum)=select) THEN Found:TRUE 
ELSE writeln(select,' not found in ,batchfilname); 
end else out:TRUE; (if select is empty) 
UNTIL ( (Found) or (out) ); 
IF not out then 
BEGIN 
Test (x ]: Eachserum; Opened: true; 
Repeat 
opened: true; 
write(select animals pos or neg for ',select,'? (+1-)'); 
read (screen ,choice); 
case choice of 
:wanted(x]:=true; 




x : x + 1 
END;(if not out) 
END; 
todo: x-1; 
writeln;writeln(selectjon will be by those ',todo:l,' 
sera'); 
wri teln; 




clearecreen; moved:=ø; seen:=; 
writeln;writeln;wri teln; 
if not serumonly then 
begin 
write( 	selecting by ,todo:l,' strings in the 
IF goforname then writeln('name') else 
writelnCid_field[field], field'); 
end 
else writeln('selecting by ',todo:l,' serum reactions'); 
If reject 
then writeln('rejects being written to ,reiectfilname); 
Write(chr(lBH),'[1;5H','Anima1s read from ' ,Infilname); 




C 	 READ THE DATA 	 ) 




If GoForName then (if selection is by name) 
begin 
Count: 1; OK: =4a1 Se; 













s_name [ count ] pos3 pos4 resul ts. name 
THEN 
begin 
(55) 	 (56) 
wr I te ( out 4 1, resul ts) ; moved : moved+l; 
wri te(chr (IDH) , 'C 12;55H' ,moved: 1); 
OK: =true; 
end; (if subin) 
end;(if len) 
Count: Count + 1; 
end; (while count) 




IF not serumonty then 
BEGIN 
ok:=false; 
If (lena(pos3,pos4,results.details(field)) ) then 
begin 
Count: = 1; 
While (count<todo) and not OK do 
begin 
If ((NOT Exact match[count])  
begin 





normal;wr1te1n;write1n;wrAte1nmove:j, records copied 
into ,outfilname); 




(subin8(posnl (count) ,posn2(count) ,s_fieldlcount) ,pos3,pos4 
,results.detailstfield])) 







write (chr ( 1BH) ( 12; 55H ,moveth 1) 
OK: true; 
end; (if subin) 
Count: =Count+1; 
end; (while count) 
end; (if len) 
if not ok and reject then write(rejectfile,results); 
END 
ELSE 
begin (select by serum) 
repeat 
if results.serums(test(x]] in p05_scores then 
begin 
if wanted(x] then ok:true else oki=false; 
end 
else begin if not wanted(x) then ok:true else 
ok: fa1 se; end; 
x: x + 1; 
until (not (ok) or (xtodo+l)); 
if ok then 
begin 
write(outfilresults);moved:moved+L; 
write(chr(lBH) • (12;55W ,moved: I); 
end else 
(S7) 	 (SB) 
Gene fregygegy 
Program CHISO (ioput,output,currentfile,serafile); 
CONST 	Ailsera 	=24; 	(max number of sera) 
Serum- length= 8; (length of serum names) 
Name- length = 4; 	(length of animals name) 
Page_length = 	 (number of lines per page) 
TYPE 	One_to_ten 	1.. 
One _to_eight=l.. B; 
Maxno 	1. .Allsera; 
Set _of_fields- 
(batch,date,sex , breed,location,sublocatlon,CBTS,spare); 
Set _of _scores=SET OF CHAR; 
Panel=Arraytmaxno] of packed 
array[l. .serum_length) of char; 
Rec_of _resul tsRECORD 
Name:Packed array(l. .Name_length] OF CHAR; 
Details:Array(set_of_fjelds] OF Packed 
array[One_to_eight] of char; 
Serums:ArraylMaxno] OF Char; 
END; 
BOLAfi1eFILE OF Rec_of_results; 
TOTALS= ArrayCi. .2] of array (maxno] of integer; 
VAR 	Results: 	 Rec_of_results; 
Test serum: 	 packed 
arrayCi. .serum_length) of char; 
Serum _panels 	 panel 
validchi, 
loop,X,Count: 	 Integer; 
Found: 	 Boolean; 
Nogo: Ar-rayCi. .2] of boolean; 




NoScores; 	 TOTALS; 
Seeni 	 Arrayti. .2]of integer; 





Datajfname: 	 STRINGCI21; 
Currentfile: BOLAfile; 
printer, 
Serafile: 	 TEXT; 
totaichi, 
chi sq, 
gf ,af ,sd: 	 LONGREAL; 
(gene frequency,antigen frequency,standard deviation) 
total: 	 Arrayll...23 of longreal; 
FUNCTION YESNO (Default:CHAR; 
Message: STRING) : BOOLEAN; EXTERNAL; 
Procedure Normal 	;EXTERNAL; 
Procedure CI earscreen; EXTERNAL; 
Procedure Reverse 	;EXTERNAL; 
FUNCTION Caseup (letter: CHAR):CHAR;EXTERNAL; 
FUNCTION calc(total ,poss:integer ;var gf:longreal; 
var af:longreal; 
var 
sd: longreal) :BOOLEAN; 
(A FUNCTION FOR CALCULATING ANTIGEN FREQUENCY, GENE 
FREQUENCY AND STANDARD DEVIATION. IT RETURNS TRUE IF THE 
CALCULATION IS PERFORMED FALSE IF NOT WHEN THE VALUES 
RETURNED ARE ZERO, THIS HAPPENS IF TOTAL <= 0 TO AVOID A 
DIVIDE BY ZERO ERROR AND IF POSS-TOTAL TO PREVENT A SO 
ROOT OF ZERO ERROR) 
var lrposs,Irtotal : longreal; 
begin 
calc:true; 
IF(tota1)-) AND (total>poss) then 
begin 
lrposs:=poss; irtotal :total; 
af : =poss/total; 
gf: (1 (sqrt (1- (poss/total) ))); 
sd:sqrt(gf/(2*total)); 
end 
else begin calc:false; af:; gf:B; sd:0; end; 
end; (calc) 
Function calcchisq(posl,pos2,negl,neg2:integer;var 
chisq:Iongreal ) :boolean; 
(a function for calculating chi-square it returns TRUE if 
the calculation was performed and FALSE if it was not 
(because an expected value is <=1)) 





total 2: pos2+neg2; 
IF (totall>0) and (total2>0) then 
begin 
exposi : = 
((posl-I-pos2) / (totall+total2))*tota1l; 
expos2: 
((posl+pos2) / (totall+tota12))etotal2; 
cx neg 1: = 
((negl+neg2) / (totall+total2))*totall; 
exneg2: = 
((negl+neg2) / (totall+total2))*total2; 
(now calculate chi-sq) 
If (exposl>l) and (expos2>1) and (exnegi>l) and 
(exneg2>1) then 
chisq:- 
(sqr(posl-exposl) / exposi) + 
(sqr(pos2-expos2) / expos2) + 
(sqr(negl-exnegl) / exnegl) + 
(sqr(neg2-exneg2) / exneg2) 
else begin chi sq: 0;calcchisq:=f alse; end; 
(59) 	 (60) 
end else begin chisq:;caicchisq:=faLse;end; 
end; (calcchisq) 
BEGIN 
ci ear screen; 
FOR X:1 TO 8 Do writein; 
wri tel n C  
writeln( 	 Chi-square 
wri tel n C 
writeln;writeln;writeln;writeln;-iteln; 
writeln(sjk 11/10/84); 
For X:1 TO 60 	do; 
REPEAT (a loop around the whole program) 
clearecreen; 
FOR Count:1 to allera do 
begin 
For X:=l to Serum_length do Serum_panel(Cnunt) (X) i= 
end; 
(now open the files with the data) 
REPEAT 
write(Fjrt File with BoLA datat ); 
readln(datalf name); 




write('Second File with BoLA data: 
readln (data2f name); 
IF NOT Fstat(data2f name) THEN writeln (There is no file 
,data2f name); 
Until (Fetat (data2f name)); 
(open the file holding the serum panel) 
REPEAT 
Write(File with serum panel: 
readln(seraf name); 
IF Not Fstat(serafname) Then writeln ('There is no file 
,seraf name); 
UNTIL (Fetat (seraf name)); 
Assign(serafile,serafnaine); reset(serafile); writeln; 
assi gn (printer 'pm ) ; rewrite (printer 
IF (Vesno('x , 'count 4 as -ye') )Then Posscores:=( 'B', '6') 
ELSE Posscores:=( '8', '6', '4'); 
(fill the array serum panel with the serum names) 
Panel_size: 0; 
WHILE (Panel_size<=Allsera) AND (NOT (eof(Sera_file))) DO 
BEGIN 
Panel _size: Panel_si ze+l; 
Count:1; 
While NOT eoln(Sera_file) and (Count <=6) DO 
BEGIN 




END; 	(white panel size) 
(the serum names are in the array Serum_panel)  
(and the variable panel_size is equal to the number u4 
sera in the panel) 
(initialise th arrays holding the counts) 
For loop:=l to 2 do 
begin 









Write(chr(lBH),'(l;5H, Animals read from 
,dataifname); 




(**loop to look at each file**) 
For loop:=i to 2 do 
begin 
If (loop=l) then Assign(currentfiie,datalfname) 
else 	 Assign (currentfile,data2f name); 
reset (currentfj le); 
(**loop to look at each animal in the file**) 
While not eof(currentfile) do 
begin 
read(currentfile,results); 
IF (results,name(l)<)'') THEN 
BEGIN 
scent loop): seen(loop)+l; 
IF loop=l then write(chr(lBH),'(i2;1H',seen(j]:l) 
else 
write(chr(iBH),'112;5H',seen(2):l); 
(**loop to look at each serum of one animal**) 
For Count:=l to panel_size do 
begin 
IF NOT (Results.serums(Count)='.') THEN 
BEGIN 
IF Results.serums(Count) IN Posecores Then 
PlusScores(loop) (count):=PtusScorestloop) tcount)+l 
Else NegScores[ioop] (count]:=NegScores(loop] (count]+l; 
END 
ELSE 	NoScorestloop] Ccount):= NoScores[loop] (count)+l; 
end; (for count) 
end;(if not C) 
end; (while not eof) 
end; (for loop) 
writeln(printer.chr(ØCH)); (form feed) 
write(printer,chr(lBH),!,chr(rd(g)) ); 
(set print style 8) 
IF (4 IN Posscores)THEN 
Write(printer,' 4 is considered +ve' ,chr(DH)) 
(61) 	 (62) 
ELSE write(printer, 	4 is considered -ye ,chr(ODH)); 
wr I teln ( printer ) ; wr item ( pr mt er ) 
write(printer,datalfname, containing ,seen(1):5, 
animals 
',data21name, containing ,seent21:5, 
animals ,chr(ODI-4)); 
wrxteln(printer, - - 
writeln(printer); 
eriteln(printer); 
write (printer, SERUM); 
for x:1 to 2 do 
write(printer, 	agen freq(V.) gene freq SD 	•); 
writeln(printer, CHI SO 	Significant ?); 
writeln(printer); 
totalchi:0; validchi:0; 
For Count:l to panel_size do 
begin 
Write(printer,Serum_panel (Count), 









tested,plusscores(loop)(count]:5, +ve 	); 






If chisq>10.03 then 
write(printer,chr(1BH),Y,chr(ord(24)) ); 
(set print style 24) 
write(printer, 	,chisq:10:2); 
IF chisq>2.7 then 
begin 
IF not (chisq>384) then 
writeln(printer,' 	P10 V. a) else 
begin 
IF not (chisq>6.63) then writeln(printer, 	P=5 
Z **) else 
begin 
IF not (chisq>10.83) then writeln(printer, 	P=I 
7 ***)else 
writeln(printer, 
P<0.1% **** ,chr (1SH) , 	,chr Cord (8)) I; 
end; 
end; 
end else writeln(printer-, 	NOT S16); 
end  
else writeln(printer, 	an expected value ( 1'); 
end; (for count) 
writel n (printer); 
writeln(printer, 	 ,validchi:5, 
CHI SO CALCULATIONS WERE MADE - THE SUM OF 
THESE CHI SOs IS , 
totalchi: 10:4); 
writeln(printer, 	 MEAN 
1S , total chi/validchi: 10: 4) 
normal; er i teln; wri teln; 
UNTIL NOT (Yesno(X,'Make another chi square comparison*)); 
Chain ( B0LA); 
END. 
(63) 	 (64) 
Cluster 
PROGRAM cluster (INPUT, OUTPUT, INDATAFILE, OUTDATAFILE, 
OLDPANELFILE, NEWPANELFILE,cIsFILE); 
CONST 	Alleera 	=240; 
NAME _LENGTH 	40; 
Serum _length 6; 
Detail _length 8; 
Maxclstr 	40; 
maxperclstr 	40; 
TYPE 	Maxno=l. .Allsera; 
Set _of_fields 
(batch ,date, sex ,breed, location ,sublocation, 
CBTS,Spare); 
Rec_of _resul tsRECORD 
Name:Packed Arrayll. .naine_length) of char; 
Details:Array[set_of_fields] of packed array 
Cl. .detail_length] of char; 
Serums:Arraylmaxno) of char; 
END; 
Snames = Array[Maxno] OF Packed 
ArrayCl. .serum_length] OF CHAR; 
BOLA4 lie 	=File Of Rec_of_results; 
VAR 	Clstrname: Arrayti. .rnaxclstr) of Packed 
Arrayll. .serum_length) of char; 
Panel sera: 	Arrayll. .Allsera) of packed 
arrayli. .6) of char; 




Temp: 	 packed arrayti. .serum_length] of 
char; 
Totalclstrs: I. .maxclstr; 
Totalsera: 	Array (1. .maxclstr) of 1. .maxclstr; 
Results: Rec_of_results; 
Out 	: 	Arraytl. .2] of boolean; 
Found ,Opened: 	BOOLEAN; 
order 	: 	ArrayCi. .Maxclstr) OF 
arraytl..maxperclstr] of maxno; 
Pas _scores: 	SET OF CHAR; 
Choice: 	 CHAR; 





Indatafile, Outdatafile: 	BOLAfi1e; 
(the pascal non text files) 
Clsfi le, 
(the file with cluster details) 
Oldpanelfile, Newpaneifile: 	TEXT; 
(the two panel files) 
FUNCTION VESNO (Default:CHAR; 
Message: STRING) : BOOLEAN; EXTERNAL; 
PROCEDURE Clearecreen; EXTERNAL; 
PROCEDURE Bleep; 	EXTERNAL; 
FUNCTION Caseup (letter: CHAR):CHAR;EXTERNAL; 
BEGIN 
Cl earscreen; 
Writeln('This program adds reactions to the animals in the 
input file); 
Writeln( corresponding to the presence or absence of 
clusters'); 
writeln('defjned in the CONTROL file); 
REPEAT 
writein; 
write('Input File: 	); 
readln(Indatafilename); 
IF NOT Fstat(Indatafilename) THEN Writeln(Ther-e is no 
file 	,Indatafilename); 
UNTIL 	(Fstat(Indatafilename)); 




write('file with serum names(the batch). 	); 
readln(oldpanelfilename); 
IF NOT Fstat(oldpanelfilename) THEN 






write(file with clustering data (CON" 	keyboard); ); 
readln(clsfilename); 
If not 	( 	(clsfilename=con) or 	(clsfilenameCON) ) then 
begin 
IF NOT Fstat(clsfilename) THEN Writeln(There is no file 
,clsfilename); 
end else clsfilename:=CON; 
(changes lower case to upper case) 
UNTIL ( 	(Fstat(clsfilename)) or (clsfil.nameCON) ); 
Assign (clsfile,clsfilename); 
reset (clef i le); 




Write(*Output file: 	); 
Readin (Outdatafi menace); 
IF Fstat(Uutdatafilename) THEN 
BEGIN 
IF Yesno(X,'Thls file exists OF to modify it) 
Then 	Opened:TRUE 
ELSE 	Opened: FALSE; 
END; 
UNTIL (Opened); 
(65) 	 (66) 
Assign ( outdataf ile , Outdataf ilename) 
if fstat(Outdatafilename) then 
begin 
Repeat 
write(overwrite ,Outdatafilename,' or append 7 (0/A)'); 
readln(choice); 
wri tein; 
case choice of 
'a', 'A' : Append (outdataf ii.) 










Write('File for new batch file! 
Readln(newpanelfilename); 
IF Fstat(newpanelfilename) THEN 
BEGIN 
IF Vesno('X','This file exists OK to delete it') 
Then OpenedaTRUE 





FOR Count:1 TO alleera DO 
BEGIN 
FOR X:1 TO serum_length DO 
Panelsera[Count](X]:' 
END; 
C fill the array Panel_sera with the names of the sera) 
Eachseruma l; 




WHILE NOT EOLN (01 dpanel FILE) AND (COUNT<=SERUPI_LENGTH) DO 
BEGIN 
Read(Oldpanelfi te,Panelsera(Eachserum]tCount]); 
Panel _sera[Eachserum] (Count] a 
Caseup (Panel _sera[Eachserum] (Count]); 
Count: Count+ 1; 
END; 
Readln(Oldpanelfile); 
Eachserum: Eachserum+ 1 
END; 
number _in_batch: eachserum-t 
For count:1 to maxclstr do 
begin 
for x:l to serum_length do clstrname(count](x]a'  
end: 
Pos_scores:=(8,6]; 
Eachclstr:l; outtl ]:false; 
while (eachctstr<=anaxclstr) and not out(l) do 
begin 
wri tein; 
If (cisfilename='CON) then(if reading from keyboard) 
write('Enter name of cluster ,eachclstr:l,: ); 
while not eoln(clfile) and (x(=serum_length) do 
begin 
read(clsfile,clstrname(eachclstr](xfl; 
x : =x + 1; 
end; 
readln(clsfile); 
If (clstrname(eachclstr](>' 	1 then 
begin 
Eachserum:=l; out(21:=false; 
While (Eachserum<=maxperclstr- ) and not out(2] do 
begin 
REPEAT 
If (c14i lename='CON')then 
(if reading from keyboard) 
Write('Enter name of serum ',Eachserum:l, 
of cluster ',clstrname(eachclstr]); 
For x:=l to serum_length do temp[x]:' p 
x : 
While not eoln(clsfile) and (x(serum_length) do 
begin 
read (cisfi le,temp(x]); 
Temp(X]:=Caseup (Tempix)); 
x : x + 1; 
end; 
readln(clsfile); 
If not (temp' 	') then 
begin 
(find the position of this serum in the panel) 
X:=l; found:=faise; 
While (x<number_in_batch) and not found do 
begin 
If (tempPanel_sera(x]) then 
begin 
found: true; 








total sera(eachcl str] a eachserum- 1; 
end; 
Until( (found) or out(21); 
Eachserum: eachserum+l 











for x:1 to totalcistre do 
begin 
writeln(cletrnameCx), has ,totalsera(x), sera); 
end; 
(now create the new batch file) 
For x:=l to number - in-batch do 
writeln(newpanelfile,Panel_sera(x]); 
for xi1 to totalcistre 	do 
writeLn(newpanelfile,cletrnameEx]); 
C 	 NOW READ THE DATA FILE ) 
writeln;write( Wait); 
While not rof(iodatafilp) do 
begin 
Read(indatafile,Results); 
For Eachclstr:l to totalcistre do 
begin 
Eachserum:1; OutEl):false; 
While (Eachserum<totalsera(eachclstr]) and not outti] do 
begin 
If not (Results.ser-ues(order(eachclstr](eachserum] 
in poe_scores) then 
out(1],true; 
Eachserumi eacheerum+i; 
end; (while eachserum) 
If not outCi) then 
Results. ssrums(number_in_batch+eachclstr), 8' 
Else 
Resu1ts.eerums(number_iri_batch+eachc1str)i.- ; 
end; (for eachclstr) 
Write(outdatafile,Reeults);write('.') 
end; (while not eof) 
WRITELN( done'); 
Chain ( BoLA'); 
end.  
IO_çI Data files 
PROGRAM FORPAS (INPUT,OUTPUT,Sourcefi 1 ,Targetfi 1); 




TYPE 	Maxno 	 l. .Allsera; 
Set _of_fields 
=(batch,date.sex,breecj,locatjon,sublocation, 
CBTS, Spare) p 
Rec_of resul tsRECORD 
Name:Packed Array(l. .name_length) of char; 
Detai1s:Array(et_of_4jelds] of packed array 
(I. .detail_length] of char; 
Seruins:Arraytmaxno] of char; 
END; 
BOLA4i1e -File 04 Rec_of_results; 
VAR 	X,Copy a 	 integer; 
Opened: BOOLEAN; 
Target 4 A lname, 
Sourcefilname: string[12]1 
Sourcefil, Targetfili 	BOLA4ILe; 
(the pascal non text files) 
FUNCTION YESNO (DefaultaCHAR; 
Message:STR INS): BOOLEAN;EXTERNAL; 
FUNCTION Caseup (letter: CHAR):CHAR;EXTERNAL; 
PROCEDURE Clearscreen; EXTERNAL; 
BEGIN 
Cl earecreen; 
writeln('This program merges files written in the'); 
writeln(PASCAL format. Data is read from the SOURCE); 
writeln('f Ale and appended to the contents of the'); 
writeln('TARGET file. If the TARGET file does not); 
writeln('exist a new file is opened'); 
writelo; (open the file to be added) 
REPEAT 
write (SOURCE filet 
readin (Sourcef A lname); 
IF Not (Fstat(Sourcefilname)) 
Then writeln('no file ',Sourcefilname); 
UNTIL (Fstat (Sourcefi lname)); 
Assign(Sourcefil,Sourcefilnaee); Reset(Sourcefil); 






IF Fstat(Targetfilname) THEN 
BEGIN 
IF Yesno('X','Thjs file exists 01< to append to it') 
Then Opened:=TRUE 
ELSE Opened: FALSE; 
END; 
(69) 	 (70) 
UNTIL (Opened) ; 
Assign(Targetfil,Targetfilname); Append(TargetfLl); 
writeln;writ.ln(How many animals to copy ?: ); 
writeln( This number EXCLUDES "deleted" records which will 
not be copied); 
write(Number: '); readln(copy); 
X:1; writein; write(wait); 
(**a************** READ THE FILES ) 
WHILE NOT eof(Sourcef ii) and (x<-copy) DO 
BEGIN 
IF (Sourcefil'.namell]<>'C) Then 
begin 
Targetf ii': Sourcef ii'; 
x,=x+l; write('.'); 
Put(Targetfil); Get(Sourcefil); 
End else get (sourcefil); 
END; 
Writeln; 
Writein ( (x-1): l, Records copied*); 
chain( BOLA); 
END. 
PROGRAM Pascal Fortran (INPUT,OUTPUT,FORFIL,PASFIL); 
CONSI ALLSERA 	 =240; 
NAMELENGTH 	=40; 
Serum length =6; 
Detail_length 	8; 
TYPE 	Maxno 	 =1. .Allsera; 




Name;Packed Array(l. .name_l,ngth] of char; 
Details:Array[set_of_fields] of packed array 
11. .detail_lengthl of char; 
Serums:Arraylmaxno) of char; 
END; 
BOLAfile 	=File Of Rec_of_results; 
VAR 	X,Count,Copy: 	integer; 
Results: 	Rec_of_results; 
Eachfield: Set _of_fields; 
Opened: 	 BOOLEAN; 
Pasf ii name, 
Forfilname: 	string(12]; 
Pasfil: 	 BOLAfile; 
(the pascal non text file) 
Forfil: 	 TEXT; 
(the fortran text file) 
FUNCTION YESNO (Oefault,CHAR; 
Message: STRING): BOOLEAN;EXTERNAL; 
FUNCTION Caseup (letter: CHAR) :CHAR;EXTERNAL; 
PROCEDURE Cl earecreen; EXTERNAL; 
BEGIN 
Writeln(lhis program converts data files from the); 
Writeln(PASCAL formatto the FORTRAN format); 
(open the PASCAL file) 
REPEAT 
write (PASCAL file: ); 
readln(pasfilname); 




(open the FORTRAN file) 
REPEAT 
Opened: TRUE; 
Write(FORTRAN file: ); 
Readln (Forfi lname); 
IF Fstat(Forfilname) THEN 
BEGIN 
IF Yesno(X,lhis file exists OK to erase it) 
Then Opened:TRUE 
ELSE Opened: FALSE; 
END; 
UNTIL (Opened); 
(71) 	 (72) 
Asjqn(Forfil,Forfi1namo); Rewrite(ForfiI); 
r 1 tel n; 
wrte(How many animals do you want to be copied ?: ); 
readln(copy); 
WHILE NOT eof(Pasf it) and (x(copy) DO 
BEGIN 
Read (Pasfi 1 ,Aesults); 
Writeln(Forfil ,Results.Name); 
For Eachfield:=Batch to Spare do 
Write(Forfil,Results.Details(Eachfjeld) ); 
writein (Forfi 1); 
For Count:1 TO 128 DO 
Write(Forfil ,Results.Serums(Count)); 
Writelo(Forfil); 
For Count:121 TO Alleera DO 
Write(Forfll ,Results.Serums(Count]); 
Writeln(Forfil); 
IF (X/10X div 10) then writeln(X:l, copied); 
K =x + 1; 
END; 
Writeln; 
Writeln((x-1):i, Records copied); 
chain(BOLA'); 
END. 
Convert Fortran data to Pascal data 




Detail - length =8; 
TYPE 	Maxno 	 l. .Altsera; 
Set -of -field s 
CBTS,Spare); 
Rec_of resul tsRECORD 
Name:Packed Array(l. .name length) of char; 
Detai ls:ArrayCset_of_fields) of packed array 
Cl. .detail_length] of char; 
Serums:ArrayCmaxno) of char; 
END; 
BOLAfile 	 File Of Rec_of_results; 
VAR 	X,Count,Copy: 	integer; 
Results: 	Rec_of_results; 
Eachfjeld: Set-of _fields; 
Opened: 	 BOOLEAN; 
Pasf 1 1 name, 
Forfilname: 	string(12); 
Pasfil: 	 BOLAfile; 
(the pascal non text file) 
Forfil: 	 TEXT; 
(the fortran text file) 
FUNCTION YESNO (Default:CHAR; 
Message: STRING) : BOOLEAN;EXTERNAL; 
FUNCTION Caseup (letter: cHAR):CHAR;EXTERPIAL; 
PROCEDURE Clear screen; EXTERNAL; 
BEGIN 
Cl earscreen; 
Writeln('This program converts data files from the'); 
Writeln('FORTRAN format to the PASCAL format'); 
(open the FORTRAN file) 
REPEAT 
write (FORTRAN file: 
readln (forf I barns); 
IF Not (Fstat(forfjlname)) Then 
writeln('no file ',forfilriarne); 
UNTIL (Fstat(forfilnam&); 
Assign(Forfil,Forfilname); Reset(forfil); 
(open the PASCAL file) 
REPEAT 
Opened: TRUE; 
Write('PASCAL file: >; 
Readln(Pasfilnarne); 
IF Fstat(Pasfilname) THEN 
BEGIN 
IF Yesno(X','This file exists 01< to erase it') 
Then Opened:=TRUE 
ELSE Opened: FALSE; 
END; 
(73) 	 (74) 
It_ LLt_Qt_CQYtID 
SEGMENT KEMPLIB; 
procedure pasdate(VAR year,day: INTEGER;VAR ms:STRING); 
(extracts the system date and converts the month to a 3 
character name) 
(the integer month from the system is held in MONTH) 
(the character month is held in string MS) 
VAR month: INTEGER; 
procedure 	date(VAR year,day,month: integer) ;.xternal; 
(date" is the PROSPERO date procedure) 
begin(pasdate) 
date ( year ,day , month) 
case month of 
1:ms:'J4N'; 2;ms:='FEB'; 3:ms:-'MAR'; 4:ms: APR; 




FUNCTION YESNO (Default:CHAR; Plessage:STRING):BOOLEAN; 
( a routine which returns true if y OR V are entered) 
C returns false if n or N are entered) 
C the default may be defined as true, false or illegal 
(V,N or X)) 
VAR 	Answer: 	 CHAR; (holds the answer) 
Check: BOOLEAN; 
(true when valid answer received) 
Screen: 	 FILE OF CHAR; 
BEGIN 	 (yesno) 
Assign (Screen, 'CON') ;reset (Screen); 
Check: FALSE; 
WHILE CheckFALBE DO 
BEGIN 
Check: TRUE; 
WRITE (Message,'? (V/N):'); 
READ(Screen,Answer) ;writeln; 
IF ( Answer(chr(ord(13))) ) (<CR>) 
THEN CASE Default OF 




WRITELN('ERROR IN VESNO CALL (SJK)'); 
END 	(case Default of) 
ELSE BEGIN 
IF(Answer'y')OR(Answer-'V') THEN Vesnot-TRUE 
ELSE BEGIN 





writeln;write( }4ow many animals to be moved ?: •); 
readln (copy); 
WHILE NOT eof(Forfil) and (X<-Copy) DO 
BEGIN 
(reset the arrays holding name & details) 
For Count:1 TO Namelength do 
Results.Name(Couot]:= '; 
FOR Count:l TO Detail - length do 
Results.Details(Spare) [Count)i 	; 
Count: =1; 
While not (eoln(Forfil)) AND (Count<=Namelength) DO 
BEGIN 
Read (Forf ii ,Resul te. Name( Count]); 
Results.Name(Count]:=Caseup(Results.Name(Count)); 
Count: =Count+ 1; 
END; 
Readln(forf ii); 
For Eachfield:=Batch to CBTS do 
BEGIN 








While not (eoln(Forfil)) And (Count<Detail_length) DC) 
BEGIN 






For Count:l TO 120 	DO 
Read(Forf ii ,Results.Serums(Couot)); 
Readln(Forfi 1); 
For Count:121 TO Allsera DO 
Read (Forfil ,Results.Serums(Count)); 
Readln(Forf il); 
IF (X/l0X div 10) then writeln(X:l,' copied'); 
X;=X+l; 
Write (Pasf ii ,Results); 
END; 
Writein; 
Wrteln((x-1)z1, Records copied'); 
chain ( bol a'); 
END. 
END; 
END; 	(while check) 
(75) 	 (76) 
END: 	(Vesno) 
FUNCTION Caseup (letteri CHAR):CHAR; 
(This function converts lower case letters to upper case) 
(It leaves upper case and other characters unchanged) 
BEGIN (caseup) 
IF (ORD(letter)>=ORD('a)) AND 
(ORD(letter)<ORD(z )) THEN 
Caseup: =CHR CORD (letter) -32) 
ELSE Caseup=letter; 
END; 	 (caseup) 
Ca set of procedures for modifying the screen output) 
(their names should be self-explanatory 	 ) 
Procedure Unline 	;begin writeCchr(IBH),,C4m);end; 
Procedure Bright ;begin write(chr(IBH),(1m);end; 
Procedure Normal 	;begin write(chr(lBH),Cm);end; 
Procedure Clearscreen;begin Write(chr(IBH),C2J);end; 
Procedure Reverse 	;begin Write(chr(lBH),C7m);end; 
Procedure Bleep ;begin Write(chr(87H)); 	end; 
PROCEDURE WIPE (X: integer); 
(runs cursor x spaces back a line erasing as it goes '} 
var y:integer; 
begin 
for y:i to X do writeCchr(lBH),11D, 	,chr(IBH),E1D); 
end; 
FUNCTION Namecheck(filenamesstring):boolean; 
(checks that the string is an OK dos name without 
extension) 
(checks that is not too long so a truncated file is 
opened) 
begin 
If not (C C CPos(t,filename)2) and (length( 
filename)<lø) 
(if drive specified then 10 
characters allowed in filename) 
OR C (Pos(:,filenam.)<>2)and (length( filename)<8 ))) 
(or if drive not specified then only 0 characters allowed) 
AND (checkfn(filename)) 	(is legal DOS name) 
AND (Pos('. ,filename)0) ) (has no extension) 
(and is legal DOS name) 
then 
begin 
namecheck fal se; 
writeln(bad file name - use 8 characters plus 
optional drive specifier); 




else namecheck: true; 
end; (namecheck) 
BEGIN( KEMPLIB ) 
END. ( KEMPLIB I 
(77) 
